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Dynamics of the innate immune
response to infection:
a mathematical modelling approach
Sophie Vanessa Hiu-Lam Ip
The innate immune system plays a vital role in the control of infection, but many aspects
of its behaviour are not fully understood. In this dissertation, I use mathematical modelling
approaches to elucidate two linked processes which are key to the innate immune response
to Salmonella infection.
First, I consider the inflammasome, a large protein complex which forms in cells following
infection. The inflammasome is responsible for coordinating cell death and the release of
cytokines, which promote further activation of the immune system. Despite its importance,
there are many conflicting accounts of this process in the existing literature, and there is no
accepted single conceptual model of inflammasome formation.
In the first chapters of this dissertation, I present a suite of deterministic ordinary dif-
ferential equation models and discrete stochastic models which highlight different elements
of the inflammasome formation process. By comparing the results from these models with
an existing dataset describing the innate immune response to infection in macrophages, I
construct a cohesive conceptual model of inflammasome formation. In particular, I propose
a novel ‘branching’ mechanism of protein recruitment to the inflammasome complex. I also
show that variation in inflammasome formation times can arise from differences in the initial
abundance of NLR oligomers present in the cell prior to inflammasome formation.
The remainder of this dissertation focuses on the formation of clusters of infected cells (or
3
‘lesions’) in tissues following Salmonella infection. Inflammasome formation on the cellular
level is a crucial part of this larger-scale process; however, the precise downstream effects
of inflammasome-coordinated signalling and cell death in this context remain unclear.
In the later chapters of this thesis, I outline a spatial partial differential equation model
of lesion formation in liver tissue following Salmonella infection, with a particular focus on
motility of infected cells and multiple forms of cell death. Through use of Turing instabil-
ity analysis and simulated solutions of the lesion model, I show that the spatial structure of
lesions can arise simply through the interactions of infected and uninfected phagocytes, bac-
teria and a chemokine. I also demonstrate the importance of decreased motility of infected
cells, and a balance of different forms of cell death with influx of uninfected immune cells, for
the successful control of infection.
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1.1 The role of innate immunity in response to infection
The innate immune system is the human body’s first line of defence against infection. Its
basic roles in this context are the identification of pathogens, the clearance of infection, and
the promotion of further immune system activation - the latter may involve the recruitment
of other immune cells, the promotion of inflammation by the release of chemical signals
known as cytokines, and the activation of the adaptive immune system. The regulatory
systems which underlie the response to infection are complex, and rely on the coordination
of processes from the subcellular level through tissues, organs and organ systems to the
organism as a whole. Understanding how these processes function, and in particular, the link
between these scales, is key to understanding how the clearance of infection is managed.
This dissertation will focus on the response to Salmonella enterica infection. Salmonella
is responsible for life-threatening diseases in humans and animals, including enteric fevers
(with typhoidal serotypes of Salmonella responsible for typhoid fever in humans) and gas-
troenteritis. Enteric fevers are a particular cause for concern in human health, with around
14 million people affected per year, mainly in lower-income countries [Stanaway et al.,
2019]. Thus, understanding how the innate immune system contributes to the clearance of
Salmonella infection, and how this process can malfunction, is extremely valuable; moreover,
understanding how Salmonella is cleared will also give insight into innate immune system
more generally.
In particular, I will be examining two steps in the innate immune response to Salmonella
infection which occur on different timescales: inflammasome formation, a subcellular pro-
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cess which occurs on a timescale of minutes following the infection of an individual cell, and
the formation of lesions in the liver, which occurs on a timescale of days.
Broadly, there are two interconnected processes which coordinate response to infec-
tion at the cellular level. Firstly, receptors on the cell surface such as Toll-like receptors
(TLRs) may detect the extracellular presence of bacteria, leading to the transcription of pro-
inflammatory cytokines and the upregulation or post-translational modification (PTM) of pro-
teins involved in pro-inflammatory signalling pathways [Bauernfeind et al., 2009, Brubaker
et al., 2015, Swanson et al., 2019]; the latter processes prepare the cell for further responses
at a later stage. Secondly, bacteria are phagocytosed, but may survive and reproduce in a
vacuole within the cell, shielded from the extracellular effects of the immune system; this is
critical for the virulence of Salmonella [Fields et al., 1986]. However, innate immune cells
have evolved a tightly-mediated signalling cascade to counter this strategy of pathogen sur-
vival within the cell, which initiates cell death and the release of pro-inflammatory cytokines
(including chemokines which attract other immune cells to the infection site), as well as re-
ducing the motility of the cell [Stehlik et al., 2003b, Man et al., 2014a]. This signalling system
is coordinated by the inflammasome, a supramolecular complex which forms following in-
fection and is responsible for processing effector proteins and cytokines. Inflammasomes
are also involved in the response to intracellular detection of numerous other threats, either
pathogenic or related to cellular damage, and are therefore a key element of innate immune
signalling. Inflammasome dysregulation has also been associated with numerous conditions
including cancer [Lee et al., 2019, Tartey and Kanneganti, 2019, Velloso et al., 2019, Zhen
and Zhang, 2019], neurodegenerative diseases [Boxberger et al., 2019, Han et al., 2019],
and autoinflammatory conditions [Canna et al., 2014, Shin et al., 2019, Boxberger et al.,
2019]. Despite its importance, there are many open questions surrounding the purpose,
structure and formation process of inflammasomes, many of which are highly debated in the
existing literature.
However, naturally, within-cell processes are not the end of the story. The signalling
pathways at the single-cell level ultimately lead to downstream effects which have ramifi-
cations for much more than just the fate of the cell in question; the release of chemokines
and reduction of cellular motility are particularly relevant here. It is not fully clear how these
downstream processes contribute to the clearance of infection on a larger scale. The effects
of Salmonella at a tissue level are well-documented; in particular, during systemic infec-
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tions, infected cells in the liver and spleen become contained within foci known as lesions.
Once again, there are many open questions surrounding lesion formation, and their precise
role in limiting the spread of infection is debated. In particular, it is unclear how single-cell
processes such as inflammasome formation give rise to lesion formation at the tissue level.
The overall aim of the research presented in this dissertation is to shed light on these
two key elements in the innate immune response, and clarify the processes which are taking
place. There are two fundamental questions I wished to answer: namely, how do inflamma-
somes form? And why do lesions form? The results presented in the following chapters may
go some way towards clarifying these issues. Both questions are also linked to an implicit
third question: how does one link an understanding of small scale processes (for example,
structural studies of interactions between proteins involved in the inflammasome, or the ac-
tions of individual cells within a lesion) to an understanding of a larger-scale process which
arises from a large number of smaller scale processes (the formation of the inflammasome
or lesion as a whole)? In order to address these questions, I have used a mathematical
modelling approach. This is ideally suited to the third unifying question, since quantitative
analysis can give an insight into how many individual constituent parts in a system give rise
to an overall outcome. Mathematical modelling has not been particularly widely used in the
study of innate immunity, with the majority of work in this field being experimental in nature,
although in recent years the use of high-throughput technologies has necessitated the intro-
duction of statistical and computational approaches. However, the more abstract approach
of mathematical modelling, focusing on conceptual model creation and translation into math-
ematical systems, has been much rarer. There have been some previous studies modelling
the formation of lesions (these will be further explained in Section 1.7) but these have not
been particularly numerous, and do not focus on the scale-crossing aspects of this process;
models of inflammasome formation are even scarcer. As well as providing useful and inter-
esting results in their own right, it is my hope that the models presented in this dissertation
will motivate a repeating cycle of experimental work and mathematical modelling, as follows:
experimental work inspires a model by providing data and highlighting areas of a biological
system which are not well-understood; a model is then developed which may suggest expla-
nations for the behaviours observed by experimental work, as well as posing questions to
be addressed through further experimental work. Experiments should then be conducted to
verify the results of the modelling work and address the questions posed therein. However,
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this experimental work will inevitably bring to light even more areas which require further in-
vestigation, and thus the cycle repeats, with models and experiments becoming increasingly
refined. The work presented in this dissertation represents a first iteration of this cycle.
1.2 Structure of this dissertation
This dissertation broadly encompasses two separate but thematically-linked sections, with
the aims of modelling the inflammasome and lesion formation respectively.
In this introductory chapter, I will describe the relevant existing literature for modelling
both inflammasomes and lesions, from both biological and mathematical perspectives, as
well as outlining the research aims.
The first chapters of this dissertation are dedicated to inflammasome modelling; in Chap-
ter 2 I present an existing experimental dataset which motivates this research, and in Chapter
3 I present two novel mathematical models of inflammasome formation. Chapters 4 and 5
are dedicated to analysis of these models, and Chapter 6 links this analysis back to the ex-
perimental data presented in Chapter 2. Finally, in Chapter 7, I discuss the results of the
inflammasome modelling project.
I then turn my attention to the lesions modelling project. In Chapter 8 I present a novel
model of lesion formation, which I analyse using analytical and computational techniques
in Chapters 9 and 10. Finally, in Chapter 11 I discuss the results of the lesions modelling
project.
The dissertation concludes with a discussion of the broader implications of this research,
as well as suggesting avenues for further work, both mathematical and experimental.
1.3 The biology of inflammasome formation
Despite its importance, the process of inflammasome formation is not well understood.
There is a wealth of existing literature describing inflammasome formation on a structural
level; the domain architecture of inflammasome constituent proteins have been mapped,
and the modes of pairwise interactions between individual proteins has been documented.
The effects of inflammasome formation are also well-understood on the cell-wide scale; the
levels of inflammasome formation can easily be measured either by quantifying levels of out-
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put of cytokines or cell death (the downstream products of inflammasome formation) or by
observing the presence of inflammasome structures using microscopy techniques.
However, it is unclear how the system behaves between these two scales; in particular,
how combinations of the well-documented protein-protein interactions give rise to complex
structures containing thousands of individual proteins. Few experiments have been suc-
cessful in exploring the region between these scales, although this is currently an area of
considerable interest. Some confocal imaging experiments have established mid-scale ob-
servations about inflammasome structure, and there has also been some success with cryo-
electron microscopy (EM) techniques, but these approaches are all in their early stages.
Conceptual models have been proposed for the internal architecture of the inflammasome
structure, but these are often vague, are based on numerous assumptions, and have not
been properly motivated by experimental observation.
In the first section of this chapter, I will give an overview of the relevant existing liter-
ature surrounding inflammasome formation on these distinct ‘micro’ (structural) and, com-
paratively, ‘macro’ (whole cell-level) scales, as well as discussing previous attempts to unify
these scales to create a cohesive conceptual model of inflammasome formation.
1.3.1 The role of the inflammasome
The formation of the inflammasome is triggered by the activation of cytosolic pattern recogni-
tion receptors (PRRs), which occurs following detection of pathogen- or damage-associated
molecular patterns (PAMPs or DAMPs). PRRs then oligomerise and recruit a scaffold protein
which forms the bulk of the complex, which may also act as an adaptor [Fernandes-Alnemri
et al., 2007]. Finally, the scaffold protein recruits and processes a final effector protein.
These three classes of protein (PRR, adaptor and effector) together form the inflammasome.
Different PRRs are activated depending on the PAMP/DAMP; the PRRs involved in in-
flammasome formation are members of the NOD (nucleotide-binding oligomerisation domain)-
like receptor (NLR) family, AIM2 (absent in melanoma 2) and pyrin, with different PRRs re-
sponding to different PAMPs/DAMPs. Here we focus on the two most-studied NLRs, NLRC4
and NLRP3, since these are the best-characterised inflammasomes; however, many of the
approaches explored in this thesis could be applicable to inflammasomes based on other
PRRs.
NLRC4 is extremely specialised in its function; it is responsible only for the intracellular
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detection of Gram negative bacteria [Zhao et al., 2011]. However, its structure and mode
of oligomerisation have been extremely well studied. On the other hand, NLRP3 responds
to a wide variety of cellular threats, including bacterial, viral and fungal infections, as well
as various damage-associated signals and foreign irritants [Kanneganti et al., 2006, Warren
et al., 2008, Thomas et al., 2009, Allen et al., 2009, Gross et al., 2009]. A comprehensive
table of NLRP3 stimuli can be found in a recent review [Swanson et al., 2019]. The NLRP3
inflammasome has also been the focus of much experimental work since it can be activated
without the use of pathogens; in particular, a common method is to ‘prime’ the cell with
lipopolysaccharide (LPS) to upregulate NLRP3 and apply post-translational modifications
[Bauernfeind et al., 2009, Swanson et al., 2019]; this is followed by treatment with nigericin
to trigger inflammasome formation. In contrast, a common method for triggering NLRC4
inflammasome formation is to infect cells directly with Salmonella, often using fluorescently
labelled bacteria so that the infection state of the cell can easily be determined. However,
the mode of activation and oligomerization of NLRP3 are considerably more complicated
than those of NLRC4, and in particular, the structure of the NLRP3 oligomer has not been
studied in detail.
For inflammasomes including either of these proteins, the scaffold protein is apoptosis-
associated speck-like protein containing a CARD (ASC), which provides a platform for caspase-
1 processing via proximity-induced proteolytic activation [Stehlik et al., 2003b, Sanders et al.,
2015, Schmidt et al., 2016]. Caspase-1 is an effector protein responsible for the process-
ing of pro-inflammatory cytokines interleukin 18 (IL-18) and IL-1β, as well as gasdermin-D
(GSDMD) [Srinivasula et al., 2002, Dinarello, 2009]; following cleavage by caspase-1, the N-
terminus of GSDMD creates pores in the cell membrane, allowing cytokines to exit the cell,
and ultimately leading to pyroptosis, a lytic and pro-inflammatory form of cell death [Shi et al.,
2015a, Liu et al., 2016, Sborgi et al., 2016, Evavold et al., 2018, He et al., 2015]. It has also
been suggested that ASC specks are released from cells during pyroptosis and continue to
process cytokines, or may be taken up by other cells to initiate further ASC speck formation;
however, these theories are controversial [Franklin et al., 2014, Baroja-Mazo et al., 2014].
So-called ‘non-canonical’ inflammasomes, may also be activated by caspases other than
caspase-1, including caspase-4 and caspase-5 in humans [Baker et al., 2015], and caspase-
11 in mice [Kayagaki et al., 2011]; this leads to pyroptosis and cytokine release via secondary
activation of the NLRP3 inflammasome.
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Interactions in the NLRC4 inflammasome; NLRC4 recruits ASC via CARD-CARD interactions, and
ASC recruits caspase-1 via CARD-CARD interactions
Alternative characterisation of the NLRC4 inflammasome; NLRC4 recruits caspase-1 directly via
CARD-CARD interactions
Interactions in the NLRP3 inflammasome; NLRP3 recruits ASC via PYD-PYD interactions, and ASC
recruits caspase-1 via CARD-CARD interactions
Figure 1.1: Schematic of protein-protein interactions in the NLRC4 and NLRP3 inflamma-
somes; reactions have been simplified to be represented in two dimensional view.
1.3.2 Structural properties
Protein structures
NLRC4 and NLRP3 are both tripartite proteins. Both contain an N-terminal domain which
recruits ASC: a CARD (caspase activation and recruitment) domain in the case of NLRC4,
and a PYD (pyrin) domain in the case of NLRP3 [Oroz et al., 2016]. They also contain
a central nucleotide binding NACHT domain, and a C-terminal LRR domain [Ting et al.,
2008]. The three domains are joined by flexible linkers. ASC consists of an N-terminal PYD
domain and a C-terminal CARD domain, also joined by a flexible linker [de Alba, 2009].
Finally, caspase-1 consists of an n-terminal CARD domain joined by a flexible linker to P20
and P10 subunits; these are cleaved following activation [Martinon et al., 2002, Manji et al.,
2002, Boucher et al., 2018] . These structures are illustrated in Table 1.1. Proteins from
these families associate via homotypic PYD-PYD and CARD-CARD interactions; NLRP3
and NLRC4 recruit ASC via PYD-PYD and CARD-CARD interactions respectively, and ASC
then recruits caspase-1 via CARD-CARD interactions (Figure 1.1) [Masumoto et al., 2001,






Table 1.1: Schematic structure of proteins involved in inflammasome formation
NLRs in the inflammasome
NLRs are generally present throughout innate immune cells in the absence of PAMPs/DAMPs,
albeit in an autoinhibited form in which they cannot interact with other inflammasome con-
stituents. In the autoinhibited form of NLRC4 derived by Hu et al., the LRR hinges down to
occlude the other domains [Hu et al., 2013]. The precise mechanism of NLRP3 inhibition re-
mains unclear; while some studies suggest that the LRR is also responsible for autoinhibition
in NLRP3, this remains controversial [Hu et al., 2013, Hafner-Bratkovič et al., 2018, Platnich
and Muruve, 2019, Swanson et al., 2019]. For inflammasome formation to take place, NLRs
must be converted into an active form and oligomerize to ‘seed’ the inflammasome. This
activation and oligomerization process is controlled by a complex system of interacting reg-
ulatory processes, including gene expression, PTMs, and ligand binding.
Prior to cellular infection, NLRP3 expression is upregulated by pro-inflammatory stimuli
which themselves are induced by other pathways; other PRRs such as TLRs and nucleotide-
binding oligomerization domain-containing protein 2 (NOD2), as well as cytokines such as
tumour necrosis factor α (TNF-α) and IL-1β induce increased expression of NLRs via ac-
tivation of transcription factor nuclear factor κ B (NF-κB) [Franchi et al., 2009, Bauernfeind
et al., 2009]. NF-κB also induces expression of IL-1β which is not constitutively expressed in
macrophages [Bauernfeind et al., 2009]. These priming signals do not affect levels of ASC,
pro-IL-18 or pro-caspase-1 [Bauernfeind et al., 2009].
However, interestingly, a basal level of NLRC4 is sufficient for inflammasome formation,
whereas basal NLRP3 levels are not. It has been shown that various microRNAs are re-
sponsible for ensuring low levels of NLRP3 expression [Zamani et al., 2020, Boxberger et al.,
2019], although they may also be implicated in NLRP3 activation [Ojcius et al., 2019]. An
initial stage of cell ‘priming’ is required for sufficient levels of NLRP3 expression for inflam-
masome formation to be possible [Bauernfeind et al., 2009], except in the case of a few
‘alternative inflammasome’ pathways [He et al., 2013, Gaidt et al., 2016, de Carvalho et al.,
2019].
Following upregulation, various PTMs are necessary for inflammasome activation. In
NLRC4, some studies suggest that phosphorylation of residue Ser533 occurs following ex-
posure to Salmonella and is necessary for endogenous levels of IL-1β production and cell
death following infection. It has been suggested that protein kinase C δ (PKCδ) or leucine-
rich repeat-containing kinase 2 (LRRK2) may be responsible, as both have been shown to
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associate with phosphorylated NLRC4, and depletion of either protein results in reduced
NLRC4 inflammasome activation [Qu et al., 2012, Matusiak et al., 2015, Liu et al., 2017].
However, the importance of Ser533 is debated [Tenthorey et al., 2020]; furthermore, it is not
clear what precise effect this phosphorylation may have on NLRC4 activation. It is possible
that phosphorylation of Ser533 may have an important role in stabilising NLRC4 in its active
form, but is insufficient for full NLRC4 activation alone.
The picture of regulation of NLRP3 via PTMs is somewhat more complicated; to date
at least 13 phosphorylation, ubiquitination and sumoylation sites have been identified in
NLRP3, some of which activate, and some of which inhibit or have no effect on inflamma-
some activity [Kelley et al., 2019, Swanson et al., 2019, Yang et al., 2019]. It has been
suggested that priming via PTMs prior to activation is a necessary prerequisite for full acti-
vation, although it is currently unclear how these PTMs are regulated.
Subcellular location of NLRP3 during inflammasome activation has also been shown to
play a significant role. Different studies appear to show conflicting results, although there is
a general consensus that during inflammasome formation, NLRP3 colocalises to the Golgi
and endoplasmic reticulum near the nucleus. Mitochondrial clustering and association with
NLRP3 has also been observed [Zhou et al., 2011, Misawa et al., 2013, Li et al., 2017]. It
has been demonstrated that NLRP3 associates with microtubule-affinity regulating kinase
4 (MARK4), which drives its movement along microtubules to the microtubule-organizing
centre [Li et al., 2017]; disruption of MARK4 decreases, but does not completely abrogate
inflammasome formation. Neither movement along microtubules nor mitochondrial cluster-
ing appear in association with NLRC4 inflammasome formation, although it has been shown
that actin polymerisation is necessary for inflammasome formation [Man et al., 2014a], sug-
gesting a role for the actin cytoskeleton in NLRC4 inflammasome formation which may be
similar to that of the microtubule network in NLRP3 inflamamsome formation.
A final method by which NLR oligomerization is regulated is interaction with pyrin-only
proteins and CARD-only proteins (POPs and COPs respectively). These proteins, which
are present only in primates, bind to NLRs via PYD-PYD and CARD-CARD interactions,
so that these domains are unavailable for interaction with other inflammasome constituents.
These proteins therefore act as a negative regulatory mechanism for inflammasome forma-
tion [Stehlik et al., 2003a, Dorfleutner et al., 2007a, Dorfleutner et al., 2007b, Atianand and
Harton, 2011]. NF-κB and IL-1β both upregulate the expression of POP1 and POP2, sug-
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gesting a negative feedback mechanism [Atianand and Harton, 2011, Bedoya et al., 2007].
However, it remains unclear how any of these regulatory processes are themselves con-
trolled, and to what extent they are important.
These regulatory processes in isolation are insufficient to prompt full NLR activation. In
the case of NLRC4, binding of a PAMP is necessary; this is an indirect interaction via an
intermediary neuronal apoptosis inhibitory protein (NAIP). Four NAIPs have been identified
in mice, although only one is present in humans. It has been demonstrated that during
Salmonella enterica serovar Typhimurium infections in mouse cells, different NAIPs recog-
nise different Salmonella-associated PAMPs. NAIP1 recognises PrgI and NAIP2 recognises
PrgJ, both constitutents of the type III secretion system (T3SS); NAIP5 and NAIP6 both
recognise flagellin [Lightfield et al., 2011, Zhao et al., 2011, Yang et al., 2013, Tenthorey
et al., 2014]. In human cells, the single human NAIP recognises multiple PAMPs, including
elements of the T3SS in multiple species of bacteria, as well as flagellin from Salmonella.
In all cases, these interactions take place via ligand binding, changing the conformation of
the NAIP involved so that it may in turn form a complex with, and activate, NLRC4 [Hu et al.,
2015, Zhang et al., 2015, Tenthorey et al., 2017, Yang et al., 2018].
The activation of NLRP3 is somewhat more complex. NLRP3 does not interact directly
with the many PAMPs and DAMPs it recognises, but instead appears to be affected by the
downstream effects of the PAMP or DAMP in question on the intracellular environment. No
single activating effect has been isolated, but links have been established with processes in-
cluding potassium and chloride ion efflux from the cell [Verhoef et al., 2005, Muñoz-Planillo
et al., 2013], calcium ion flux [Murakami et al., 2012], the production of reactive oxygen
species (ROS) [Cruz et al., 2007, Dostert et al., 2008], lysosomal disruption [Hornung et al.,
2008], and mitochondrial dysfunction [Zhou et al., 2011, Shimada et al., 2012]. In partic-
ular, potassium ion efflux is often cited as a putative underlying common feature to these
conditions, although it has been shown that NLRP3 inflammasome formation can occur in-
dependently of potassium ion efflux [Meng et al., 2009, Groß et al., 2016, Sanman et al.,
2016]. It is possible that NLRP3 inflammasome formation is in fact activated combinatorially
by these different cellular conditions, with high overall levels of one or more such factors
leading to activation.
Notably, spontaneous inflammasome activation appears in a number of autoinflamma-
tory conditions including macrophage activation syndrome (MAS), and cryopyrin-associated
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periodic syndromes (CAPS). Both of these conditions are caused by mutations in the genes
encoding NLRC4 and NLRP3 respectively, which cause spontaneous oligomerization and
thus inflammasome activation in the absence of DAMPs/PAMPs [Meng et al., 2009, Canna
et al., 2014, Moghaddas et al., 2018].
Following activation by interaction with a PAMP/DAMP, NLRs may then propagate their
active forms to other NLRs still in their autoinhibited form via complex formation. Activation
of a single NLR therefore precipitates a chain reaction of NLR activation, and the formation
of an oligomer consisting of active NLR monomers. In the case of NLRC4, the formation
of this oligomer has been studied through the use of cryo-EM. The structure of a NAIP5-
NLRC4 complex has been determined by Zhang et al. [Halff et al., 2012, Zhang et al.,
2015], and the structure of a NAIP2-NLRC4 complex has been determined by Hu, Zhang
and others [Hu et al., 2015, Zhang et al., 2015]; notably both the Hu and Zhang studies
use NLRC4 with the CARD domain removed. Active NLRC4 monomers form complexes via
interactions between NACHT domains. However, the precise form of the NLRC4 oligomer
remains controversial. Many early studies suggested that active NLRC4 forms a closed
ring containing 10-12 NLRC4 monomer subunits, and a single NAIP (Figure 1.2); however,
other studies suggest that the oligomer may form an extended filamentous structure, with
the CARD domains forming a central core [Diebolder et al., 2015, Li et al., 2018] (Halff et al.
propose that NLRC4 in isolation forms helices, while it forms closed rings when associated
with NAIP5 [Halff et al., 2012]). It is possible that earlier studies which show a closed ring
oligomer structure may in fact have observed a short segment of a helical oligomer, which
has been ‘flattened’ into a closed ring through errors in averaging. However, this debate
has not been satisfactorily resolved, especially as these studies have for the most part been
conducted with NLRs and NAIP in isolation, and may not accurately reflect conditions in the
cell.
Far less is known about the structure of NLRP3 oligomers than NLRC4 oligomers; it has
been suggested that NLRP3 forms rings through ATP-dependent interaction of NACHT do-
mains, although this is a conjecture based on analogy with NLRC4 interactions [Lechtenberg
et al., 2014, Sharif et al., 2019]. However, the binding of NIMA-related kinase 7 (NEK7) has
been shown to be necessary for NLRP3 inflammasome formation [He et al., 2016, Schmid-
Burgk et al., 2016, Shi et al., 2016a]; it appears to bind directly to NLRP3 and facilitate
NLRP3 oligomerization, stabilising interactions between adjacent monomers [Sharif et al.,
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Figure 1.2: A common conceptual model of inflammasome formation (see [Halff et al., 2012,
Hu et al., 2015, Zhang et al., 2015]) suggests that the NLRC4 oligomer consists of a closed
ring of 10-12 NLRC4 monomers and a single NAIP which interact via NACHT domains.
2019]. Alternative splicing has also been proposed as regulatory mechanisms for NLRP3,
with one splice variant lacking the interaction surface necessary for NEK7 binding, and there-
fore inhibiting oligomerization [Hoss et al., 2019].
Recent studies have demonstrated that other inflammasome PRRs including NLRP1
and AIM2 oligomerise into helical structures [Gong et al., 2021, Hollingsworth et al., 2021,
Matyszewski et al., 2021] using cryo-EM techniques; however, it is worth noting that these
studies focus on the behaviour of individual domains (PYD in the case of AIM2, and CARD
in the case of NLRP1). It is therefore worth bearing in mind that the structures formed by the
full-length proteins may be slightly different.
ASC in the inflammasome
Similarly to NLRC4 and NLRP3, ASC is present endogenously throughout innate immune
cells. Following PAMP/DAMP detection, it is recruited into the inflammasome by PYD-PYD
or CARD-CARD interactions with NLRP3 and NLRC4 respectively, and further aggregates
around this NLR seed to form a well-defined focus or ‘speck’. The speck is around 0.7 µm
in diameter and can be easily visualised on an individual cell level by fluorescently labelled
ASC [Cheng et al., 2010, Man et al., 2014b, Kuri et al., 2017].
The most basic assumption for the role of ASC is that it acts as an adaptor protein,
forming a bridge between NLRs and caspase-1. In the case of the NLRP3 inflammasome
this is certainly the case. In the NLRC4 inflammasome, however, caspase-1 may interact
directly with NLRC4 via CARD-CARD interactions, although ASC specks are still observed
in infected cells, and the absence of ASC has been shown to lead to significantly decreased
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levels of NLRC4 inflammasome activation [Stehlik et al., 2003b, Proell et al., 2013, Li et al.,
2018]. It is also unclear on the basis of this reasoning why the formation of such a large
structure would be necessary if ASC is merely acting as an intermediary between NLRs and
pro-caspase1.
Once ASC has been recruited by NLRs, a common conceptual model of inflammasome
formation suggests that ASC forms filaments via PYD-PYD interactions, since ASC PYD
domains form filamentous structures in isolation, via homotypic interactions [Vajjhala et al.,
2014, Lu et al., 2014, Sborgi et al., 2015]. However, this might suggest a stellate form for the
completed inflammasome, with multiple ASC filaments projecting from an NLR core. This
does not reflect the inflammasome phenotype in endogenous cells, which generally appear
as ‘smooth’, compact structures. Some mutant phenotypes do display a somewhat stel-
late or ‘Medusa’s head’ appearance, both in ASC overexpression systems, and systems in
which ASC CARD-CARD interactions have been disrupted [Masumoto et al., 2001, Sahilli-
oglu et al., 2014]. Mutants expressing only ASC PYD domains show formation of filamentous
structures, whereas mutants expressing only ASC CARD domains show formation of ‘punc-
tate’ structures [Sahillioglu et al., 2014, Dick et al., 2016, Kuri et al., 2017].
One proposed explanation for these different phenotypes is that the PYD-PYD ASC fila-
ments are later crosslinked via CARD-CARD interactions, forming a more compact pheno-
type [Dick et al., 2016, Franklin et al., 2018]; however, it is not clear whether these processes
are in fact temporally separated. Another possibility would be that ASC filament extension
via PYD-PYD interactions occur concurrently with CARD-CARD interactions, which may ei-
ther allow two growing filaments to crosslink or allow a monomer to join with an existing
filament, forming a new ‘branch’. Recent studies have suggested that full-length ASC forms
filaments through a combination of CARD-CARD and PYD-PYD interactions, with filaments
stacking laterally [de Alba, 2019, Nambayan et al., 2019]; these contrast to earlier studies
in which ASC CARD and PYD domains were studied in isolation [Vajjhala et al., 2014, Lu
et al., 2014, Sborgi et al., 2015].
There are clearly regulatory systems which limit ASC aggregation, since in endogenous
systems, ASC monomers do not appear to interact in more than a transient fashion in the
absence of PAMPs/DAMPs. Spontaneous ASC speck formation has been observed in some
ASC overexpression systems, but this may be artefactual [Kuri et al., 2017]. It is therefore
unclear what mechanisms prevent the clustering of ASC in resting cells. Various regulatory
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mechanisms have been proposed, for example, the action of COPs and POPs; similarly
to their regulation of NLRs, these may bind to the CARD and PYD domains of ASC and
caspase-1, limiting the potential for ASC interaction with NLRs and caspase-1 processing
[Humke et al., 2000, Lamkanfi et al., 2004, Lee et al., 2001, Druilhe et al., 2001, Bedoya
et al., 2007]. Another regulatory system is negative regulation by IκB kinase α (IKKα), which
controls ASC aggregation in the nuclear and perinuclear area; ASC is moved out of the
nucleus through the action of IKKi, and the kinase activity of IKKα is limited through the
recruitment of PP2A following the introduction of a DAMP/PAMP [Martin et al., 2014]. It has
also been shown that various isoforms of ASC exist, as the product of differential splicing;
one such isoform may in fact inhibit IL-1β processing [Matsushita et al., 2009, Bryan et al.,
2010]. However, as with NLR regulatory processes, it is still unclear how these regulatory
processes are themselves controlled, and to what extent they are important.
Interestingly, the behaviour of ASC has been likened to that of prions, and in particular,
it has been demonstrated that ASC can recapitulate the behaviour of prion proteins in yeast
[Cai et al., 2014]. This suggests that ASC, like NLRs, may normally exist in an unreactive
form; however, its propensity for reacting with other ASC monomers may increase upon
interaction with an active NLR, and may propagate this increased propensity to further ASC
monomers.
1.3.3 Cell-level properties
At the cell level, the inflammasome is a very unusual structure. It contains thousands to tens
of thousands of individual proteins (the exact number has not been quantified), and yet it can
form within minutes of the introduction of a stimulus. In fact, ASC is depleted from across
the cell and absorbed into a single complex [Fernandes-Alnemri et al., 2007]. Multiple ASC
specks within a single cell are not often observed, with the exception of some ASC overex-
pression systems, in which occasionally two, or infrequently, more than two inflammasomes
are seen [Man et al., 2014b]. This process is extremely energetically unfavourable, and ASC
speck formation is not necessary for pyroptosis or IL-1β production in NLRC4 inflammasome
systems, although disruption of speck formation decreases the efficiency of IL-1β production
[Proell et al., 2013, Dick et al., 2016]. Moreover, this appears to be a ‘digital’ response; the
output of IL-1β, for example, shows ‘all-or-nothing’ behaviour [Liu et al., 2014].
Another intriguing aspect of inflammasome formation is the differences between cells
34
even within the same sample. Even cells treated simultaneously with inflammatory stimuli
will form inflammasomes at different times; some will not form inflammasomes at all [Man
et al., 2014b]. The latter effect is considerably more marked in NLRP3 systems compared to
NLRC4 systems. Of course, some variation should be expected in such a complex biological
system, but it is unknown what the primary cause for this variation is, and whether there is a
biological benefit which arises from it. Similarly, it is natural to ask whether we can explain
the differences between variation within NLRP3 samples and NLRC4 samples due to some
difference in the abundance or behaviour of NLRP3 and NLRC4.
1.3.4 Crossing scales
Conceptual models of inflammasome formation often assume a radial or tube-like structure.
Radial structures often feature concentric rings of NLRs, with ASC forming a ring inside an
NLR oligomer, with caspase-1 gathering in the centre of the structure [Lechtenberg et al.,
2014, Brewer et al., 2019]. Alternatively, a ring-like NLR oligomer is portrayed as the seed
for a single extended ASC tube-like structure, with caspase-1 attaching alongside or to the
ends of this tube [Lu et al., 2014, Shen et al., 2019]. Some slightly more sophisticated
inflammasome structure models include multiple ASC filaments which may be cross-linked
[Franklin et al., 2018, Broz and Dixit, 2016].
However, since attempts to ascertain the structure of the full inflammasome have been
limited to date, these models are based on a number of assumptions. It is unclear how
many NLR oligomers are involved in a single inflammasome, and, if these oligomers form
extended filaments rather than discs, how large these oligomers are. The spatial arrange-
ment of ASC filaments is also uncertain. In fact, while these radial and tube-like models
of inflammasome formation are consistent with established structural information about the
domain interactions driving inflammasome formation (and are amenable to representation
in two-dimensional cartoon form), they are at odds with established inflammasome imaging.
In particular, confocal fluorescence microscopy carried out by Man et al., in which NLRC4,
NLRP3, ASC and caspase-1 were labelled in endogeneous cells, demonstrated that a two-
dimensional cross-section of the inflammasome shows concentric rings of ASC, NLRC4 and
caspase-1 [Man et al., 2014b]. Similarly, imaging by Sanders et al. suggests that ASC forms
spherical structures with caspase-1 gathering on its outer surface [Sanders et al., 2015].
While it is not clear why these two studies show different arrangements of proteins within
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the inflammasome structure, and it is possible that some spatial artefacts may have oc-
curred due to labelling, this view of the inflammasome certainly suggests that several NLR
oligomers are involved in a single speck, and that there is a more complex organisational
structure than the simple radial or tube model. This view is corroborated by more recent
correlative light and electron microscopy of the ASC speck in zebrafish larvae, which show
a highly branched structure of ASC filaments [Kuri et al., 2017]; however, this does not give
any insight into the interaction between ASC and other inflammasome constituent proteins.
It is worth bearing in mind that all of these studies consider only static images, and show only
the endpoint of inflammasome formation, so we can infer little about intermediate formation
stages.
1.4 Mathematical modelling of the inflammasome
As far as I have been able to ascertain, there has only been one previous attempt to create
a mathematical or computational model of ASC speck formation [Cheng et al., 2010]. In this
study, Cheng and colleagues carried out live imaging of HeLa cells transfected with yellow
fluorescent protein (YFP)-labelled ASC using confocal laser scanning microscopy. The in-
tensity of YFP measured at sampled points within the area of a cell was used as a proxy
for the concentration of ASC at that point in the cell; taking intensities over all timepoints
in the time series gives a view of ASC depletion over time. Comparing results for points in
the cytosol, nucleus and speck of each cell showed a decrease in ASC concentrations in
the nucleus and cytosol, while intensities in the speck increased. Furthermore, the distance
from the centre of the ASC speck to each sampled point was measured, and the rates of
ASC depletion compared to the distance from the speck. It was shown that there was no link
between distance from the speck and the rate of depletion of ASC.
The authors then compared the results to a simple model of ASC aggregation. This
tracked ASC concentrations in a two-dimensional representation of the cell, including the
following reactions between ASC monomers and a single incipient ‘speck’ complex:




Free ASC monomers associate with a growing speck of size n to create a speck of size
n + 1 at a constant rate kon, and ASC monomers dissociate from the speck at a constant
rate koff .
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The ASC was allowed to diffuse freely through the cell, and the concentration of ASC
throughout the domain over time was simulated. The data extracted from the time series
were then compared to simulation results when active transport was included, and excluded
from, the model. The closest similarities arose for the model with diffusion only, suggesting
that active transport is not a factor in ASC aggregation, at least in the transfection system
considered here.
The use of fluorescence microscopy as a proxy for ASC abundance is a useful way of
extracting quantitative and spatial data describing the distribution of ASC throughout the cell
through the process of ASC speck formation. However, there were a number of limitations
to both the analysis pipeline used, and the model presented in this study. Firstly, the system
of transfecting HeLa cells is somewhat artificial; aggregation of ASC was not initiated by
infection or other inflammasome formation-initiating treatment, but rather prompted only by
transfection. The resulting data cannot then be directly compared to ASC aggregation explic-
itly caused by inflammasome formation. The addition of the large YFP tag to the transfected
ASC may also have affected the ASC aggregation kinetics. It is unclear how the authors
chose sample points from which to extract characteristic intensities across the cell, nor is
it clear how the cell was divided into areas corresponding to the nucleus and cytoplasm.
Moreover, it is not clearly established that the chosen points are representative of intensities
across the compartment in question. Finally, the model of ASC speck formation is extremely
simplistic; while it may be representative of aggregation occurring in transfection systems,
it assumes that aggregation rate is independent of speck size, and does not capture the
different possible modes of interactions between ASC monomers. Other proteins involved in
inflammasome formation, such as NLRs, have not been included in the model, and although
this would not have been appropriate in the ASC transfection-related aggregation context
considered in this study, NLRs may play a much more important role in ASC aggregation in
the inflammasome context. Finally, this model assumes that only a single speck is present
at any given time, with all other ASC in the cell existing in monomeric form, although no jus-
tification is given for this assumption; it would be more natural, especially since no ‘seeding’
processes have been included in the model, to assume that any ASC monomer can interact
with any other ASC monomer.
The absence of a compelling mathematical model of inflammasome formation motivates
the creation of a new model which explicitly considers both the other proteins involved in
37
inflammasome formation beyond only ASC, and which distinguishes between linear growth
of ASC filaments and potential crosslinking or branching of these filaments.
1.5 The mathematics of coagulation processes
Despite the lack of mathematical models explicitly depicting inflammasome formation, there
is a much broader class of existing mathematical and physical models which have been used
to analyse the kinetics of coagulation or aggregation processes. Some popular approaches
include a physical perspective, including the study of the formation of micelles, i.e. self-
assembled aggregates of surfectants; the modelling of micelle formation was pioneered by
Murray and Hartley [Murray and Hartley, 1935]. Another popular approach is the study of
the fractal structure of randomly-formed aggregates, which was particularly prevalent in the
1980s; this area focuses on how self-similar structures can arise via diffusion-limited aggre-
gation of particles, and was pioneered by Witten and Sander in 1981 [Witten and Sander,
1981]; a useful review is given by Jullien [Jullien, 1987].
However, in this research we will focus on the simplest possible mathematical models of
aggregation. These models often use a mass action formulation (i.e. the assumption that
the rate at which a reaction occurs is proportional to the concentration of the reactants). The
reactions may be expressed using a deterministic or stochastic approach.
The deterministic approach uses ordinary differential equations (ODEs), or, in the case
of spatial models, partial differential equations (PDEs). These equations track the concen-
tration of various reactants over time; in the case of coagulation modelling, these would
take the form of xi(t), the concentrations of clusters of a size i over time. Deterministic
approaches are often a useful first recourse for reaction modelling, due to the range of ac-
cessible mathematical tools for analysis. In some cases, it may not be possible to solve
these equations explicitly, to give the concentration of each reactant over time, especially for




nxi(t), which can be used to derive properties of the distribution of
cluster sizes at time t. The ODE system can also be manipulated to give a PDE for the gen-
erating function G(s, t) =
∑
i xi(t)s
i; the generating function uniquely defines the distribution
of cluster sizes for each time, and may be used to infer the moments of this distribution. In
some cases, it may be possible to use G to derive solutions for xi. However, it is also pos-
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sible to solve ODE systems equations numerically, using a computational integration solver.
While this is generally less challenging than finding an analytical solution, the results will
only be an approximation of an analytical solution, and the solver may fail to converge alto-
gether for ODE systems with particular undesirable qualities (such as ‘stiffness’). Moreover,
numerical solutions are only valid for a single parameter set; to understand how changing
parameter values affect results, multiple numerical solutions must be calculated. Finally, an
analytical approach may be used to consider more global properties of solutions to an ODE
system without explicitly deriving these solutions fully; for example, proving the existence
and uniqueness of a solution given certain parameters and intial or boundary conditions, the
existence and stability of equilibria in the system, and the asymptotic behaviour of the system
(in practice, this often means the behaviour of the system on very short or long timescales).
However, ODEs often fail to show behaviour which is important in biological systems. Due to
their deterministic nature, ODEs are unable to capture the stochastic variation which arises
even within the same biological samples. They also fail to capture accurately the dynamics of
systems which involve switching or small numbers of reactants, due to the use of continuous
concentrations, rather than absolute numbers of reactants, as variables in these systems.
Alternatively, a stochastic approach may be used; the reactions in a system are sum-
marised by a set of propensity functions, which are an analogue of the reaction rates in
deterministic systems. The abundances of reactants are tracked as discrete counts over
time. These systems may be analysed using a master equation approach; the propensity
functions can be used to construct an ODE for the time evolution of P (x, t), the probability
that the system is in a state x at a time t. In the case of a coagulation system, x will often
take the form of a vector x = (x1, x2, · · · , xN ); in this case, P (x, t) is the probability that for
i = 1, · · · , N there are xi clusters of size i at time t. In some simple cases, it may be possible
to solve the ODE directly for P (x, t); however, it is much more common to use the master
equation to derive equations for the moments, or derive a PDE for the generating function
G(s1, s2, · · · , sN , t) =
∑




2 , · · · , s
xN
N , where the sum is taken over all possible
values of x. Once again, the generating function can be used to derive the moments of the
system, or in some cases, P (x, t). Another common approach is to view the system as a
continuous-time Markov chain (CTMC); this is particularly useful for analysing the distribu-
tions of times at which the system enters an absorbing state (for example, the time at which
a cluster of a given size first emerges). Alternatively, the system may be simulated algorith-
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mically using a kinetic Monte Carlo method; the Gillespie algorithm is a popular foundation
for approaches to simulating reaction models. While technically approachable, these simu-
lation processes are generally considerably more computationally intensive than numerical
schemes for integrating ODEs.
It is generally assumed that ODE models and their stochastic analogues will behave
similarly, in that ODE models depict the behaviour of the stochastic system in the ’mean-
field’ limit, as the number of monomers in the system becomes very large. However, for
many of the models described below this has not been rigorously proved, and moreover the
removal of effects due to small monomer numbers may not be desirable.
One of the key problems that arises with either approach in aggregation systems is the
extremely large number of variables involved; assuming that cluster sizes are treated as
discrete, each possible size gives rise to a new variable. Indeed, many models of this type
do not limit the possible size of clusters, leading to infinitely large ODE or stochastic systems
which cannot be closed. The introduction of a generating function can circumvent this issue,
as it is a single function which can summarise abundance of all possible cluster sizes.
Another important factor to consider is the initial conditions of the system. There is often
an assumption of monodispersity of initial conditions (ICs); that is, that initially all clusters in
the system have the same size. In practice, this is generally taken to mean that initially only
monomers are present. However, the case of polydisperse ICs (i.e., clusters of different sizes
are present) may be particularly of interest in systems where we have nucleation processes
or some other source of heterogeneity in cluster population. It cannot be assumed that
systems with polydisperse ICs behave analogously to those with monodisperse ICs, and in
fact, may lead to substantially different solutions in some models. It is therefore important to
establish assumptions about ICs in aggregation models.
In the following sections, I will discuss some of the predominant models of aggregation
processes, as well as some extensions which are particularly relevant to the problem of
inflammasome formation. I will discuss some of the key approaches used in analysing these
models, and their relevance to inflammasome modelling.
Since aggregation models are widespread, with a history extending at least back to the
early twentieth century, and applied in numerous fields of study, there is a considerable
lack of consistency in terminology used in the literature. In general, for ease, I will use
the language commonly used in protein aggregation; individual aggregate subunits will be
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(a) Becker-Döring (b) Smoluchowski/Marcus-Lushnikov
Figure 1.3: Two basic coagulation processes; clusters grow linearly by addition of monomers,
or by coagulation of clusters
referred to as ‘monomers’, and monomers which have adhered together will be referred to
as ‘clusters’, except in the case of clusters which are explicitly linear, which I refer to as
‘filaments’. In general, I will also assume that such clusters grow at rates independent of
their size, and I refer to this phenomenon as ‘linear growth’.
1.5.1 Basic processes
There are two main approaches which have dominated the study of the kinetics of protein
aggregation, namely models in which clusters may grow only via the addition of monomers,
and models in which larger clusters may also coagulate [Aldous, 1999]. The most com-
mon formulation of these two aggregation schemes are the Becker-Döring model [Becker
and Döring, 1935] and the Smoluchowski model [Smoluchowski, 1916] (Figure 1.3). In this
section, I will outline the mathematical structure of these models, give a summary of the
common approaches to analysing these models, and describe their limitations.
BD models
The Becker-Döring (BD) model was first proposed in a simplified form by Becker and Döring
[Becker and Döring, 1935] and extended by Burton [Burton, 1977]. In the BD model,
monomers may join with other monomers or with larger clusters, and individual monomers
may also dissociate from clusters, but clusters may not interact with one another. This can
be summarised using the reactions in Table 1.2.
Here xi is the abundance of clusters containing i monomers, and ai and bi are aggre-
gation and breakage rates respectively, of clusters of size i. The rates ai and bi may be
functions of i, to reflect different cluster shapes or aggregation and breakage styles, but a
case assuming linear growth has ai and bi constant (which I will assume to be the case from
henceforth).
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Reference Reaction Propensity function Explanation
A x1 + xi
ai−→ xi+1 aix1xi for i 6= 1, a1x1(x1 − 1)
otherwise
Monomer binds to fila-
ment of length i to form
filament of length i+ 1
B xi
bi−→ xi−1 + xi bixi Monomer dissociates
from filament of length
i to form filament of
length i− 1
Table 1.2: Reactions in the Becker-Döring model
The BD model is especially popular for analysing systems in which aggregates form fil-
amentous structures, since it can be assumed that most growth occurs via linear monomer
addition to the filament end. Notably, the BD model has been used in analysing industrial
systems [Coveney and Wattis, 1996], and biological processes such as prion and actin poly-
merisation [Hu and Othmer, 2011, Davis and Sindi, 2016, Holcman, 2017].
The deterministic approach gives the Becker-Döring equations, a set of ODEs describing



















= ai−1xi−1x1 − bixi
Note the factor of 1/2 in the equation for dx2dt ; in general, monomers may be added to
either end of the filament. However, the joining of two monomers is a symmetrical process
so the rate at which such reactions occur is halved. Note also that the factor of 1/2 is not
included for the corresponding reaction in the equation for dx1dt , since two monomers are
removed via these reactions.
A common approach to analysing this system is to consider the large-time asymptotic
behaviour; the system will approach a steady state dependent on parametrisation, and much
of the existing analysis of the deterministic system is concerned with determining this steady
state, its stability, and the behaviour of the system as it approaches this steady state [Ball
et al., 1986, Wattis and King, 1998].
42
In general, a master equation approach is used to analyse stochastic BD systems; for
example, Davis and Sindi [Davis and Sindi, 2016] analyse the following system with constant
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where x(t) is a vector in which xi(t) is the number of clusters containing i monomers
present at time t, P (x, t) is the probability that x gives the number of clusters of each size at
time t, and we define the operator W±i P (x, t) = P (x± (e1 +ei−ei+1), t) where {ei} are the
standard basis vectors. Terms A1, A2 and B1 correspond to reactions moving out of state
x, and terms A3, A4 and B2 correspond to reactions which move the system into state x.
In particular, terms A1 and A3 account for reactions involving two monomers; the propensity
function is slightly different to the analogous rates in the deterministic system (See Table
1.2) to avoid the possibility of a monomer reacting with itself. Note in particular the form of
term A3; this term accounts for the system reaching x via the merging of two monomers into
a filament of length two. Prior to this step, there were x1 + 2 monomers in the system, each
of which may react with x1 + 1 other monomers, so the rate of this reaction is proportional to
(x1 + 2)(x1 + 1). The factor of 1/2 in terms A1 and A3 are included to account for symmetry
in cluster joining, as in Equation 1.2.
An area of particular interest in stochastic BD modelling is determining the time taken for
a cluster of a given size to first form. This is essentially a stopping time problem in analysis of
a Markov chain; the derivation of this stopping time can therefore be analysed via numerical
or asymptotic techniques [Davis and Sindi, 2016, Hu and Othmer, 2011, Michaels et al.,
2016]. Notably, Yvinec et al. [Yvinec et al., 2012, Yvinec et al., 2016] derive a full analytic
solution for first formation times of a cluster of size n in BD systems using the backwards
Kolmogorov equations; however, this solution grows in complexity extremely quickly with n.
In summary, the BD model is a popular view of linear aggregation which is particularly
amenable to mathematical analysis, but it is not appropriate to the modelling of many pro-
cesses due to that very simplicity. While linear growth has been observed in many systems,
the limitation to linear growth only is not appropriate in many contexts. Furthermore, many
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Reference Reaction Propensity function Explanation
K xi + xj
ai−→ xi+j K(i, j)xixj for i 6= j,
K(i, i)xi(xi − 1) otherwise
Clusters of sizes i and j
merge to give cluster of
size i+ j
Table 1.3: Reactions in the Smoluchowski model
of the features of interest in this system derive from the interplay between growth and frag-
mentation, which is less relevant in systems such as inflammasome formation.
However, the BD model is the basis of many more complex models of coagulation, no-
tably the nucleated polymerisation model of prion-like protein aggregation, which will be
discussed further in Section 1.5.2.
Coagulation models
Coagulation models present a different view of aggregation to that of BD models, allowing
merging of clusters of any size. These models have also been used in modelling a diverse
range of systems including the formation of aerosols [Drake, 1972, Gillespie, 1972, Ramab-
hadran et al., 1976, Pruppacher and Klett, 1978], polymers [Stockmayer, 1943], and even
celestial bodies [Lee, 2000] and social groups [Gueron and Levin, 1995].
The reactions in coagulation models are summarised in Table 1.3.
Here, the rate of reaction K(i, j) is often described as a ‘kernel’, and may depend on
the size i and j of the reactants. The precise form of the kernel may be as simple as a
constant, or a linear combination of i + j and ij. More sophisticated kernels may be used
to explicitly take into account the motion of the complexes in space, or the shape of the
complex. Summmaries of some common kernels and their uses are given in reviews by
Aldous, and Jeldres et al. [Aldous, 1999, Jeldres et al., 2018].
Note that it is rare to include breaking or fragmentation in these models, since this gen-
erally leads to the models becoming analytically intractable.
The most widespread basis for coagulation modelling is a deterministic approach pio-
neered by Smoluchowski [Smoluchowski, 1916]. The equations describing the evolution of














Note the factor of 1/2 in the first term, which is included to avoid double-counting of the
same complex due to symmetry of i and j. If i is even, there is a central term for which
j = i − j; however, the factor of 1/2 is still included, since this corresponds to a reaction in
which two clusters of equal size merge. Similarly to Equations 1.2 and 1.3, we include the
factor of 1/2 to account for symmetry.
Alternatively, cluster size can be regarded as continuous, which is justifiable for large
populations of reactants over longer timescales. This yields integro-differential equations
which may be more amenable to some forms of analysis. Now writing x(i, t) for the number













A notable property of the Smoluchowski equations is that for some kernels, the total mass
of the system,
∑∞
i=1 ixi(t) in the discrete case, and
∫∞
0 ix(i, t)di in the continous case, is not
conserved. In particular, the total mass is constant until a critical time, after which it begins
to decrease. Although from Equations 1.4 and 1.5 it would appear that mass is conserved,
following the argument of Wattis et al., consider the flux Jr from clusters of size less than or
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For some choices of kernel, this limit may be nonzero; consider, for example, a case
in which the cluster size distribution decays algebraically for t sufficiently large (xi i−γ for
some γ as i → ∞); then choosing K(i.j) as a function of iγ and jγ leads to a nonzero
limit for Jr. There is therefore a flux of mass out of the system due to the formation of a
cluster of infinite size known as a ‘gel’, to which mass is lost; this phenomenon is known as
‘gelation’, and the critical time at which this cluster emerges is known as the ‘gelation time’.
The gelation phenomenon was first characterised in the Smoluchowski equations by Van
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Dongen [Van Dongen, 1987]. This has often been used as a model for phase transitions in
physical systems.
Explicit solutions to the Smoluchowski equations have been calculated in some cases,
generally only up to gelation times; notably, Davies et al. [Davies et al., 1999] use a gen-
erating function to derive solutions to Equation 1.4 for monodisperse ICs and constant




−kz into Equation 1.4 gives a partial differential equation which can
be solved using the method of characteristics. The distribution of particle sizes as a function
of time can be retrieved by expanding the solution for G in powers of e−z. For example, for a

































j=1 xj . Supposing an initial monomer concentration of 1, the initial
conditions are G(z, 0) = e−z.







This can be solved to give X = 2t+2 .
Equation 1.10 can now be solved to give the following:
(1.12)G =
4
(t+ 2)((t+ 2)ez − t)




A discrete stochastic approach analogous to the Smoluchowski equations, known as
a Marcus-Lushnikov (ML) process, was proposed first by Marcus [Marcus, 1968]. While
the deterministic Smoluchowski equations are expected to give the limit of the equivalent
ML process as the number of reactants tends to infinity, in many cases this has not been
rigorously established.
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These models involve reactions of discrete numbers of reactants in a finite volume; using





















K(i, j)(xi + 1)(xj + 1)W
+





K(i, i)(xi + 1)W
+
ii P︸ ︷︷ ︸
K4
Here, N is the total number of monomers and W+ij P (t,x) = P (t,x + (ei + ej − ei+j)),
where {ei} are the standard basis vectors. Term K1 accounts for reactions which take the
system out of state x, and term K3 accounts for reactions bringing the system into state x.
Terms K2 and K4 are correction terms for terms K1 and K3 respectively, which account for
the impossibility of a cluster joining to itself.
Exact solutions for cluster size distribution have been derived for a number of ML pro-
cesses characterised by ICs and kernel. Notably, Lushnikov has derived exact solutions
for linear and product kernels and monodisperse initial conditions using a generating func-
tion approach [Lushnikov, 1978]. Lushnikov’s approach was extended by Fronczak et al.,
who provide a generating function-derived solution for arbitrary initial conditions and product
kernel [Fronczak et al., 2019].
A particularly interesting approach is presented by D’Orsogna et al. [D’Orsogna et al.,
2015]. Instead of seeking a solution for the full system, the authors of this study truncate the
system and, applying techniques developed in earlier studies of BD systems [Yvinec et al.,
2012, Yvinec et al., 2016], use backward Kolmogorov equations to derive distributions of
‘first-passage’ times for when clusters of given sizes are first formed. A similar approach has
been used by Holcman and Hozé in examining the time taken for viral capsids to assemble
[Hozé and Holcman, 2014, Holcman, 2017].
In summary, the Smoluchowski and ML models are analogous deterministic and stochas-
tic approaches to modelling coagulation. While fragmentation of clusters is often neglected
in these models due to increased analytical complexity, they also offer the possibility of mod-
elling the growth of aggregates through other means than simple linear filament formation.
In addition, since dissociation of inflammasomes is not generally observed in endogenous
systems, the effects of fragmentation may well be less important in ASC coagulation; it is
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certainly less important than capturing the potential for more complex coagulation than only
linear growth. Furthermore, although it is tempting to compare gelation to the sudden emer-
gence of a large complex in inflammasome formation, the mass loss that occurs during this
transition may be undesirable in this system.
While the reactions in a Smoluchowski or ML model alone would be unlikely to be appli-
cable to a biological system, there is a considerable body of literature examining extensions
to these models, including models with input or removal of monomers over time, involving
several species of reactant within the same complex, and catalytic reactions. I will examine
these extensions in more detail in the following section.
1.5.2 Common variants
NP models
One particularly well-developed instance of coagulation modelling is prions and prion-like
proteins. This is an important area of study due to its therapeutic implications; prions and
prion-like proteins such as amyloid-β and tau proteins are implicated in various neurological
conditions including scrapie, spongiform encephalopathies and Creutzfeld-Jakob disease,
and various forms of dementia. However, these proteins also display some behaviours which
are both biologically and mathematically interesting. Prion-like proteins are present endoge-
nously in cells in non-pathogenic monomeric forms, but the prevailing biological view is that
they may also exist in misfolded pathogenic multimeric forms; monomers may be converted
into the pathogenic form via interaction with a pathogenic multimer. These multimers often
take the form of filamentous structures (which may themselves aggregate to form larger fibril-
lar structures or ‘plaques’); filaments may also fragment and thus propagate the pathogenic
monomer form. Another common assumption is that filaments are unstable below a certain
critical size nc; prion proliferation is therefore ‘seeded’ by the appearance of one or more
nucleating filaments of size nc. These seeds may appear spontaneously given a sufficiently
long timeframe, or may be introduced by an external source. This process is often referred
to as ‘nucleated polymerisation’ (NP).
NP models are of particular interest in inflammasome modelling, due to the prion-like
characterisation of inflammasome proteins; in particular, the proposed nucleation and au-
tocatalytic properties of ASC and various NLRs, and the biological link between ASC and
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Reference Reaction Explanation
A x1 + xi
ai−→ xi+1 Monomer binds to filament of length i to form filament
of length i+ 1
B xi
bi−→ xi−1 + xi Monomer dissociates from filament of length i to form
filament of length i− 1
N ncx̂
kn−→ xnc nc monomers nucleate to form a single cluster of size
nc
Table 1.4: Reactions in the Oosawa-Kasai NP model
prions [Cai et al., 2014], suggest a model incorporating some of the elements often used in
NP modelling.
The earliest NP-type models were developed by Oosawa and Kasai in 1962 [Oosawa
and Kasai, 1962] . They present a deterministic ODE model of filament formation with a rate
limiting step in which nuclei of size nc are formed. These nuclei extend into filamentous forms
via linear monomer addition; monomers may also dissociate from the ends of filaments. The
reactions involved are detailed in Table 1.4 and Figure 1.4a.
Here x̂ is the concentration of (non-pathogenic) monomers in the system and xi is the
concentration of filaments of length i, for i ≥ nc. The parameters a, b and kn respectively
describe the rates of monomer addition to and dissociation from filaments, and nucleation;
it is assumed that these rates are constant. Note that in contrast to the Becker-Döring and
Smoluchowski systems, monomers are denoted x̂ rather than x1 to reflect the fact that the
monomer population is distinct from the cluster population, and that (with the exception of
nucleation) monomers cannot form clusters without interacting with other clusters.



















= ax̂(xi−1 − xi)︸ ︷︷ ︸
A





The Oosawa-Kasai approach was further developed by Masel, Nowak and others [Nowak
et al., 1998, Masel et al., 1999]. They proposed an ODE model of prion proliferation including
monomer production and degradation, filament clearance, filament growth through monomer
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Reference Reaction Explanation
C ∅ c−→ x̂ Monomer created
D1 x̂ d1−→ ∅ Monomer degraded
D2 xi
d2−→ ∅ Filament of length i degraded
A x̂+ xi
a−→ xi+1 Monomer is added to filament of length i to form fila-
ment of length i+ 1
B xi
b−→ xj + xi−j Filament of length i fragments into filaments of length
j and i− j where j ≥ nc and i− j ≥ nc
xi
b−→ xj + (i− j)x̂ Filament of length i fragments into filament of length
j and i− j monomers, where j ≥ nc and i− j < nc
Table 1.5: Reactions in the Masel-Nowak NP model
addition and filament fragmentation. In contrast to the Oosawa-Kasai model, nucleation
via reaction of monomers is not included in the model; filaments arise either through initial
conditions or through fragmentation of larger filaments. It is assumed that filaments smaller
than the critical size nc are automatically destroyed, dissociating into monomer subunits. A
summary of the reactions involved is given in Table 1.5 and Figure 1.4b.
Here x̂ is the concentration of monomers and xi is the concentration of filaments of
length i. The parameters c, d1 and d2 respectively describe the rates of monomer production,
monomer degradation and filament degradation; a and b are the rates of monomer addition
to filaments and filament breakage, either into two smaller filaments, which may immediately
degrade into monomers if smaller than nc. It is assumed that all parameters are constants.
Note that we assume that when a filament fragments, at least one of the remaining fragments
is greater in size than nc.









































Note the form of the terms describing breakage, B1, B2 and B3. A filament of length i
can fragment in i − 1 locations, hence the form of term B2. Up to nc − 1 monomers may
be created from a cluster of size greater than the number of monomers released, hence the
form of term B1; any cluster of size greater than j may fragment to give a cluster of size
j, hence the form of B3. The factor of 2 in terms B1 and B3 account for the fact that the
monomers may be released from either end of the filament.
Some notable results from Masel demonstrate that this many-dimensional ODE system
can be reduced via summation to give a closed system in terms of the zeroth and first
moments X =
∑∞














= ax̂X − d2Y − bnc(nc − 1)X
Although this reduced system cannot generally be solved analytically, it is considerably
more amenable to analysis than the full system above. Masel also showed that there are
clear parallels between this model and an epidemiological model, deriving an ‘R0’-like value
which gives critical conditions for expansion of the prion population, and deriving estimates
for this parameter from experimental data. A similar model reduction approach can be used
with the Oosawa-Kasai model, which can be solved analytically in some cases [Michaels
et al., 2017].
Much of the existing literature on these models has centred around an analytical ap-
proach. Starting with work by Greer et al. [Greer et al., 2006], in which the Masel and
Nowak model is adjusted to regard filament size as continuous, many subsequent stud-
ies have been concerned with establishing the well-posedness of the problem, existence
and uniqueness of solutions, existence and stability of equilibrium points in the system, and
asymptotic approximation of large-time behaviours [Prüss and Pujo-Menjouet, 2006, Simon-
ett and Walker, 2006, Engler et al., 2006, Calvez et al., 2009, Helal et al., 2013]. While these
analyses contribute rigour to the derivation of solutions and determination of conditions when
a disease-state equilibrium may arise, they also have relatively little impact on a biological
discussion of prion proliferation.
In a similar vein to the somewhat abstract mathematical analysis of the deterministic
Masel and Nowak NP model, there have been various attempts to analyse a stochastic ver-
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(a) Oosawa-Kasai. N. nucleation, A. monomer addition B. monomer dissociation
(b) Masel-Nowak. D2. filament degradation, B. filament fragmentation, A.
monomer addition, C. monomer creation D1. monomer degradation
Figure 1.4: The two most common forms of NP model
sion of the NP model. For example, a stochastic differential equation approach has been
used to analyse the NP model, deriving asymptotic solutions for large times and the distri-
bution of first nucleation times [Doumic et al., 2016, Eugène et al., 2016, Robert and Sun,
2019].
Others have taken a more simulation-based approach to stochastic NP modelling. No-
tably, Proctor et al. [Proctor et al., 2012, Proctor et al., 2013] use a Gillespie-like algorithm
to simulate an NP process to model amyloid-β and tau protein proliferation in the brain.
Since experimental measurements for parameter values in their model were not available,
they used parameter sets sampled using a Latin hypercube sampling method from across
a feasible domain informed by experimental results. For each simulation they tracked the
total number of clusters over time, and in particular, noted the time at which the cluster den-
sity exceeded a threshold corresponding to the appearance of disease symptoms; this gave
distributions of characteristics comparable to existing experimental amyloid-β and tau pro-
tein datasets. They also investigate the effects of various medical interventions by altering
parameters of the model and noting the effect on the measured percentages of disease oc-
cupancy. A similar approach is taken by Kashchiev [Kashchiev, 2018], who uses stochastic
simulations of an Oosawa-Kasai-like model to ascertain a distribution for times at which the
52
first filament of size n or larger appears.
Due to its links with experimental work, the field of prion-like protein modelling shows how
coagulation models can be successfully compared to experimental data. However, in many
ways the existing literature is limited in its applicability to inflammasome systems; as with BD
systems, the limitation to linear growth is not ideal. Moreover, much of the analysis relies
on the assumption of constant coagulation kernels, which is a considerable simplification of
a full coagulation model. While nucleation is certainly an important factor in inflammasome
formation, this is caused by NLR activation rather than through spontaneous formation of a
sufficiently large seed. Finally, the timescales involved in inflammasome formation are much
shorter than those involved in prion modelling (seconds rather than years), and many of the
processes included in the Masel-Nowak model, such as protein transcription and degrada-
tion, are not significant on the much shorter timescales of inflammasome formation. There-
fore, the NP model may form a useful basis for modelling some aspects of inflammasome
formation, but some adaptation will be required.
1.5.3 Extensions
While extensive analysis has been conducted on models such as the BD, Smoluchowski, ML
and NP models, and it has been demonstrated that they are rich in mathematical complexity,
they nevertheless fail to fully capture the complexity of biological systems. In particular, the
roles of different protein species, different cellular compartments and different coagulation
mechanisms are of particular interest when modelling the inflammasome. In this section I
will therefore discuss models which combine the basic models discussed previously, or add
elements which may be useful in constructing models of the inflammasome.
Combining linear growth and coagulation of clusters
It is unusual for models to combine several of the basic models previously described; how-
ever, some studies have made progress in analysing models incorporating multiple coagu-
lation mechanisms. So far, these appear to focus mainly on deterministic models, perhaps
due to the complexity and large number of reactions in such systems.
Few models combine BD and Smoluchowski aggregation, but one study by Wattis et
al. [Wattis, 2006a] establishes some full solutions and asymptotic results for a deterministic
system with both BD and Smoluchowski kinetics.
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However, models that combine NP dynamics with Smoluchowski-like coagulation of clus-
ters are somewhat more common, since many prion proteins have been observed to form
plaques, consisting of multiple filaments which have separately coagulated; however, these
are generally concerned with large-time asymptotic and numerical results [Ramabhadran
et al., 1976, Li and Roberts, 2009, Schreck and Yuan, 2013, Mobilia et al., 2003].
Multispecies models
Another important consideration in aggregation systems is that in many cases, multiple
species of monomer are involved. There have been a number of attempts to extend co-
agulation models to include multiple species, both determinstic [Lushnikov, 2014, Ke et al.,
2003, Fernández-Dı́az and Gómez-Garcı́a, 2010] and stochastic [Trautmann, 1993, Lau-
renzi et al., 2002, Lushnikov, 2006]. Notably, analytical solutions have been derived for the
full deterministic model for a product kernel and arbitrary numbers of species using a Laplace
transform approach [Fernández-Dı́az and Gómez-Garcı́a, 2010]. The stochastic system is
naturally somewhat more complex, although Lushnikov has derived solutions for the clus-
ter size distributions over time for the two-species model with the kernel K(i1, i2, j1, j2) =
i1j2 + i2j1 (where il and jl are the numbers of monomers of species l in the clusters involved
in a joining reaction).
However, these models assume a symmetry in the behaviour of monomers of different
species; the only difference in their behaviour is encoded in the coagulation kernel. In sys-
tems such as inflammasome formation, however, the different species of proteins involved
may drive different forms of aggregation; for example, NLRs may have a similar role to
‘seeds’ in a NP model, but ASC forms filaments, and may or may not branch.
Intracluster reactions
So far there has been little discussion of the morphology of clusters involved in aggregation
processes. In many aggregation studies mentioned above, it is assumed that any relevant
properties of clusters involved in reactions are encoded in the reaction rates or kernels. How-
ever, it is also useful to examine these properties more explicitly. For example, a number of
studies have explicitly considered the growth of clusters in Smoluchowski systems which al-
low include branching [Hendriks and Ernst, 1984, Noureddini and Timm, 1992], intracluster
crosslinking of monomers [Galina et al., 2002, Lazzari et al., 2014], or cluster compaction
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[Wattis, 2006b]. A model of ovalbumin filament formation also considers a special case of
a linear model where end joining in a filament is permitted (so that a closed loop struc-
ture is formed) [Kalapothakis et al., 2015]. In general these approaches rely on numerical
or asymptotic solutions, with the exception of the study of branching by Noureddini et al.
[Noureddini and Timm, 1992], and the compaction study by Wattis [Wattis, 2006b], which
give exact solutions.
Spatial models
While kernels and reaction rates of aggregation processes may be constructed to take
cluster morphology into account, in many cases they are also adjusted to take into ac-
count the effects of spatial properties of the system such as diffusion, without explicitly
adding a spatial element to the model; for example, a Brownian kernel of the form K(i, j) =
(i1/3+j1/3)(i−1/3+j−1/3) may be used to model systems in which clusters undergo Brownian
motion. However, while this kernel-based approach can account for the change in reaction
rates due to movement of reactants, it still assumes a well-mixed system; the approach can-
not introduce spatial inhomogeneities in initial conditions or monomer source terms, nor can
the solutions demonstrate spatial inhomogeneity.
The simplest models to consider space explicitly divide the spatial domain into two com-
partments. While this is still a fairly unrealistic depiction of the domains in which most aggre-
gation processes take place (especially in biological contexts), it greatly increases the com-
plexity of the system; as well as introducing reactions accounting for movement of monomers
and clusters between compartments, the reaction system must involve twice the number of
variables (as there must be duplicate variables for each compartment). This has been con-
sidered both from a Smoluchowski [Hussain et al., 2014] and a ML [Siegmund-Schultze and
Wagner, 2006] perspective. Both of these studies rely on asymptotic and numeric solutions,
although Siegmund-Schultze observes that the majority of the variation between actualiza-
tions of the system occur in late stages, where there are only a few large clusters present;
thus, movement of a single complex from one compartment to another leads to a very large
change in the total number of monomers per compartment.
Extending this methodology to more than two compartments suggests the use of a net-
work approach, with nodes corresponding to compartments, and edge weights correspond-
ing to rates of movement between compartments [Shirvani and van Roessel, 2004, Bertsch
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et al., 2017, Fornari et al., 2019, Fornari et al., 2020]. Alternatively variables could be taken
as functions of continuous space [Herrero et al., 2000, López-López et al., 2005, Olesen
et al., 2005, Matthäus, 2006, Krapivsky, 2015, Achdou et al., 2013, Cohen et al., 2014,
Bertsch et al., 2017, Fortin, 2019]. In general, analytical solutions are not possible, so these
studies have presented numerical, simulation or asymptotic results.
1.5.4 Modelling the inflammasome
An ideal inflammasome model would contain a combination of the models described above;
there does not appear to be an existing model that encompasses all of these processes,
and it would be extremely complex. We therefore require a minimal model of inflammasome
formation which will include the aspects of the system which we are most concerned to
investigate, while excluding aspects which would introduce undue complexity. This model
should include multiple proteins, which may individually grow in a linear fashion, similarly
to the NP models, but the possibility of branching growth and interaction between different
species of protein is also included. In addition, it would be useful to incorporate the possibil-
ity of clusters merging in a Smoluchowski or ML-like fashion. Including intracluster reactions
may be useful for modelling crosslinking within the inflammasome once it is formed. Finally,
adding spatial structure to the model, at least separating the cell into nuclear and cytoso-
lic compartments (similar to the model presented in [Cheng et al., 2010]) would allow the
differing dynamics in these compartments to be analysed.
Both stochastic and deterministic modelling techniques may be useful here; in many
ways, a stochastic depiction of inflammasome modelling would be most natural, especially
given that the final state of the system is a single cluster. Stochastic modelling also provides
the opportunity to investigate the source of variation in inflammasome formation between
technical replicates, which could be compared to different actualizations of the stochastic
system (or different runs of a stochastic simulation). However, deterministic modelling is
more amenable to analysis, and may still give useful insight into the behaviour of the system.
It is interesting to note that much of the existing coagulation modelling is fairly abstract
in nature; with the exception of NP modelling (which is explicitly informed by biological pro-
cesses) and some industrial applications, many of the studies described above are con-
cerned with mathematical manipulation of the models. While exact solutions are often useful,
for many models described above they cannot be obtained, and much of the existing analy-
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sis relies on asymptotic results for large times or analysis of gelation processes. Neither of
these is of particular concern in inflammasome modelling; in the former case, the monomer
pool in inflammasome formation is limited, and the end result of the system not particularly
interesting (all reactants are absorbed into a single cluster), and in the latter case, although
we are interested in the emergence of a single large complex, this does not correspond to
the infinite-mass situation which is described by gelation.
1.6 The biology of lesion formation
1.6.1 Early stages of Salmonella infection
Salmonella infections are usually acquired orally, via consumption of contaminated food in
the case of humans. Both typhoidal and nontyphoidal serotypes cross the intestinal wall and
enter the bloodstream either via endocytosis into M-cells or by passing through tight junctions
[Hopkins et al., 2000, Rescigno et al., 2001, Paradis et al., 2021]. Typhoidal serovars may
also be internalised by CD18-positive leukocytes and breach the gastrointestinal wall within
these cells [Vazquez-Torres et al., 1999].
The bacteria can then pass directly into the bloodstream, or reach the bloodstream via
lymph vessels and nodes. Typhoidal serovars travel either extracellularly or inside leukocytes
[Vazquez-Torres et al., 1999], and ultimately arrive at the liver and spleen, where they are
internalised by resident phagocytes [Richter-Dahlfors et al., 1997, Salcedo et al., 2001].
In general, it is advantageous for the bacteria to reside and replicate within native cells;
Salmonella has evolved numerous features to evade detection and clearance mechanisms
within phagocytes by which they have been engulfed; this is critical to the virulence of
Salmonella [Fields et al., 1986]. Phagocytic cells rely on reactive oxygen and nitrogen
species (ROS and RNS)-dependent processes to limit intracellular bacterial growth; how-
ever, these can be subverted by the Type 3 Secretion System (TTSS) in Salmonella which
inteferes with localization of ROSs and RNSs to the phagosome and the production of
ROSs, allowing replication of bacteria within the cellular environment [Mastroeni et al., 2000,
Vazquez-Torres et al., 2000, Salcedo et al., 2001, Cirillo et al., 1998, Helaine et al., 2010].
This ability to persist in the intracellular environment allows bacteria to avoid the dangers
of the extracellular environment; in particular, extracellular bacteria are vulnerable to op-
sonisation which increases ROS-dependent antimicrobial function of phagocytes with which
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they come into contact [Fields et al., 1986, Rossi et al., 2019]. Eventually, however, the
compromised cell is removed via cell death, but this may allow further dispersal of bacteria,
promoting the spread of the infection [Lindgren et al., 1996, Brown et al., 2006]. Therefore, it
is necessary for the innate immune system to find a balance between cell death processes,
which prevent bacteria replicating within the cell, and release of bacteria from lysed cells.
1.6.2 Formation and morphology of legions
As discussed previously, a key characteristic of Salmonella infections is the formation of
lesions (i.e. a cluster of infected phagocytic cells) in the liver and spleen. For ease, from
now on I will consider only the processes of inflammasome formation in the liver, since more
data is available to parametrise the model, although the model laid out in later chapters
could theoretically also be applied to the spleen with some changes in parametrisation. An
overview of stages in lesion formation is given in Figure 1.6.2.
Early in the systemic infection, bacteria reside in individual isolated resident cells in the
liver. Infected cells, or cells which have had extensive contact with bacteria, release various
cytokines including TNF-α, IL-12, IL-18 and interferon (IFN)-γ. TNF-α acts as a chemokine,
attracting other immune cells to the site of an infection, and has a particularly important
role in lesion formation, and thus also limitation of disease spread, since lesions cannot
form correctly — or at all — in its absence [Mastroeni et al., 1991, Mastroeni et al., 1992,
Mastroeni et al., 1993, Everest et al., 1998]. IFN-γ also plays a key role, although this
appears to be more associated with bacterial killing and prevention of bacterial infiltration
of cells than lesion formation [Kagaya et al., 1989, Muotiala and Mäkelä, 1990, Nauciel
and Espinasse-Maes, 1991]. IL-12 and IL-18 promote IFN-γ production by other immune
cells [Mastroeni et al., 1996]. IL-12 is also responsible for immunosuppresion during acute
infection [Mastroeni et al., 1996]. It has also been demonstrated that IL-4 and IL-15 may
be important in clearance of Salmonella infection [Everest et al., 1997, Hirose et al., 1999].
There is also a role for cellular adhesion molecules such as ICAM-1; these are expressed in
regions near lesions. However, it is unclear how their presence affects lesion formation or
bacterial clearance, and experiments comparing the response of naive and vaccinated wild-
type and ICAM-1 knockout mice suggest a link with acquired, rather than innate, immune
processes [Clare et al., 2003].
Cytokines are also released through pyroptosis since this is a lytic form of cell death,
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and the cell contents are dispersed. As more cells are attracted by chemokines and become
infected in a localised area surrounded by healthy tissue, a lesion is formed [Richter-Dahlfors
et al., 1997].
At early times, lesions are dominated by recruited neutrophils [Richter-Dahlfors et al.,
1997, Conlan, 1997]. At later times, around a day into the infection, the neutrophils are re-
placed by macrophages; lesions are dominated by monocyte-derived macrophages, which
arrive via the bloodstream [Hormaeche and Mastroeni, 1990]. It is unclear to what extent
Kupffer cells (resident macrophages in the liver responsible for immune surveillance) are in-
volved in this process; these cells derive from an entirely different lineage from the monocyte-
derived macrophages, which arrive via the bloodstream [Beattie et al., 2016]. In some cases,
resident macrophages have been observed to remain at inflammatory sites, but do not ap-
pear to be depleted by the processes of infection and cell death which the monocyte-derived
macrophages undergo, although they have been shown to phagocytose Salmonella [Nnalue
et al., 1992]. The motility of Kupffer cells may be an important factor; the majority of Kupf-
fer cells appear to be sessile, although there is some disagreement on the extent to which
Kupffer cells are motile [Frevert et al., 2006].
The lesions evolve into spatially separated clusters which are approximately spherical in
shape, and around 50 − 100µm in radius [Richter-Dahlfors et al., 1997, Man et al., 2014a].
Each cell shows low bacterial counts, with the majority of cells containing a maximum of less
than ten bacteria (this number is higher in immunocompromised hosts) [Sheppard et al.,
2003, Helaine et al., 2010]. The rate of bacterial replication decreases with the bacterial
load in that cell, although the lysis rate remains constant [Brown et al., 2006].
Bacteria are released from the lesion when cells within the lesion undergo cell death;
in general this is thought to be via pyroptosis, although it has been suggested that apop-
totic cell death plays a role in dissemination of bacteria [Richter-Dahlfors et al., 1997, Grant
et al., 2008b, Yu et al., 2020]. The bacteria released go on to infect other phagocytes and
form further lesions [Sheppard et al., 2003]. Interestingly, lesions appear to be completely
functionally independent, bacteria released from one lesion do not spontaneously join other
lesions, and the reinfection rate of phagocytes which have already been infected is very low
[Sheppard et al., 2003, Gog et al., 2012]. Furthermore, mature lesions do not increase sig-
nificantly in size; instead, as the total bacterial burden grows, the total number of lesions
increases [Sheppard et al., 2003].
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In the delicate balance maintained by the immune system between the removal of cells
which have been compromised, and the prevention of bacterial growth, it is unclear what role
lesion formation plays. Failure to form lesions leads to rapid growth and spread of bacteria
[Conlan and North, 1992], but it is not clear whether this is directly related to the spatial
structure of lesions, or whether lesion formation is simply a side effect of the combined dy-
namics of chemokines, phagocytic cells and bacteria. One interesting theory is that at later
times, fibroblasts are attracted to lesions by the chemokine gradient and form a barrier sur-
rounding the lesion, possibly to prevent the escape of bacteria to form further lesions. This
theory is analogous to the process of foreign body granuloma formation, a reaction which
occurs in response to implanted biomaterials; in particular, neutrophils are first recruited to
the implant site, then prompting the recruitment of macrophages, which attempt to phago-
cytose the implant (thus far, this process is analogous to lesion formation). The recruited
macrophages then amalgamate into foreign body giant cells, before fibroblasts are recruited
to form a dense outer ‘capsule’ around the implant [Anderson et al., 2008, Morais et al.,
2010, Sheikh et al., 2015, Dondolossa et al., 2016]. It would therefore be useful to investi-
gate whether the recruitment of fibroblasts or another similar process would be necessary
for stable lesion formation.
1.6.3 Unanswered questions
The existing literature on Salmonella lesion formation leaves some room for clarity, which
could be expanded upon using mathematical modelling. Firstly, it is unclear how the spatial
structure of lesions forms at all. A spatial mathematical model would be useful in determining
whether chemokine gradients are sufficient for spatial patterns to form, and, in combination
with reaction and diffusion processes, remain stable over time, or whether another mech-
anism (such as the lesions becoming enclosed by a layer of fibroblasts) is necessary to
maintain the shape of lesions. Secondly, it is unclear what prevents the spread of bacteria
and cells between lesions; it is possible that cellular stiffening and reduction of motility plays
an important role here [Man et al., 2014a], but this requires further investigation. Thirdly, it is
unclear what role different cell death pathways may play in lesion formation — in particular,
to what extent apoptosis plays a role alongside lytic cell death.
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(a) An infected resident phagocyte produces
chemokines to attract other phagocytes
(b) Neutrophils are recruited and infected to
form a lesion. Neutrophils in the lesion pro-
duce chemokines, and lyse, releasing bacte-
ria and a large amount of chemokines.
(c) Neutrophils are replaced by
macrophages. Macrophages in the le-
sion produce cytokines and chemokines, and
lyse, releasing bacteria and a large amount
of chemokines.
(d) It has been suggested that at later stages,
lesions are surrounded by a layer of fibrob-
lasts which prevent bacteria escaping.
Figure 1.5: Stages in Salmonella lesion formation
1.7 Mathematical modelling of tissue-level innate immune and
inflammatory processes
There have been various previous attempts to model innate immune and inflammatory pro-
cesses at the tissue or organ level. In general, these models track the abundance of different
varieties of cell in a tissue; these often include macrophages, neutrophils, monocytes and
resident cells in the tissue. In the case of models of infection, infectious agents such as
bacteria or viruses are also tracked. Finally, other relevant substrates such as pro- or anti-
inflammatory mediators, medical treatments, or downstream products of the system which
are of particular interest (for example, biomarkers of disease) may be included. Throughout
this section, I will refer to all entities represented by a variable in this model as ‘reactants’.
In the case of spatial models, the abundance of each of these reactants at each location
is noted separately (or alternatively, for some classes of model, the location of each individual
cell or other reactant may be tracked over time). Reactants may interact only when they are
in close spatial proximity.
Most tissue-level models of inflammation can be categorised as one of the following:
• Non-spatial, continuous, deterministic ODE models
• Spatial, continuous, deterministic PDE models
• Spatial, discrete, stochastic agent-based models
In this section, I will document applications of each of these types of model in modelling
inflammation in tissues, explaining the mathematical form of the class of model, giving exam-
ples of the scenarios which have been modelled using this methodology, and examining in
more depth models which have been particularly influential in the development of this field,
or which are particularly relevant to the modelling of Salmonella infection.
In particular, it is important to note that in developing mathematical models, especially
of systems as complex as the innate immune response to infection, there is inevitably a
trade-off in determining the level of detail to be included in the model. Simpler models have
the benefit of parsimony; reducing the system to its most basic process often gives more
insight into the components of the system which are most important in achieving a given
outcome. In addition, more complex models may rely on the availability of many parameter
values, some of which may not have been measured experimentally; attempting to fit these
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parameters to experimental data could easily lead to overfitting. On the other hand, it is
important not to oversimplify a model to the extent that key elements of the process are
removed. Furthermore, in some contexts, a modeller will be less concerned with illuminating
the underlying mechanisms of a system and more concerned with creating a model with
more predictive power (for example, for in silico experimentation such as tests of therapeutic
interventions), in which case, a complex model may be more appropriate.
1.7.1 Nonspatial ODE models
The simplest class of model is the nonspatial ODE model. Nonspatial ODE models assume
that the reactants are homogeneously distributed over the spatial domain, and only track the
net change in their abundances over the whole domain. The terms in the ODE models corre-
spond to processes which change these abundances, which may be intrinsic to a particular
reactant (for example, birth and death of cells and bacteria, or degradation of substrates), or
could correspond to the interaction between reactants (for example, killing or phagocytosis
of bacteria, production of substrates by cells, or reactions between substrates). As for the
aggregation models described above in Section 1.5.1, these might take a simple mass action
form (rates of change are directly proportional to the abundance of the reactants involved in
the interaction); however, in many cases, it may be more appropriate to use a form of term
which reflects saturation at high abundances, particularly in processes involving bacterial or
substrate uptake by cells. A common form is a ‘Michaelis-Menten-like’ sigmoid term. For two
arbitrary variables R1 and R2, this may take the form dR1dt = −R2
R1
K+R1
for a constant K. This
would reflect a situation in which R2 depletes R1, and the rate of uptake generally increases
with R1, although the rate reaches a plateau as R2 becomes saturated. The constant K is
half of the value of R1 at which R2 becomes saturated.
Such ODE systems can easily be solved numerically, and in some cases analytically. An-
other common approach is to identify fixed points in the system, and determine their stability;
these fixed points give insight into the ultimate fate of the system. Bifurcation analyses can
give insight into how changing the parametrisation of the model affects the number, location
and stability of fixed points. In the case of inflammation in particular, different configura-
tions of fixed points are often interpreted as different clinical outcomes for the inflammatory
process. Bifurcation analysis can thus give insight into how parameter values affect the
outcomes of inflammation in different scenarios.
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ODE models have been used to investigate inflammation in numerous contexts, notably
including wound healing [Nagaraja et al., 2014, Cooper et al., 2015], traumatic brain injury
[Vaughan et al., 2018], psoriasis [Valeyev et al., 2010], rheumatoid arthritis [Baker et al.,
2013], necrotising enterocolitis [Arciero et al., 2010, Arciero et al., 2013] and influenza in-
fection [Price et al., 2015]. However, the majority of models of inflammation either focus on
the behaviour of immune system constituents rather than the specific inflammatory trigger
(‘generic’ models), or describe the scenario of bacterial infection.
The earliest significant ODE model of inflammation was developed by Lauffenburger and
Keller as early as 1979 [Lauffenburger and Keller, 1979], and later refined by Alt and Lauffen-
burger [Alt and Lauffenburger, 1985]; these models were specifically developed to investigate
the effects of transport of innate immune cells and bacteria on inflammation, and were used
to calculate early estimates of the chemotaxis coefficient and rate of phagocytosis. The
model was also used to explain clinical observations of severe infections in patients with de-
fects in leukocyte chemotaxis. The model consists of a very simple three-component ODE
system describing interactions between phagocytes, bacteria and an ‘attractant’ chemokine.
The model includes simple linear and mass action terms corresponding to death of bacteria
and phagocytes, phagocytosis of bacteria, release of attractant by phagocytes, and birth of
bacteria. Significantly, this model indirectly includes chemotaxis of the phagocytes towards
the attractant; however, since this is a non-spatial model, the chemotaxis process is defined
as introduction of phagocytes from outside the system at a rate proportional to the attrac-
tant concentration. An alternative characterisation was later proposed by Lauffenburger and
Kennedy [Lauffenburger and Kennedy, 1981]; this model is a two-component ODE system
with variables representing bacteria and phagocyte abundance, without explicit inclusion of
an ‘attractant’. However, this model includes a more sophisticated characterisation of the
population dynamics of the reactants, notably including a sigmoid population growth term for
bacteria. The presence of two steady states was also demonstrated, which could correspond
to a disease-free state, and chronic or acute infection.
Analysis of the above models was mostly confined to considering the steady states of the
system, and thus the ultimate fate of the system, although notably different parametrisations
may give rise to systems with a single steady state, or a bistable system, in which either an
equilibrium or elimination state is reached, depending on ICs.
Other influential early models were developed by Kumar et al. [Kumar et al., 2004] and
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Reynolds et al. [Reynolds et al., 2006]. The former model attempts to explain the dynamics
of acute inflammation following bacterial infections using a three-component ODE system
including a general bacterial pathogen and early and late proinflammatory mediators. This
model is unusual in that it does not explicitly include immune cells. In contrast, the model pre-
sented by Reynolds et al. includes a bacterial pathogen, neutrophils, an anti-inflammatory
mediator and a variable which measures overall damage to the tissue resulting from inflam-
mation. The latter variable is a useful tool to link the inflammatory process directly to clinical
outcomes. In both cases, bifurcation analyses were carried out on the respective models,
identifying areas in the parameter space corresponding to different possible fates for the sys-
tem, which in turn correspond to different clinical presentations of sepsis. In particular, the
model by Kumar et al. identifies possible conditions for persistent or recurrent infections.
A particularly persuasive model was developed by Dunster et al. [Dunster et al., 2014].
This is a generic ODE inflammation model including five components, namely apoptotic and
active neutrophils, macrophages, and pro- and anti-inflammatory mediators. A series of
slightly different models was considered to refine model design; for example, models with
and without an anti-inflammatory mediator, and with and without a positive feedback loop
in which pro-inflammatory mediators are released by neutrophils. Once again, a bifurcation
analysis approach was used to assess the different possible outcomes of inflammation.
More recently, the development of much more complex models has been more common.
For example, Shi et al. [Shi et al., 2015b] developed a very large ODE system describing
bacterial infections of the liver, including Kupffer cells, bacteria, neutrophils, damaged tissue,
monocytes, hepatocytes, TNF-α, HMGB-1 (another pro-inflammatory cytokine) and IL-10.
This model is unusual in that it includes a large class of specifically-defined cell and cytokine
types, specifically including resident cells which are not directly included in the inflamma-
tory process. This gives a useful insight into the wider downstream effects of inflammation;
however, in contrast to the models described above, the complexity of this model is such
that stability analysis would have been unfeasible, and the authors’ analysis was conducted
using only numerical solutions to the model. The model was used to reproduce clinical find-
ings regarding the lack of efficacy of anti-TNF-α treatments in resolving sepsis; however,
this model arguably suffered from a lack of parsimony in terms of its ability to elucidate the
underlying processes.
Finally, a recent model presented by Torres et al. exemplifies another approach [Torres
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et al., 2019]; this model, of infection in the peritoneal cavity, is an ODE system with com-
ponents describing neutrophils, active and inactive macrophages, a generic inflammatory
stimulus and a pathogen. This study was particularly interesting since it was deliberately de-
signed to fit an in vivo experimental dataset, with the aim of developing a tool for hypothesis
testing of therapeutic interventions. The authors conducted a very thorough goodness-of-fit
and sensitivity analysis for each of the parameters in the model.
There is a clear development of ODE models from simpler models, for which bifurcation
analysis is possible, to more complex models, which include many interacting elements but
which realistically can only be analysed numerically. Adding complexity to the system comes
at a cost of begin unable to use tools such as bifurcation analysis to gain insight, and poten-
tially obfuscates the most important underlying mechanisms driving particular behaviours or
clinical outcomes.
A common difficulty is the lack of accurate experimentally-derived parameter values; this
is less problematic when carrying out bifurcation analysis, which attempts to take a global
view of the parameter space, but is a significant issue for models with a large number of
parameters (except in the case of the Torres et al. model, which was specifically motivated
by an existing experimental dataset).
It is notable that so many of these models omit biologically important elements of the
system (for example, the omission of cytokines in the Lauffenburger and Kennedy model, or
immune cells in the Kumar et al. model). These omissions demonstrate that the reactants
which have been removed may not be necessary in creating a system which demonstrates
mathematically interesting and relevant behaviour, although we may wish to include them in
a model to understand their behaviour. However, it is particularly notable that none of the
models described above give a clear account of the dynamics of bacterial spread. Of course,
this is unavoidable when using generic inflammation models, but even the models outlined
above which explicitly portray bacterial infection do not tend to include phagocytosis of bac-
teria, reproduction of bacteria within cells, or cell lysis, focusing instead on the behaviour of
extracellular bacterial growth and death.
Despite their differences, all of the models described above were created with the ul-
timate aim of understanding the endpoints of the system, corresponding to long-term out-
comes. This is a particular aim of steady-state and bifurcation analysis, which focuses on
long-term, equilibrium behaviour of the system. While often especially relevant to clinical
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applications, these approaches give less insight into how those long-term states arise. Fur-
thermore, the assumption of spatial homogeneity is a considerable simplification of tissue
structure in organisms, and may lead to overlooking interesting spatial behaviour occurring
during inflammation (the formation of lesions during Salmonella infection is a clear example).
This motivates the development of models which do include a spatial element, albeit at the
cost of the simplicity and tractability of the ODE models described above.
1.7.2 Spatial PDE models
The simplest generalisation of the non-spatial ODE models are ODE models in which the
spatial domain is divided into discrete compartments, with variables in the ODE correspond-
ing to abundances of each reactant in each compartment. This approach has been used to
model the spread of infection at the whole-organism level, with compartments correspond-
ing to different organs [Grant et al., 2008a]. However, on the tissue level, there is no such
clear delineation into compartments, and a more natural approach when exploring spatial
structure is to use spatial PDEs.
Many spatial PDE models are, or are very similar to, reaction diffusion models; these
traditionally describe chemical reactions in a spatial setting, and consist of a PDE system
with spatially-homogeneous terms describing reactions (which may take the same form as
those in the ODE models described above), and diffusion terms of the form ∂R∂t = D∇
2R for
a variable R, where ∇2 is the Laplace operator and D is the diffusion coefficient.
It also is common for models of inflammation to include terms for chemotaxis, which is
particularly important when modelling the movement of immune cells towards areas with
high chemokine concentration. The form usually used to describe chemotaxis in a reaction-
diffusion system was originally derived by Keller and Segel [Keller and Segel, 1970, Keller
and Segel, 1971]. For a cell abundance R and a chemokine concentration c, a chemotaxis




= D∇2R−∇ · (χR∇c) + spatially homogeneous terms
Here, χ is a chemotaxis coefficient which in theory may be a function of R and c but in
practice is often constant.
In general, these reaction-diffusion systems with or without chemotaxis cannot be solved
analytically; numerical solutions may be obtained, although this is generally somewhat more
67
computationally intensive than for ODE systems. An alternative approach, pioneered by Tur-
ing in 1952 [Turing, 1952], is Turing instability analysis. This approach is used to establish
necessary conditions on the parameters of a reaction-diffusion model for stable spatial pat-
tern formation of any of the reactants to take place. Essentially, this can occur when a fixed
point in a spatially homogeneous version of the system (i.e., the fixed point of the ODE sys-
tem obtained by removing diffusion and chemotaxis terms) becomes unstable once small
spatial perturbations are introduced. This approach can give considerable insight into the
long-term behaviour of a reaction-diffusion system without the need for analytical or numeri-
cal solutions, and is easily generalised to systems containing chemotaxis terms.
As with ODE models, spatial PDE models have been used extensively in modelling in-
flammatory processes, including plaque formation in the central nervous system in multiple
sclerosis [Lombardo et al., 2017, Moise and Friedman, 2021], foreign body reactions to medi-
cal implants [Ibraguimov et al., 2012, Salomonsky and Segal, 2017], necrotising enterocolitis
[Barber et al., 2013] and wound healing [Arciero et al., 2011]. However, once again, the most
prominent models have been generic inflammation models, or models of bacterial infection.
It is worth noting that spatial PDE models are most associated with processes that involve
stable spatial structures or patterns, such as plaques or lesions, since these situations are
most appropriate for Turing instability analysis.
The earliest influential spatial PDE model of inflammation was developed by Lauffen-
burger and Kennedy in 1983 as a simple spatial extension of their 1981 ODE model, de-
scribed above. Their main focus was on deriving stable solutions, and examining the be-
haviour of the net population sizes. However, this study was primarily concerned with the dif-
ferences in net outcome when the spatial and analogous non-spatial models were compared,
rather than in examining spatial structure formation; furthermore, only a one-dimensional
system was considered.
Two models of inflammation particularly relevant to the problem of Salmonella infection
were developed in 2012; one by Penner et al. examining pattern formation in generic skin in-
flammation [Penner et al., 2012], and one by Pigozzo et al. modelling microabcesses formed
due to bacterial infection in a generic tissue [Pigozzo et al., 2012]. The Penner et al. model
is a three-component PDE system including macrophages and a pro- and anti-inflammatory
chemokine; stable and travelling wave solutions are derived, as well as different possibilities
for spatial pattern formation including spots, stripes and gridlike structures. This model was
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used to demonstrate that, provided inhibitor dynamics are sufficiently slow, spatial structures
can form in solutions which are comparable to rashes forming on the skin. The Pigozzo et al.
model is much more complex, with variables representing abundance of living and dead bac-
teria, neutrophils, active and inactive macrophages, proinflammatory cytokines, and healthy
and unhealthy tissue. The model also includes crowding effects, which is unusual for this
class of model. The main focus of this study was to develop computational solutions for the
system for a single microabcess, tracking its development over time, in order to reproduce
experimental measurements of abcess growth. In fact, this model was arguably too com-
plex, since the numerous processes included led to difficulties interpreting the model and,
in particular, understanding which processes are most important in determining the ultimate
behaviour of the reactants; it is also too complex to be amenable to analytical techniques
such as Turing instability-style analysis. The model also includes numerous processes, in-
cluding production of chemokines by numerous cell types, which had not been parametrised
based on experimental data; the parameters in question had to be fitted in order to replicate
experimental results, and it is unclear how reliable these estimates are.
Finally, notably, a generic inflammation model was presented recently by Bayani et al.
[Bayani et al., 2020a]; this model is a five-component spatial PDE system including active
and apoptotic neutrophils, macrophages, and pro- and anti-inflammatory mediators. This
study includes both a bifurcation analysis of spatially homogeneous solutions and computa-
tional solutions revealing possible spatial patterns for results, which establish how aberrant
spatial structures can lead to persistent inflammation. However, none of the end states
identified in this model correspond to the characteristic lesion pattern seen in Salmonella
infection.
Overall, although the PDE models described above do give more insight into the spatial
behaviour of inflammation systems than ODE models, there are still limitations here. The dif-
ficulties of accurate parametrisation has not been averted, and the trade-off between model
complexity and amenability to analysis has not been resolved.
Furthermore, although the Penner et al., Pigozzo et al., and Bayani et al. models
described above could certainly be used to model Salmonella infection in the liver, none
of these have explicitly included the dynamics of bacterial infection and replication within
phagocytes, nor do they differentiate between apoptotic and lytic cell death, or consider the
importance of the latter in inflammatory processes . Furthermore, none of these models
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demonstrates the characteristic development of multiple lesions throughout the tissue.
1.7.3 Agent-based models
The final common class of model of inflammation is agent-based models (ABMs); in contrast
to ODE and PDE models, these are generally discrete and stochastic, and entirely computa-
tional simulation-based. In these models, cells, bacteria, cytokines and other reactants are
represented as individual ‘agents’, which behave independently according to a set of pre-
determined rules which reflect their behaviour in the biological system. The rules for each
agent define how they move in space (either in continuous space or on a lattice grid), how
they interact with other agents, and when they might be introduced to or removed from the
system altogether. In general, these rules are used to update the location and status of
each agent at discrete time steps. In some cases, ‘hybrid’ models are used, in which some
reactants are represented as agents, and others are described as background environmen-
tal factors controlled by ODEs or PDEs, which may affect the behaviour of agents. This is
particularly common for substrates such as chemokines, and the extracellular matrix (ECM)
if this is included in the model.
Similarly to discrete stochastic models, ABMs may have the advantage of accuracy at
small reactant counts over continuous, deterministic ODE and PDE approaches; ABMs may
also be more suitable for representing behaviour such as fluctuations and switching, if this
arises.
Another major advantage of ABMs is their flexibilty; they can easily be adapted to include
different behaviours for agents simply by updating the defining rules. It is also possible to
include far more complex behaviours than are practical to represent in an ODE or PDE; for
example, explicitly including the biomechanics of cells (this may include changes of dynam-
ics due to deformation, collision, adhesion or interaction with the ECM). It is also much more
feasible to combine modelling approaches across scales using ABMs; a number of ABMs
have been developed which integrate the results of inflammation at an organ level to un-
derstand the effects at a whole-organism level [An, 2001, Cockrell and An, 2017, McDaniel
et al., 2019]. However, the flexibility of ABMs comes at a cost; they are generally time con-
suming and computationally expensive to run (although they are usually easily parallelised),
especially in comparison to most ODE or PDE solvers. Construction of an ABM generally re-
lies on a large number of assumptions, including parameter estimates, as they often include
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processes which have not been quantified based on experimental data. Furthermore, they
lack the transparency of ODE and PDE models, and the results are not easily generalised to
different parametrisations, making them difficult to interpret.
ABMs have been used in numerous contexts related to inflammation and injury, including
vocal fold inflammation [Li et al., 2008, Seekhao et al., 2018] and ulcer formation in spinal
cord injury [Solovyev et al., 2013, Ziraldo et al., 2015]. Other models have been created
to represent chronic pathologies including fibrosis of the liver [Dutta-Moscato et al., 2014],
asthma [Song et al., 2012, Pothen et al., 2015], pulmonary fibrosis [Warsinske et al., 2016]
and chronic obstructive pulmonary disorder [Ceresa et al., 2018]. Other models have linked
the effects of inflammation with oncogenesis [An and Kulkarni, 2015]. As with ODE and PDE
models, however, most models describe generic inflammation or specific bacterial infections;
aside from Salmonella infection, models have been created specifically to describe the ef-
fects of Mycobacterium tuberculosis [Fallahi-Sichani et al., 2010, Cilfone et al., 2013, Marino
and Kirschner, 2016], Heliobacter pyri [Carbo et al., 2013, Alam et al., 2015], and Pseu-
domonas aeruginosa [Seal et al., 2011].
One ABM particularly relevant to lesion formation was developed by Shi et al. [Shi et al.,
2016c, Shi et al., 2016b]. The aim of this study was to analyse how innate and adaptive
immune processes link to organ dysfunction, persistent infection or healing in Salmonella in-
fection in the liver, and to provide a tool to trial potential therapeutic interventions. This ABM
includes many classes of agents including hepatocytes, Kupffer cells, bacteria, resting and
active neutrophils, TNF-α, HMGB-1, monocytes, monocyte-derived macrophages and IL-10.
This model captured much of the complexity of inflammation resulting from Salmonella in-
fection, and unusually, a complex spatial domain was constructed to represent the structure
of liver tissue. However, although many parameter values were derived from existing ex-
perimental literature, in many cases approximations or estimations had to be used to fully
parametrise the model. Furthermore, instead of analysing the spatial behaviour of the sys-
tem, much of the analysis in this model focused on derived global variables such as total
counts for different classes of agents across the domain. This therefore calls into question
how necessary the construction of a biologically accurate spatial structure was in this analy-
sis. It is also worth noting that this model does not include phagocytosis of bacteria or lysis
of infected cells.
More recently, a hybrid ABM of general inflammation on a tissue level was proposed
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by Bayani et al. [Bayani et al., 2020b]. In this model, macrophages and neutrophils are
modelled as agents, while background levels of pro- and anti-inflammatory mediators are
modelled using spatial PDEs. Significantly, results from this model were linked successfully
to in vitro cell tracking data, demonstrating that the ABM succesfully captured the movement
of individual cells; the model was also used to demonstrate how aberrant chemotaxis in
neutrophils can lead to failure of resolution of inflammation. However, once again there was
little consideration of spatial pattern formation in this study, with a focus on overall abundance
of inflammatory markers over time.
Overall, ABMs capture the complexity of biological systems extremely well, and are par-
ticularly useful tools both in a clinical or in silico experimental context, and are much more
likely to have predictive power than the ODE and PDE methods described above. However,
they do not necessarily give more insight into the aspects of a system which are particularly
responsible for its characteristic behaviour. While conclusions can still be drawn by statistical
analysis of simulation output (which is in fact similar to the approach used in Chapter 5 of
this thesis, albeit in a different context), it is worth considering whether, for some purposes,
a less computationally-intensive method such as spatial PDE modelling might in fact give
more insight.
It is also worth noting that, once again, none of the models described here give a clear
representation of bacterial infection and intracellular reproduction dynamics, nor is lysis ex-
plicitly included in the models described above.
1.8 Research aims
As outlined above, there are many unanswered questions and inconsistencies surround-
ing both inflammasome formation processes and lesion formation. The overall aim of this
research with regard to the inflammasome is to provide a more cohesive answer to the ques-
tion of how the inflammasome forms. In particular, I wished to address the following points:
• Where does variation in inflammasome formation between samples arise?
• Why is there variation between the behaviours of different inflammasome systems?
• What form do NLR oligomers take?
• How many NLR oligomers are involved in the formation of a single inflammasome?
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• Do ASC specks form through linear filamentous growth of PYD-PYD filaments, or does
branching of these filaments occur?
Answering these questions using a coagulation modelling methodology will allow us to
build towards a logically cohesive conceptual model of inflammasome formation.
The aim of this research with regard to lesion formation is to clarify why the distinct forms
of hepatic lesions resulting from Salmonella infection arise; most importantly, why lesion size
is stable over time, why there is very little mixing of cells and bacteria between lesions, and
why lesions are limited in size even as the bacterial population grows.
In order to do this, I will use a simple spatial PDE model of inflammation. I have chosen
to use this approach since it permits analysis of spatial structure without the complexity of
an ABM. In addition, since insight into the system rather than predictive power is useful here,
an ABM would be less appropriate. Unlike previous studies, the focus here will be on spatial
structure and pattern formation, rather than the total number of reactants at late times and
characterisation of late-time behaviour corresponding to different clinical outcomes.
Furthermore, since it is rare for models to include the downstream effects of inflamma-
some formation, including lytic cell death and reduction of motility in macrophages following
infection, these will all be built into the model. This will allow us to examine how these
processes affect lesion formation in more detail. In particular, I aim to establish how the bal-
ance of apoptosis and lysis, and the decrease in motility of phagocytes following infection,
contribute to lesion formation.
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Chapter 2
Analysis of an experimental dataset
describing inflammasome formation
2.1 Introduction
Any successful model of the inflammasome must be created in the context of the existing
experimental data. While this data is abundant, much is either qualitative, or fairly sparse
in terms of data points, rendering it inappropriate for statistical analysis or model fitting.
Some of the most mathematically useful datasets involve time series microscopy of cells
with fluorescently labelled proteins, similarly to the dataset described in [Cheng et al., 2010],
for transfected ASC in HeLa cells.
In this chapter I will present two existing experimental datasets of inflammasome forma-
tion, which are based on time series imaging of cells forming NLRP3 inflammasomes. I will
demonstrate how quantitative data describing abundance of reactants involved in inflamma-
some formation can be extracted from these images, as well as explaining the shortcomings
and difficulties of analysing this dataset. I will then describe various methods of extracting
summary statistics from the quantitative data, which will be analysed in its own right, and
later compared to mathematical models (see Chapters 4 and 5). I will also discuss how
these datasets motivate model development. Finally, I will explain possible future extensions
to the analysis of these datasets, both mathematical and experimental.
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2.2 Description of experimental dataset
The two datasets I have used are similar to the datasets presented in the previous study
carried out by Cheng et al. [Cheng et al., 2010], but represent ASC speck formation as a
result of NLRP3 inflammasome activation. These datasets can be used to derive relative
abundances of ASC monomers over time, as well as ascertaining the time of ASC speck
formation, in cells showing inflammasome formation.
In order to be able to carry out statistical analyses on these datasets, I summarise the
relevant time series data for each cell by deriving a number of ‘characteristic times’, which
describe biologically meaningful properties of each time series; for example, time at which
an ASC speck forms, and time taken for monomer abundance to be reduced by a given frac-
tion in both compartments; these are explained more fully in Sections 2.3.3 and 2.3.4. This
‘characteristic time’ approach allows easy comparison of time series within the dataset, so
that conclusions may be drawn about variation in inflammasome formation within a popula-
tion. Analogous characteristic times can also be derived from the solutions to mathematical
models, giving us a direct point of comparison between experimental data and models.
Both experimental datasets used were generated by Alessandro Rizzo, and consist of
live-imaging time series of murine macrophages from a cell line (C57/BL6 NLRP3-/- NLRP3-
flag ASC-mCerulean) which overexpresses ASC with a cerulean fluorescent tag [Andrea
et al., 2013]. In one sample, caspase-1 has also been labelled with FLICA, and in the
other, MitoTracker has been used to image the mitochondria of the cell. However, I primarily
focused on the behaviour of ASC, which is isolated in the cerulean channel (the varieties of
MitoTracker and FLICA used both appear in the red channel).
The cells were seeded at a density of 2 × 108 cell/ml in a glass-bottomed dish and the
following day were primed with 200 ng/ml LPS for 3 hours. In the case of the MitoTracker
data, at this point the cells were stained with MitoTracker Red CMXRos. The cells were then
treated with 10 µl nigericin immediately prior to imaging (in the case of the FLICA dataset,
1.5 µl of FLICA 660-YVAD-FMK was dissolved in the media). This stimulated formation of
the NLRP3 inflammasome in the cells in the sample.
For the FLICA dataset, imaging was carried out on a Leica SP5 multi-channel AOBS
confocal laser scanning microscope, equipped with a temperature and CO2-controlled sam-
ple chamber for live-cell imaging, zoom 2x, laser 458 50%, 633 20%, objective HCX PL
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APO CS 40.0x1.25 OIL UV, with images taken at intervals of 5.16 seconds. For the Mito-
Tracker dataset, imaging was carried out on an Olympus FV1200 microscope equipped with
a temperature and CO2-controlled sample chamber for live-cell imaging, zoom 2x, laser 458
1.5%, 559 0.5%, objective PLAPON60XOSC2 NA:1.40 with images taken at intervals of 1.69
seconds.
The FLICA dataset consists of four time series taken over three independent experi-
ments, and the MitoTracker dataset consists of eleven time series taken over five indepen-
dent experiments, with a variety of different endpoints.
In the resulting images, fluorescence in the cerulean channel is initially diffuse throughout
the cell, both in the nucleus and cytosol (Figures 2.1 and 2.2). Following activation, the total
intensity in the nucleus and cytosol decreases almost to background levels, with depletion
of intensity faster in the cytosol than the nucleus, while intensity in the speck area sharply
increases as the inflammasome was assembled.
For each cell in these images, I therefore tracked the total intensity of the cerulean chan-
nel in the nucleus, cytosol, and the area where the ASC speck finally formed, over time.
These intensity measurements are arbitrary and cannot be used to derive the exact con-
centrations or abundances of ASC in the cell; however, they can be used as a proxy for the
total abundance of ASC monomers in each region relative to other regions, and the initial
intensities. I therefore extracted quantitative data from the FLICA and MitoTracker datasets
using a custom-designed, semi-automated MATLAB script, loosely based on code written
by Alessandro Rizzo and Eugenia Cammarota. I will describe this analysis in the following
section.
2.3 Analysis of data
2.3.1 Preprocessing
Since there are many frame-wide discontinuities in intensity across time series, I normalised
intensities in each frame by dividing by the total intensity across the frame at each timepoint.
This had a smoothing effect on output data, which was then more amenable to fitting.
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t = 0s t = 1700s
Figure 2.1: First and last frame of image from the FLICA dataset (Well 1, 14/05/2014)
shown in the cerulean channel; time is measured from the addition of LPS. ASC appears
as cerulean in these images; initially ASC is diffuse throughout the cells. In the final frame,
some cells display a very bright, concentrated spot corresponding to the ASC speck, indicat-
ing that inflammasome formation has taken place; others still show ASC diffuse throughout
the cell, indicating that inflammasome formation has not taken place.
t = 0s t = 135s t = 290s
Figure 2.2: Example frames cropped to show one cell from the dataset in Figure 2.1. ASC
is initially diffuse throughout the cell. By t = 135s after infection, an ASC speck is visible,
but not all ASC has been depleted from the rest of the cell; the nucleus, from which ASC is
depleted more slowly, is visible as a shadow adjacent to the speck. By t = 290s, virtually all
ASC throughout the cell has been depleted.
2.3.2 Extraction of intensity traces
In order to isolate the cell and nucleus areas, the script requires submission of a user-
defined region of interest (ROI) using a point-and-click method to delineate a polygon on a
user-specified frame in which the relevant area can be seen clearly (Figure 2.3). While this
method requires considerable input from an individual user, it is generally robust to variations
in frame choice and ROI definition. I analysed only cells which remain fairly static, remain
fully within the field of view throughout the time series, do not overlap with other cells, and
display a fully-formed speck before the time series concludes. In total, I identified 53 usable
cells in the FLICA dataset and 23 usable cells in the MitoTracker dataset All cytosolic and
nuclear traces are shown in Figure 2.4.
Following user submission of cell and nucleus areas, the speck area is defined auto-
matically by thresholding, for a user-specified frame in which it is clearly visible; setting a
threshold of 85% of the maximum intensity within the cell area in the given frame was suf-
ficient to isolate the speck in all cases. The intensities of pixels within each of these ROIs
(cytosol, nucleus and speck) are then integrated over time to give individual intensity traces
(Figure 2.5).
In general, the traces for cytosolic and nuclear regions show an initial lag in which the in-
tensity remains approximately constant, followed by a period of sharp decrease to a plateau
intensity at background level, as ASC monomers are absorbed into the ASC speck. The
initial lag is likely to originate from various processes, including time taken for nigericin to be
internalised by the cells, and for activation (and possibly oligomerisation) of NLRP3 to take
place. There is considerable variation in the length of this lag, even within the same sam-
ple. There is also variation in the gradient of the intensity decrease in nuclear and cytosolic
traces corresponding to monomer depletion by speck formation. The speck region shows an
initial lag followed by a sharp increase as the ASC speck forms, finally reaching a plateau as
the pixels become saturated. All traces show considerable noise due to random fluctuations
in intensity. Not all cells within the dataset show speck formation before the endpoint of the
timeseries; however, it is useful to track the number of cells which do not form specks during
the time series, to gain a fuller view of the distribution of speck formation times.
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Cell ROI Nucleus ROI
Figure 2.3: Examples of ROI delineation to demarcate the cell and nucleus areas (shown as
yellow polygons) for a cell from the FLICA dataset.
Cytosolic traces, FLICA dataset Cytosolic traces, MitoTracker dataset
Nucleus traces, FLICA dataset Nucleus traces, MitoTracker dataset
Figure 2.4: Plots of all traces from the FLICA and MitoTracker datasets in the nuclear and
cytosolic regions
Cytosolic and nuclear traces Speck area trace
Figure 2.5: Representative examples of traces extracted from data for one cell from the Mi-
toTracker dataset. Note that all traces have been scaled by the total intensity in each frame.
Following an initial plateau, the cytosolic and nuclear traces show a decrease corresponding
to ASC monomer depletion, followed by another plateau as no ASC monomers remain. After
the initial plateau, the speck trace shows a rapid increase as the ASC speck grows, which
reaches another plateau as the pixels in this area become saturated.
2.3.3 Fitting breakpoints
In order to understand when inflammasome formation begins and monomers begin to be de-
pleted, I aimed to divide the traces into two periods over which the intensity is approximately
constant (the initial lag and final plateau), separated by a period of intensity decrease for the
cytosolic and nuclear regions, and a period of increase in the speck region. Identifying the
onset of intensity decrease in the speck and nuclear regions gives an estimate for the time at
which inflammasome formation begins; meanwhile, identifying the time at which the speck
region reaches a plateau gives an estimate for the time of completion of inflammasome for-
mation. Identifying the start and end of the decrease in intensity in the nuclear and cytosolic
regions also gives an interval for which a rate of decrease can be fitted.
In order to identify the ‘breakpoints’ between these regions, I fitted a trilinear model to
each trace, i.e., a continuous curve consisting of three straight lines with different gradients;
an example is shown in Figure 2.6. I assumed that the gradient in each trace before and
after inflammasome formation is approximately constant, but need not be zero (this may
help to account for the photobleaching effect). Similar methods have been used elsewhere
to identify changepoints in the gradients of noisy data, for example, in identifying epidemic
onset from disease prevalence data [Charu et al., 2017]. It is worth bearing in mind that
the initial lag may partly arise through other processes (for example, NLR oligomerization)
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taking place before cluster joining and growth begins; however, the models demonstrate that
the depletion of monomers and growth of clusters may follow sigmoid kinetics, which may
also contribute to the initial lag. This will be examined further in Chapter 6.
I have assumed that the ith datapoint xi is approximately distributed as follows:
(2.1)xi = β0 + β1ti + β2(ti − tb1)+ + β3(ti − tb2)+ + εi
where ti is the time at which measurement xi is taken, tb1 and tb2 are the start and end
point of the interval of speck formation, β0 is the initial intensity, and β1, β2 and β3 are the
gradients of each section of the trilinear fit. εi is the error at datapoint i; I have assumed
these are independent and normally distributed with the same variance, which allows the
model to be treated as a standard linear model.
(ti − tbj )+ is defined as follows:
(2.2)(ti − tbj )
+ =

ti − tbj if ti > tbj
0 otherwise
I fitted this model to all traces, calculating the maximum likelihood for each possible pair
of tb1 and tb2 by fitting a standard linear model using the least squares method. I then
estimated the values of tb1 and tb2 by choosing the pair yielding the largest overall maximum
likelihood.
In some cases, I excluded cells from further analysis since the code failed to fit one
or more traces associated with that cell; this generally took place when speck formation
occurred within a few frames either of the start or finish of the time series, so that either the
first or last section of the trilinear fit was extremely short, or the noise around these points
prevented identification of the breakpoint in question by the algorithm. I also excluded traces
for the nuclear and cytosolic regions which did not show a negative gradient between the
two breakpoints.
For both datasets, the trilinear fit model successfully identified intervals of speck for-
mation with negative gradient for cytosolic and nuclear traces for only 34/53 FLICA traces
and 19/23 MitoTracker traces; however, it was more consistently successful than any other
method trialled (for example, using separate bilinear fits to identify both breakpoints). The
trilinear fit method is also preferable since it does not require constraints on the β values,
considers the whole trace rather than just a small interval, and requires no user input.
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Figure 2.6: Trace extracted for the nuclear compartment for one cell from the FLICA dataset,
with trilinear fit and fitted exponential decrease for that trace plotted in purple and green
respectively.
Once I had identified the interval of speck formation in nuclear and cytosolic traces, I then
fitted a single-term exponential function of the form aebt to this interval, to quantify the rate
of decrease in the cytosolic and nuclear traces during speck formation; an example is given
in Figure 2.3.4.
2.3.4 Estimation of monomer depletion characteristic times
Another set of variables which can easily be compared to simulated data and models are the
monomer depletion characteristic times t1/q — the time taken for each monomer population
to deplete by a fraction 1/q of its initial value. For each usable trace, I therefore estimated
the value of t1/2 and t1/10. To avoid noise due to random fluctuations in intensity, I first
smoothed the data by calculating a moving median for each point in the time series, using a
window size of 10 (this was sufficient to smooth noise in the original dataset without losing
too much resolution). I then located the first timepoint after tb1 when the intensity was less
than (1−1/q)β0, for the values of tb1 and β0 calculated earlier. An example is given in Figure
2.7. I also excluded traces for which t1/2 and t1/10 could not be identified, leaving 30 traces
in the FLICA dataset and 20 in the Mitotracker dataset.
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Figure 2.7: Example of total intensity in the nuclear region for a cell in the FLICA dataset,
scaled by total intensity across the frame (plotted in purple), with smoothed data plotted in
green above. Characteristic times for this trace are also shown: t1/q represents the time
taken for the intensity to decrease by a fraction 1/q.
2.3.5 Limitations
Even post-normalisation, the trace extraction method described above inevitably results in
somewhat noisy data; while cells are theoretically fairly static throughout the time course,
especially in cells in which inflammasomes have already formed (see [Man et al., 2014a]),
there is still some movement on the whole-cell level. Cells may move laterally, out of the
user-designated ROI, and in some cases, enter the ROI of other cells. In some rare cases,
the cells may move out of the focal plane, so that the speck is no longer visible. Further
inaccuracies are caused by the phenomenon of photobleaching, which results in a decrease
of intensity of individual fluorophores over time; this is particularly evident in many traces
which demonstrate an initial slight decrease in intensity well before speck formation or in the
plateau following speck formation (Figure 2.5). Furthermore, the information which can be
extracted from the trace for the speck area is limited due to the fact that the pixels in this
area tend to saturate before cytosolic and nuclear intensities have fully depleted.
It is also important to note that macrophages are three-dimensional entities; I have as-
sumed that the two-dimensional images in this dataset form a representative slice through
the cell, and that there is negligible variation in abundances in the z-direction, but this cannot
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be guaranteed. A further source of inaccuracy arises from the fact that the speck area is
removed from the cytosolic compartment before the speck itself is formed; however, this is
sufficiently small that it is unlikely to make a significant difference to our overall results.
Finally, it is worth bearing in mind that the data is truncated by the endpoint of the time
series of images; ASC speck formation times cannot be identified past this time, although in
practice the truncation time may be somewhat earlier, since breakpoints cannot be identified
if speck formation happens very close to the end of the time series. Other characteristic times
cannot be identified for cells with sufficiently late ASC speck formation times. It is impossible
to distinguish, on the basis of this dataset, whether the cells that do not form specks will
never do so, or would do so at timepoints beyond the end of the time series; however, cells
do not have an indefinite window for inflammasome formation to take place, since other
biological processes will eventually intervene. Therefore, cells which would theoretically fall
in the upper end of the distribution of speck formation times will not in fact ever demonstrate
speck formation.
A summary of endpoint times and the number of cells analysed for each time series is
given in Table 2.1.
2.4 Results
2.4.1 Estimation of relative protein abundances in nucleus/cytosolic region
I also used nuclear and cytosolic traces to estimate the relative abundance of monomers in
the nuclear and cytosolic regions at equilibrium; this is a useful guideline for simulations and
modelling. I took the ratio of abundances to be equal to the ratios of the respective fitted
β0s for nuclear and cytosolic traces. Since there appeared to be a number of outliers in
both datasets, I took x̂n(0)x̂c(0) to be the median observed value of the ratio of β0 for the nuclear
and cytosolic traces. This gave x̂n(0)x̂c(0) = 1.48 for the FLICA dataset, and
x̂n(0)
x̂c(0)
= 1.11 for the
MitoTracker dataset.
2.4.2 Comparison of datasets
Using a Mann-Whitney U test shows that there are no significant differences between the
two datasets for any of the following statistics: tb1 , tb2 , decay constants, t1/2 and t1/10 for
cytosolic and nuclear traces and tb1 , tb2 for speck traces; p-values are given in Table 2.2.
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FLICA 12/05/2014 Well 2 1750 42 12 4
FLICA 14/05/2014 Well 1 1700 19 40 9
FLICA 14/05/2014 Well 2 3230 5 29 6
FLICA 26/05/2014 Well 1 3490 10 14 5
MitoTracker 07/08/2015 Image0006 NA NA NA NA
MitoTracker 11/08/2015 Image0008 2500 4 1 0
MitoTracker 11/08/2015 well 2 5000 6 5 3
MitoTracker 12/08/2015 Aug-15 5000 5 3 0
MitoTracker 12/08/2015 Image0005 NA NA NA NA
MitoTracker 13/08/2015 Image01 01 NA NA NA NA
MitoTracker 13/08/2015 Image0002 NA NA NA NA
MitoTracker 13/08/2015 Image0005 5000 2 2 0
MitoTracker 13/08/2015 Image0007 5000 1 1 1
MitoTracker 14/08/2015 Image0003 5000 2 18 13
MitoTracker 14/08/2015 Image0005 2335 3 2 0
Table 2.1: Traces analysed from the FLICA and MitoTracker datasets. Samples with no
speck-forming cells appropriate for analysis have been excluded. The number of cells show-
ing a speck by the end of the time series, as well as the number of cells which do not show
a speck, are given for each sample image. The number of traces which were successfully
processed for each image are also given (i.e. traces in which cytosolic, nuclear and speck
region traces were all successfully fitted, with a negative gradient in the second of the three
continuous straight line segments forming the trilinear fit).
Statistic p-value
Decay constant (cytosol) 0.5516
Breaktime 1 (cytosol) 0.7209
Breaktime 2 (cytosol) 0.9894
t1/2 (cytosol) 0.4668
t1/10 (cytosol) 0.7609
Decay constant (nucleus) 0.5516
Breaktime 1 (nucleus) 0.3613
Breaktime 2 (nucleus) 0.8634
t1/2 (nucleus) 0.6433
t1/10 (nucleus) 0.6623
Breaktime 1 (speck) 0.2607
Breaktime 2 (speck) 0.4349
Table 2.2: p-values when comparing statistics derived from FLICA and MitoTracker datasets
respectively using a two-tailed Mann-Whitney U test to test the null hypothesis that the statis-
tics have the same distribution for the two datasets. There is no significant difference be-
tween the datasets at the 0.05 level.
Therefore, I have pooled the results from the two datasets; although the methods of data
acquisition were slightly different and different molecular tags in the preparation were present
in the cells, this does not appear to have had a material effect on results for the cerulean
channel. Furthermore, despite the variation in time series endpoints, many of the speck
formation times are concentrated at earlier timepoints, so the distributions are affected very
little.
2.4.3 Comparison of results in nuclear and cytosolic regions
Using a paired one-sided Wilcoxon signed rank test to compare decrease onset times for
nuclear and cytosolic intensity traces shows that nuclear traces have later decrease onset
times (tb1) with p = 2.6367 × 10−4 for the pooled datasets. Likewise, exponential decay
constants are greater for cytosolic data with p = 5.9390 × 10−5 (Figures 2.8 and 2.9). Un-
surprisingly, t1/2 and t1/10 are significantly larger for nuclear traces compared to cytosolic
traces (p = 2.0152 × 10−7 and p = 2.8357 × 10−7respectively). This suggests that in gen-
eral, depletion of ASC monomer from the nuclear compartment occurs later and is slower
than depletion of monomers from the cytosolic compartment. This supports the assumption
that the inflammasome forms in the cytosolic compartment, and that no clusters are present
within the nucleus, since monomers in the nuclear compartment must first cross into the
cytosolic compartment before they can be absorbed by a cluster.
Notably, the distributions of all breaktimes and both t1/2 and t1/10 have a strong positive
skewness; this suggests that most cells that form inflammasomes within the time series do
so at early timepoints, but also that there is a spread of inflammasome formation occurring
at much later timepoints for a minority of cells.
2.5 Discussion
2.5.1 Summary of results
In this chapter I have described two typical imaging datasets showing the formation of NLRP3
inflammasomes, and presented a method to extract and then analyse quantitative data from
the image time series. I have demonstrated how summary statistics can be obtained from
the resultant quantitative datasets, or ‘traces’. These include ‘breakpoints’ estimating when
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Figure 2.8: First and second breakpoint times for nuclear and cytosolic traces fitted to trilinear
model with pooled datasets. Mean is shown with a circle, mean ± standard deviation is
marked with a star, and maximum and minimum values are marked with a cross. Depletion
from nuclear regions occurs later than in cytosolic regions.
Figure 2.9: Exponential decay constants, for nuclear and cytosolic traces fitted to trilinear
model with pooled datasets. Mean is shown with a circle, mean ± standard deviation is
marked with a star, and maximum and minimum values are marked with a cross. Depletion
from nuclear regions is slower than from cytosolic regions.
(a) t1/2 (b) t1/10
Figure 2.10: Monomer depletion characteristic times for nuclear and cytosolic traces for
pooled datasets. Mean is shown with a circle, mean ± standard deviation is marked with a
star, and maximum and minimum values are marked with a cross. Depletion from nuclear
regions is slower than from cytosolic regions.
depletion of ASC monomers from nuclear and cytosolic regions begins and ends and analo-
gous onset times for the emergence of the ASC speck; estimates for the rate of decrease in
monomer abundance; and the monomer depletion characteristic times t1/q, which describe
the time taken for the ASC monomer abundance in a region to drop by a fraction 1/q.
These statistics are useful for comparison with models and other datasets, but also valu-
able in their own right. In particular, I have demonstrated that depletion of ASC monomers
from the nuclear region of the cell occurs more slowly and later than depletion from the
cytosolic region.
2.5.2 Motivation for model development
Since this dataset tracks the relative abundance of ASC monomers over time, this naturally
suggests a model which similarly tracks the abundance of ASC monomers and NLRs over
time, similar to the aggregation models described in Chapter 1. While the data only captures
the dynamics of ASC monomers, and to some extent the emergence of the ASC speck, the
mathematical model will certainly have to include other variables not included in the dataset
(for example, abundance of NLR oligomers, and clusters of various sizes).
The dataset also suggests key attributes which we would expect a successful model to
display; in particular, we expect to see ASC monomer abundances gradually declining to
zero, alongside rapid emergence of a single ASC speck. As demonstrated, the dynamics
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of monomer depletion from the nuclear and cytosolic regions of the cell are clearly different,
and even if the model is not fully spatial, it would be useful to include a division of the ASC
monomer population between these two compartments.
The model must be constructed with these essential properties in mind. It will also be im-
portant to determine the values of various summary statistics from the mathematical model
which can be compared to those derived from the experimental dataset in this chapter (for
example the monomer depletion characteristic times t1/2 and t1/10, and the time taken for
ASC specks to form); this will allow a more quantitative comparison of the model to the
experimental data.
The resulting models will be discussed in the following chapter.
2.5.3 Future work
The analysis in this chapter has a number of limitations, which could be addressed in future
mathematical and experimental work. There were some key limitations with the dataset,
perhaps most importantly the limited number of usable traces, and the limited number of both
technical and biological replicates. This reduces the robustness of our results, makes it much
harder to establish clear trends or fit distributions to the data, and will also pose difficulties
when comparing to mathematical models (this will be examined further in Chapter 6). To add
to the difficulty in analysing these datasets, there was also considerable inconsistency in the
lengths of the time series and the frame rates used. The large degree of noise in each of the
traces also led to difficulties in fitting many traces, reducing the size of the usable dataset
even further. Therefore, a key priority in continuing the work of inflammasome modelling
must be the creation of more, larger, and more consistent datasets. The analysis described
in this chapter could then be easily repeated.
A possible extension would be creating similar datasets in three dimensions; this would
be much more technically challenging than the two dimensional time series imaging de-
scribed above, but it would help to address the issue of cells and ASC specks moving out
of the plane of focus, and also allow us to establish whether our assumption that a two-
dimension slice of a cell is representative of all z-values is justified.
Another limitation of working with these existing datasets is that the intensity of fluo-
rophores only gives us a proxy for the abundance of ASC monomers in each region; since
concentrations or absolute numbers of ASC monomers are not currently available, this will
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further add to the difficulties in modelling inflammasome formation. However, hopefully the
creation of a model of inflammasome formation will motivate the need for such measure-
ments to be taken, as well as providing a mathematical framework from which certain pa-
rameters such as reaction rates can be derived.
Finally, the existing datasets are limited in that they show only the behaviour of ASC in
inflammasome formation (due to the inclusion of FLICA and MitoTracker in the two datasets
examined, it would technically be possible to examine the behaviour of Caspase-1 and the
mitochondria in relation to inflammasome formation, although the datasets for each of these
would be even smaller). In future, it would be useful to include fluorescent tagging of other
proteins involved in inflammasome formation, especially the relevant NLR; this would allow
us to investigate how NLR activation and oligomerisation affects initial lag times, as well as
how they influence aggregation over the course of inflammasome formation. These experi-
ments would similarly be more technically challenging than those carried out to generate the
datasets used in this analysis, since it would require multi-channel fluorescence microscopy,
and fluorophores would have to be chosen carefully to avoid bleedthrough between chan-
nels. Furthermore, it may be necessary to use different cell lines, and the results may not
be directly comparable. However, this would give us an extremely useful insight into the
interaction between inflammasome constitutents, which we must currently infer from ASC
dynamics only. It would also be useful to conduct similar experiments with other varieties
of inflammasome (the NLRC4 inflammasome would be a particularly interesting contrast) so
that the results could be compared; this would give a useful insight into the differences in
behaviour between inflammasomes. The analysis pipeline established in this chapter could
easily be adapted to any of these scenarios.
Further extension to the processing pipeline described in this chapter would be useful;
there is much potential in this problem for moving beyond the user input-reliant approach
described here. In particular, machine learning techniques could be used as a more so-
phisticated approach to tracking cells between frames; this has the advantages of requiring
far less user supervision, as well as removing the issue of cells moving out of the user-
established region over the time series. However, this would be somewhat computationally
intensive, and require a substantial training data set; these techniques would be much more
appropriate once larger datasets are available. It would also be potentially possible to extract
detail from these images at a finer spatial resolution than the division of the cell into nuclear
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and cytosolic regions; however, this would require finer-resolution images than were avail-
able here. If such images were available, it may also be possible to quantify the distribution
of sizes of clusters over time, which would allow much more direct comparison to the models
which will be presented in the following chapters.
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Chapter 3
Development of a model of
inflammasome formation
3.1 Introduction
The analysis of the inflammasome formation dataset presented in Chapter 2 motivates the
creation of a model of inflammasome formation similar to the models of protein coagulation
described in Section 1.5.
In this chapter I will describe two models of inflammasome formation: a ‘full’ model, which
is closer to the underlying biological processes, and a ‘simplified’ model, which removes
some of the more complex aspects of the full model but is significantly more amenable to
mathematical analysis. While they have been inspired by models of comparable biological
processes (especially prion formation, as described in Section 1.5.2), both models are en-
tirely novel; as far as I have been able to establish, there are no other existing models of
inflammasome formation with this level of detail, and these models are also substantially
mathematically different to other mathematical models of coagulation processes, due to the
combination of multiple spatial compartments, and multiple constituent monomer species
with different behaviours.
For both variations, I present a continuous deterministic ODE version of the model, and
a discrete stochastic version; these are appropriate in different contexts, and both will be
analysed further in later chapters. For both models, I will explain the reactions considered,
as well as the simplifications and assumptions included in the model. I will also examine
some useful mathematical properties of each model.
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Finally, I will outline the ‘characteristic times’ which will be used to summarise model
solutions, and which can be compared to key features of the experimental data derived in
the previous chapter.
3.2 Full model of inflammasome formation
3.2.1 Variables and reactions
To explore the process of inflammasome formation, I focus my attention on abundances of
the NLR of interest and of ASC, since these proteins drive inflammasome formation. I as-
sume that initially there are a number of NLR oligomers, formed following activation, of given
sizes, and a given number of unbound ASC monomers. These monomers and oligomers
combine to form clusters. Building on the existing conceptual models of ASC-ASC and
ASC-NLR interactions (for example, [Masumoto et al., 2001, Moriya et al., 2005, Lu et al.,
2014, Sahillioglu et al., 2014, Vajjhala et al., 2014, Chu et al., 2015, Sanders et al., 2015, Dick
et al., 2016, Oroz et al., 2016, Kuri et al., 2017, Li et al., 2018, de Alba, 2019], I assume that
each NLR monomer in a cluster can ‘seed’ an ASC filament, which extends via PYD-PYD
interactions.
I include in the model a mechanism which allows clusters to join by crosslinking of these
filaments; this is a putative reaction which has not been observed experimentally, and can be
included or removed from the model based on one parameter value. Varying this parameter
will allow us to establish the effect such a process would have on inflammasome formation,
and indeed ascertain whether it is necessary in the system.
I also assume that ASC CARD-CARD reactions occur concurrently with PYD-PYD inter-
actions; since both PYD-PYD and CARD-CARD interactions in isolation can lead to filament
formation [de Alba, 2019], this suggests that an individual ASC monomer could form a unit
in two separate filaments, one formed via PYD-PYD interactions and one formed via CARD-
CARD interactions. This suggests that if CARD-CARD and PYD-PYD interactions do occur
concurrently, this could lead to branched structures forming. While there is currently no ex-
plicit supporting biochemical evidence for this theory, this would be a natural consequence of
concurrent CARD-CARD and PYD-PYD filament-forming reactions, and could explain why
branching structures have been observed in images of ASC specks [Kuri et al., 2017]. In
order to test this theory,branching reactions can be removed from the model by setting the
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corresponding reaction rate to zero.
In order to track the number of possible reactions with each cluster, I track the number of
ASC filaments within the cluster, and the number of ‘free’ NLRs associated with each cluster
which have not yet formed the basis of a filament. I also track the total number of ASC
monomers in each cluster; this does not play a role in the dynamics of the model, but allows
the total size of each cluster as well as just the number of filaments to be tracked.
Neither of these models are explicitly spatial, although I do separate ASC abundances
into two separate cellular compartments corresponding to the nucleus and cytosol. ASC
is located endogenously in both compartments, but the depletion of ASC in the nucleus
during inflammasome formation is generally slower than in the rest of the cell, since the
completed inflammasome complex is normally located outside the nucleus, in the perinuclear
region [Cheng et al., 2010]. I have also confined NLR oligomers and clusters to the cytosolic
compartment.
The variables used in both models are given in Table 3.1, with an illustrative example
given in Figure 3.1. The reactions considered are illustrated in Figure 3.2 and formally de-
fined in Table 3.2. The full ODE model is outlined in Section 3.2.4. Propensity functions for
reactions in the discrete stochastic model are given in Table 3.2.
I have developed these models for NLRC4 inflammasome formation, although I have not
made any assumptions about reaction rates (Reactions C1 and C3 both nominally describe
CARD-CARD interactions but I have not assumed c1 and c3 are equal - see Table 3.2 for
details). This model could therefore be adapted easily to reflect other inflammasome sys-
tems; for example, for the NLRP3 inflammasome, similar reactions occur but C1 reactions
are PYD-PYD rather than CARD-CARD reactions.
Note the form of the propensity function for reaction C2 when two clusters of the same
size react together (Table 3.2); the propensity function changes from c2fixf,n,axi,j,k for clus-
ters of different sizes to 12c2f
2xf,n,a(xf,n,a − 1) for clusters of the same size. If we have a
reaction involving clusters with sizes (f, n, a) and (i, j, k), where (f, n, a) 6= (i, j, k), then the
rate of reaction is proportional to the total possible number of ordered pairings of such clus-
ters, which is xf,n,axi,j,k. However, if the clusters are the same size (f, n, a), both are drawn
from the pool of xf,n,a such clusters; there are 12xf,n,a(xf,n,a − 1) possible pairings, where
ordering is not considered since the clusters are functionally identical. This is similar to the
correction terms used in BD models (see Equations 1.2 and 1.3).
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Variable Explanation
x̂c Total abundance of ASC monomers present in cytosol
x̂n Total abundance of ASC monomers present in nu-
cleus
xf,n,a Total abundance of clusters in cytosolic compart-
ment with f growing ASC filaments, n free NLRC4
monomers, a ASC monomers
Table 3.1: Variables used in ODE and stochastic models. ‘Abundance’ refers to concentra-
tion in ODE models and absolute numbers in stochastic models.
Figure 3.1: The NLRC4 inflammasome in this model: NLRC4 monomers (pink) are joined by
CARD-CARD interactions (dashed pale green). Active ASC monomers (pale blue) are either
joined to NLRC4 monomers via CARD-CARD interactions, or to other active ASC monomers
via PYD-PYD interactions (solid dark green), forming filaments. In the example shown, the
cluster has two filaments, one free, unbound NLRC4 monomers, and three ASC monomers;
this cluster would count towards x2,1,3.
Reference Reaction Propensity function
C1 x̂c + xf,n,a
c1n−−→ xf+1,n−1,a+1 c1nx̂cxf,n,a
C2 xf,n,a + xi,j,k
c2fi−−→ xf+i,n+j,a+k c2fixf,n,axi,j,k for (f, n, a) 6= (i, j, k),
1
2c2f
2xf,n,a(xf,n,a − 1) otherwise
C3 x̂c + xf,n,a
c3f−−→ xf+1,n,a+1 c3fx̂cxf,n,a






Table 3.2: Rates of reactions in ODE and stochastic models. The reactions are explained
more fully in Figure 3.2.
(a) Reaction C1: An inactive ASC monomer joins a cluster via a CARD-CARD interaction with
NLRC4 in a cluster, and is activated. The number of free NLRC4 in the cluster decreases by one,
and the number of filaments increases by one. Here, x2,1,3 + x̂c → x3,0,4.
(b) Reaction C2: Two clusters join via CARD-CARD interactions between active ASC in a cluster.
A new cluster is formed, where the number of free NLRC4 and filaments is the sum of those of the
constituent clusters. Here, x1,1,1 + x2,1,3 → x3,2,4.
(c) Reaction C3: An inactive ASC monomer joins a cluster via a CARD-CARD interaction with active
ASC in a cluster, and is activated. The number of filaments in the cluster increases by one. Here,
x̂c + x2,1,3 → x3,1,4.
(d) Reaction P: An inactive ASC monomer joins a cluster via PYD-PYD interaction with active ASC
in a cluster, and is activated. The filament the monomer joins is extended, but the total number of
free NLRC4 and filaments in the cluster is unchanged. Here, x2,1,3 + x̂c → x2,1,4
(e) Reaction M1: An inactive ASC
monomer moves from the nuclear to the
cytosolic compartment.
(f) Reaction M2: An inactive ASC
monomer moves from the cytosolic to
the nuclear compartment.
Figure 3.2: Reactions considered in the full inflammasome model
3.2.2 Simplifications and assumptions
It has been necessary to introduce a number of simplifications of, and assumptions about,
the biological processes of inflammasome formation when creating this model. Partly this
is inherent in the process of model formation, in which we simplify processes which are not
relevant to the questions at hand; however, in the case of inflammasome formation, there
are also a number of aspects of the biological process which are poorly-understood, or have
not been quantified to the extent which would be ideal when creating a model. Therefore,
it has been particularly necessary to introduce various assumptions about the process of
inflammasome formation, some of which are foundational to the model, and some of which
may be adjusted in order to test the hypotheses we have established around inflammasome
formation.
First, for simplicity, I have not included caspase-1 in the model, since my aim is to under-
stand the dynamics of inflammasome formation in its early stages. Caspase-1 is recruited
later in the inflammasome formation process, and is unlikely to affect the early dynamics
of ASC recruitment and cluster formation. Therefore, while it would certainly be useful and
interesting to consider the dynamics of caspase-1 recruitment, this is outside the scope of
the current model.
I also assume that NLR oligomer formation and ASC aggregation are temporally sepa-
rated, with oligomer formation occurring before aggregation begins; thus we assume that we
have a fixed set of NLR oligomers which we use as ICs for our model. This was a useful
assumption, since the mechanisms of NLR oligomer formation are not all well understood;
for example, although the structure of the NLRC4 oligomer has been studied in-depth, this is
not the case for other NLR oligomers, and furthermore the regulatory processes underlying
the formation of these oligomers are complex and have not been fully characterised. More-
over, by not explicitly modelling the oligomer formation process, the models presented here
may be applicable to a much wider class of inflammasomes. By taking different distributions
of NLR oligomer sizes as ICs for our model, we can test various options for those distri-
butions while avoiding having to make any assumptions about the process of NLR oligomer
formation. Furthermore, although it would not be unreasonable to expect that NLR oligomers
continue to grow (and NLR-NLR interactions could even be a mechanism by which cluster
joining could take place) since we expect the overall abundance of NLRs to be significantly
less than the abundance of ASC monomers, it is likely that reactions involving ASC will be
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much more important in driving the reaction dynamics. I have therefore disregarded NLR-
NLR joining processes for the sake of simplicity.
Since the stoichiometry of NLRs and ASC monomers in the inflammasome is not en-
tirely clear, I have assumed that each NLR can form the basis of a single ASC filament, and
that each ASC monomer in a cluster at the end of a filament can recruit at most two fur-
ther ASC monomers (via a PYD-PYD and CARD-CARD interaction respectively). This is a
considerable simplification of the complexity of the protein-protein interactions involved (see
for example the comprehensive work of Lu et al. and Nambayan et al. in documenting the
mechanism of ASC-ASC interactions [Lu et al., 2014, Nambayan et al., 2019]). However,
this level of detail is sufficient for a mathematical model concerned with the dynamics of
ASC depletion and cluster formation over significantly longer timeframes and spatial scales
larger than individual reactions between monomers. Furthermore, I have assumed that all
the reactions in the model are irreversible, since the emergence of the ASC speck is certainly
irreversible, although this does not necessarily imply that on shorter timescales all reactions
are entirely irreversible.
A key aspect of any model of inflammasome formation must be a mechanism which pre-
vents aggregation of ASC in the absence of a stimulus. In this model, informed by the prion-
like behaviour of ASC, I assume that ASC can only interact directly with NLRs, or with ASC
in a cluster. This could be interpreted biologically as ASC gaining an alternative allosteric
conformation following interaction with NLRs, which may then be propagated to other ASC
monomers, in a manner not dissimilar to NLR oligomerisation. Naturally, there are many
other processes at play in the biological system; in particular, I have broadly overlooked the
role of post-translational modifications and COPs and POPs. However, the ‘allostery-like’
description of ASC behaviour is very simple, and does not require the introduction of any
more reactants into the system; it also allows us to build on the prion proliferation mod-
els of Oosawa and Kasai, and Masel and Nowak [Oosawa and Kasai, 1962, Nowak et al.,
1998, Masel et al., 1999]. Furthermore the methods by which PTMs and COPs and POPs
regulate inflammasome formation are insufficiently well-documented to allow construction of
a mathematical model. It is also worth noting that although the mechanism described above
was inspired by the possibility of ASC gaining alternative allosteric conformations, it does not
assume that this is in fact the case; the prion-like formulation is simply a simple mathematical
model that displays the behaviour required to emulate inflammasome formation, which could
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have many biological interpretations.
One feature of inflammasome formation we want to interrogate with this model is whether
branching of ASC filaments occurs during inflammasome formation (i.e. initiation of new fil-
aments via CARD-CARD reactions occurring concurrently with filament extension via PYD-
PYD interactions), or whether this only occurs via crosslinking once filaments are fully formed.
I have therefore allowed filament branching to occur; however, the rate at which this occurs is
controlled by a single parameter (c3) which may be set to zero to remove branching from the
model. I have assumed that the rate of branching is proportional to the number of filaments;
essentially, I have only allowed branching to occur at the end of filaments. This reflects the
fact that the ends of filaments will be more accessible than ASC monomers closer to the
NLR oligomer at the centre of a cluster. I have not included crosslinking of existing ASC fila-
ments within clusters, since this is unlikely to affect the early dynamics of ASC clusters, and
it would be extremely difficult to keep track of the links within a cluster (although intra-cluster
crosslinking would naturally affect the availability of monomers within a cluster available for
inter-cluster crosslinking).
Another aspect of conceptual models of the inflammasome which we wish to examine
further is the possibility of clusters joining via ASC-ASC interactions. Once again, I have
included a parameter which controls the rate of such reactions (c2) which can be set to zero
to exclude joining from the model. I have also assumed that joining of clusters is proportional
to the number of filaments in the clusters involved, again because this is an approximation
of the number of ASC monomers close to the surface of each cluster.
Finally, I have included the simplest possible spatial structure, dividing the cell into a
nuclear and cytosolic region. This is suggested by the structure of the experimental data
analysed in Chapter 2. Within these compartments I have assumed that reactants are well-
mixed, and ignored finer-grained spatial effects. This is of course a significant simplification,
and overlooks the effects of interactions with other cellular structures (such as mitochondria
and the cytoskeleton, which have both been implicated in inflammasome formation [Zhou
et al., 2011, Misawa et al., 2013, Man et al., 2014a, Li et al., 2017]) as well as molecular
crowding. However, these considerations are beyond the scope of this initial inflammasome
model. I have also assumed that clusters including NLRs reside only in the cytosolic com-
partment, since this is where stimuli are initially located. It is also unlikely that clusters will
cross the nuclear membrane, both due to their relatively large size (which will inhibit both
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their speed of movement and ability to pass through pores in the nuclear membrane), and
due to the fact that we rarely observe inflammasomes forming in the nucleus [Cheng et al.,
2010].
It is worth noting that accurate measurements of the abundance of ASC and NLRs in the
cell, either absolute or relative, are not available. Therefore, it will be necessary to explore
a range of possible initial conditions for abundances of ASC monomers, as well as a range
of different initial conditions for NLR oligomer sizes and abundances, reflecting the different
models of NLR oligomer forms. Values for the reaction rates in this model are likewise not
available; however, it is possible to rescale the model to remove the dependence on some
variables. Naturally this reduces our ability to fit models to data, although there are too
many parameters in the model to be able to carry out straightforward model fits to the data
described in Chapter 2.
3.2.3 Expected behaviour of the model
In order to accurately reflect the inflammasome formation process, there are a number of
basic properties we wish the model outputs to display.
Since in most cases the inflammasome is characterised by the formation of a single dom-
inant cluster, we expect the total number of clusters to tend towards 1; this would correspond,
in the ODE models, to the concentration of clusters tending towards zero. The time at which
all initial clusters have merged and a single cluster emerges (or in the continuous model, the
time at which the concentration of clusters reaches zero) could therefore be regarded as the
time at which an ASC speck has truly formed.
Furthermore, we would expect the population of ASC monomers in the cytosolic and nu-
clear compartments of the cell to decrease to zero, since inflammasome formation generally
depletes all ASC monomers in the cell. This may not coincide with the emergence of the
ASC speck (and in fact, in the dataset presented in Chapter 2 we often see the emergence
of a speck before cellular ASC is fully depleted), but we would certainly expect ASC depletion
in both compartments to be the ultimate fate of the system. The experimental data examined
in Chapter 2 also suggests this occurs in a monotonic fashion.
We would therefore expect a successful model of an inflammasome to display these
basic properties:
• System ends with a single cluster
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• ASC monomers are depleted monotonically throughout the cell, and are ultimately all
subsumed into clusters
3.2.4 Full ODE model
































For f < 0, n < 0, a < 0:
(3.1c)xf,n,a = 0 for all t





















+ c3x̂c[(f − 1)xf−1,n,a − fxf,n,a]︸ ︷︷ ︸
C3











Note the form of the second term of Equation 3.1d; the factor of 1/2 is present, in the
case of (i, j, k) 6= (f/2, n/2, a/2) since these terms are counted twice in the summation;
in the case (i, j, k) = (f/2, n/2, a/2), only one such term is counted in the sum, but the
inclusion of the factor of 1/2 is due to both reactants being functionally identical (see also
Section 3.2.1). Note also that the rate of reaction of two clusters of the same size has been
slightly adapted from the propensity function given in Table 3.2; since in the ODE model
we are considering xf,n,a as concentration rather than total count (for which the propensity
functions have been formulated), the −xf,n,a term should be excluded; this gives a good
approximation for the joining rate when xf,n,a are sufficiently large.











































xf,n,a(0) = 0 if f > 0 or a > 0
x0,n,0(0) are given by the distribution of NLRC4 oligomer sizes; in general, I assume that
there is a given initial concentration of clusters X0, each containing 10 NLRs (although this
assumption will be interrogated further in later chapters). In this case, we have:
xf,n,a =

X0 if f = 0, n = 10, a = 0
0 otherwise
We can reduce the system of equations given in System 3.1 via summation, similarly
to the Masel-Nowak model [Masel et al., 1999]; this reduced system of ODEs captures the
features of interest while leaving the system more amenable to analysis. The sum variables
used are defined in Table 3.3, and equations given in System 3.2. Note that X designates
the total concentration of clusters, F denotes the total concentration of filaments, N denotes
























0 sF,F (0) = 0
x̂n(0) = x̂
(n
0 ) sN,N (0) = 100X
2
0
X(0) = X0 sA,A = 0
F (0) = 0 sF,N = 0
N(0) = 10X0 sF,A = 0












= c1x̂c(2sF,N +N) + c2s
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= c1x̂c(2sN,A +N) + c2s
2












= c1x̂c(sN,N − sN,A −N) + c2sF,NsF,A + (c3 + p)x̂csF,N
The intial conditions for this system of equations are as follows:




dt = 0, so from the ICs we have the conservation relation x̂c +





Interestingly, the variables x̂c, x̂n, F and N do not depend on any other variables, but I
have included other variables for interest, to create a larger closed system.
3.2.5 Stochastic model
As will be seen in later chapters, we encounter issues with the ODE model as we reach
situations with few clusters; the use of continuous variables representing concentrations is
then problematic, and furthermore our approximation of joining rates (in which the possibility
of self-joining of clusters is ignored) no longer holds when there are few clusters. These
considerations are particularly important when considering events which occur late in the in-
flammasome formation process (for example, the emergence of a single ASC speck). These
issues can be resolved by using a stochastic version of the model.
104
The reactions outlined for the ODE model can easily be used in a stochastic context
instead, using the propensity functions given in Table 3.2. Realisations of this model can then
be simulated using, for example, the Gillespie algorithm [Gillespie, 1972]. It is also possible
to use more analytical techniqes, for example, using a master equation approach, or applying
a CTMC approach as used by Yvinec et al. in stochastic BD models, D’Orsogna et al. in ML
models, and Kashchiev in NP models [Yvinec et al., 2012, Yvinec et al., 2016, D’Orsogna
et al., 2015, Kashchiev, 2018]. However, due to the extremely large number of reactants
involved, this system is somewhat intractable to such analysis. Furthermore, difficulties
arise because of the non-constant ‘kernel’ of cluster joining, the concurrent processes of
cluster growth and joining, and movement between cellular compartments. This motivates
the construction of a simplified model which is more amenable to analysis.
3.3 Simplified model
I have also created a simplified version of the inflammasome formation model which is much
more analytically tractable; in its ODE form it can be solved analytically, and the stochastic
form is also considerably more amenable to analysis. This analytical approach is useful since
it gives much more precise and easily-interpretable solutions than the numerical integration
and simulation techniques which are necessary for analysing the full model. However, natu-
rally there may be disadvantages to removing key elements in the full model, which can be
seen by comparing results for the full model and simplified model.
3.3.1 Description of simplified model
The alterations to the full model which give the simplified model are as follows:
• Assume cluster merging rate is independent of cluster size
• Consider the total population of ASC monomers in the cell rather than separating into
subpopulations based on subcellular location
• Assume free NLRs and filaments behave identically in terms of ASC recruitment
Removing the size dependence of cluster joining reactions may be somewhat biologically
implausible, but this simplifies considerably the coagulation aspect of the model by essen-
tially setting the joining kernel to be constant. Furthermore, it is useful to remove the size
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dependence of joining to establish what role, if any, it plays in determining the behaviour of
the model.
Combining the two cellular compartments to give a single population of ASC monomers
means we lose some of the structure present in the experimental data — we cannot com-
pare the output of this model to the separate nuclear and cytosolic traces derived in Chapter
2, but instead must consider the cell as a whole. However, once again, this simplifies the
mathematics considerably (especially since we expect movement between compartments
to happen on a much faster timescale than cluster growth and joining). Furthermore, ASC
monomers in the nuclear compartment are essentially passive in the full model; it is there-
fore useful to establish whether the nuclear compartment really displays any mathematically
interesting behaviour, or if its inclusion in the model merely adds a lag to the depletion of
ASC monomers.
Finally, the conflation of filaments and free NLRs once again is a considerable devia-
tion from our biological assumptions; in developing the full model, it was important to keep
track of both of these variables since ASC joining to NLRs and to other ASCs cannot be
assumed to happen at the same rate. However, conflating filaments and free NLRs allows
us to use only two subscripts to denote cluster size. This simplification may be justified
by the assumption that the initial number of NLRs is small compared to the initial number
of ASC monomers; therefore, unless the rate of joining of ASC to NLRs is extremely slow,
the population of free NLRs will be depleted relatively quickly compared to the timeframe
of inflammasome formation and ASC monomer depletion. Furthermore, in the case of the
NLRC4 inflammasome, both ASC binding with NLRC4 and putative ASC filament branch-
ing reactions occur via CARD-CARD interactions; this suggests that a similar rate for both
reactions is not unreasonable.
The variables and reactions used in the simplified model are very similar to those in the
full model; these are laid out in Figure 3.3 and Tables 3.4 and 3.5.
3.3.2 Simplified ODE model
The reactions described in Table 3.5 can be expressed using the following ODEs:
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(a) Reaction C2: Two clusters join via CARD-CARD interactions between active ASC in a cluster.
A new cluster is formed, where the number of free NLRC4 and filaments is the sum of those of the
constituent clusters. Here, x1,1,1+x2,1,3 → x3,2,4. The rate of clusters joining is independent of cluster
size.
(b) Reaction C: An inactive ASC monomer joins a cluster via a CARD-CARD interaction with an NLR
or active ASC in a cluster, and is activated. The number of filaments in the cluster increases by one.
Here, x̂c + x2,1,3 → x3,1,4.
(c) Reaction P: An inactive ASC monomer joins a cluster via PYD-PYD interaction with active ASC
in a cluster, and is activated. The filament the monomer joins is extended, but the total number of
free NLRC4 and filaments in the cluster is unchanged. Here, x2,1,3 + x̂c → x2,1,4
Figure 3.3: Reactions considered in the simplified inflammasome model
Variable Explanation
x̂ Total concentration of ASC monomers present
throughout the cell
xf,a Total concentration of clusters in cytosolic com-
partment with f growing ASC filaments and NLR
monomers, and a ASC monomers
Table 3.4: Variables used in ODE and stochastic versions of simplified model
Reference Reaction Propensity function
C x̂+ xf,a
cf−→ xf+1,a+1 cfx̂xf,a
C2 xf,a + xi,j
c2fi−−→ xf+i,a+j c2fixf,axi,j for (f, a) 6= (i, j),
1
2c2f
2xf,a(xf,a − 1) otherwise
P x̂+ xf,a
pf−→ xf,a+1 pfx̂xf,a

























+ cx̂[(f − 1)xf−1,a−1 − fxf,a]︸ ︷︷ ︸
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We assume that initially there is a concentration of X0 NLR oligomers each containing
10 NLRs; this gives initial conditions
(3.4a)xf,a =

X0 if f = 10, a = 0
0 otherwise
(3.4b)x̂(0) = x̂0
Similarly to the full model (See System 3.2), the ODEs given in System 3.3 can be re-

















The initial conditions are as follows:
(3.6a)x̂(0) = x̂0
(3.6b)X(0) = X0
(3.6c)F (0) = 10X0
This system is very similar in form to the reduced system for the full model (Equation
3.2); note in particular the form of the equation for X, in which the right-hand side is now
dependent only on X, due to the constant joining rate.
3.3.3 Simplified stochastic model
As with the full model, it is useful to have a stochastic version of the simplified model, es-
pecially when considering events which occur late in the inflammasome formation process.
We can create a simplified stochastic model of inflammasome formation using the reactions
and propensity functions described in Table 3.5, and simulate results using, for example, the
Gillespie algorithm [Gillespie, 1972]. One primary motivation for constructing the simplified
model is that this stochastic model is sufficiently simple that it can be analysed analytically,
without the need to rely on simulations. We can therefore consider the reactions within the
framework of a CTMC, for which there are numerous existing mathematical tools for analysis.
3.4 Characteristic times
In order to compare results from the full model, simplified model and the dataset presented
in Chapter 2, my main approach will be the use of characteristic times. These have been
defined for the experimental data in the previous chapter (see Sections 2.3.3 and 2.3.4); I will
now describe the characteristic times for the models presented in this chapter, and explain
how they link to the characteristic times derived for the experimental data. The characteristic
times are summarised in Figure 3.4.
3.4.1 First joining time
The time at which two clusters first join is a useful marker of the transition from cluster
growth by monomer addition only to a phase of growth in which cluster joining begins. This
quantity cannot be measured in the experimental data presented in Chapter 2, but is useful
for understanding the differences between the simplified and full models, and also in how
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(a) Monomer depletion characteristic times
t1/q: time for monomer count to decrease
by a fraction 1/q. A possible example of
monomer count over time is shown in blue;
the time taken for monomer count to de-
crease by a fraction 1/q is shown in green.
(b) Single cluster emergence time TS : time at
which only one cluster remains. First joining
time TF : time of first joining event. A possi-
ble example of total cluster count over time is
shown in blue. Time until first joining event
is shown in dark green. Time until only one
cluster remains is shown in light green.
(c) Dominant cluster emergence time TD:
time at which one cluster becomes much
larger than other clusters at that time. Lines
in blue and pink represent the sizes of all
clusters over time for one run of the model;
the time at which the cluster which eventu-
ally dominates (shown in pink) first diverges in
size from the other clusters is shown in green.
Figure 3.4: Schematics illustrating characteristic times for the inflammasome models; all
figures show one possible scenario for monomer depletion and cluster growth, for a single
run of the model.
different parametrisations of each model affect the kinetics of the inflammasome formation
process. I will refer to this characteristic time as the ‘first joining time’, or TF , throughout this
thesis.
3.4.2 Inflammasome emergence time
The time at which the inflammasome is fully formed is naturally extremely important in this
analysis, and can be compared to the time at which the ASC speck appears in the experi-
mental data; in practice, this is taken to be the second speck trace breakpoint (see Section
2.3.3), although the initial lag before inflammasome formation begins must be subtracted
first. A natural comparison can be drawn to the earliest time in the models at which all clus-
ters have merged into a single cluster; I will refer to this as the single cluster emergence
time, or TS , throughout. There may still be unbound ASC monomers present at this time, but
all clusters of size greater than 1 will have merged into a single cluster, which may continue
to grow via recruitment of unbound ASC. Note that this quantity cannot be calculated for the
ODE variants of the models, due to the continuous nature of the variables. However, another
possible characterisation of the time of inflammasome formation is the time at which a single
large cluster has emerged; as we will see, this is characteristic of many solutions for both
models, and is analogous to the emergence of a giant component in random networks, or
indeed to gelation in Smoluchowski and ML models, although without the mass loss char-
acteristics. This could be a better characterisation of the time at which a large ASC speck
emerges. I will refer to this characteristic time as the dominant cluster time, or TD.
I have defined the dominant cluster emergence time as the time at which one cluster
becomes an outlier in terms of the size distribution of all other clusters at that time. I have
used a simple measure to calculate the threshold for a cluster becoming a ‘large outlier’
based on the mean and standard deviation as follows:
Threshold = mean + 3× standard deviation (3.7)
If the cluster sizes are normally distributed, we would expect around 0.1% of cluster sizes
to lie above this value.
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3.4.3 Monomer depletion characteristic times
As described previously, the time of single cluster emergence generally does not coincide
with the time of single cluster emergence. It is therefore also useful to designate character-
istic times which describe monomer depletion, for both cellular compartments in the case of
the full model. To quantify the rate of monomer depletion, I will use the monomer depletion
characteristic times t1/q, the time taken for the monomer population in a compartment (or
throughout the cell, in the case of the simplified model) to decrease by a fraction 1/q. These
can be compared directly to t1/q as calculated for the experimental data (see Section 2.3.4),
although once again the initial lag should be subtracted first.
3.5 Discussion
3.5.1 Summary
In this chapter, I have presented two models of inflammasome formation; a ‘full’ model, which
includes the key biological aspects of inflammasome formation, and a simplified model,
which is an adapted version of the full model which is more amenable to mathematical
analysis. Both models have the potential to explore unanswered questions in inflamma-
some formation; in particular, both allow branching of ASC filaments and joining of clusters
to be included or excluded, and allow for the flexible input of different distributions of NLR
oligomer sizes as ICs. I have also established the basic expectations we have for solutions
of a model of inflammasome formation; namely, that the system approaches a state with a
single inflammasome, via monotonic depletion of ASC monomers. Finally, I have defined the
characteristic times which will be used to analyse the models, and compared them to the
experimental data introduced in Chapter 2.
Both the full and simplified models will be explored further in the following chapters, and
the differences between solutions to these models will be explained.
3.5.2 Further work
The models I have presented here are only a starting point for the possibilities of modelling
inflammasome formation. While I have established a simple foundation for future modelling
attempts, these models immediately prompt a number of natural extensions.
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Firstly, other reactants could be included in the model. Adding caspase-1 would be
useful, to interrogate the assumption that caspase-1 does not affect the dynamics of inflam-
masome formation. Furthermore, it is still not clearly understood why the inflammasome
structure is required for caspase-1 recruitment at all; studying the dynamics of caspase-1
recruitment using a model similar to those presented might shed some light on this issue.
However, more quantitative data describing the total abundance of processed caspase-1
over time would be extremely useful for developing such a model. It would also be a natural
extension to add PTMs, COPs or POPs to the model. This could be as simple as introducing
a process by which NLRs are phosphorylated or dephosphorylated, with the two NLR popu-
lations interacting differently with ASC. However, it would be useful to have more information
available about the processes through which PTMs occur before including this factor in the
model.
It would also be possible to add reversibility of reactions into the model; in particular, this
may allow an alternative characterisation of prevention of ASC clustering in the absence of
stimuli (for example, it would be possible to create a model in which ASC monomers may
form clusters in the absence of stimuli, but the rate of dissociation is very high unless the
clusters are in some manner stablised by interaction with an activated NLR). This could be
a useful change to the current simple model of prion-like ASC activation, since the model
currently does not account for spontaneous ASC speck formation in ASC overexpression
systems.
A more sophisticated treatment of NLR oligomerisation would be another natural step
in improving the existing models; there is nothing to suggest that NLR reactions cannot
continue once ASC recruitment has begun. However, once again it may be easier to create
such a model if we have more experimental data on NLR behaviour over time. If we were,
for example, to include NLR oligomerisation as an element in a model of inflammasome
formation, we would require much more information about the input of stimulus into the cell
over time.
One interesting extension to the existing inflammasome model would be to examine the
structure of the final inflammasome more closely. Currently, we do not track the precise struc-
ture of the inflammasome over time but only the the number of free NLRs, ASC filaments
and total ASC monomers in the inflammasome. Therefore, it is difficult to assess the degree
of crosslinking or branching in the completed inflammasome. A natural strategy to approach
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such a problem would be to consider the inflammasome as a network, with nodes represent-
ing individual proteins and edges representing reactions between proteins. It would then
be much easier to include crosslinking reactions within a cluster. Furthermore, we would
then have a network representing the complete inflammasome which could be analysed for
properties such as connectedness. This could allow us to investigate the relative importance
of different protein interactions in inflammasome formation, and investigate the appearance
of ‘Medusa’s head’ phenotypes in ASC overexpression systems, which could correspond to
low levels of connectivity in inflammasome networks.
The simple two-compartment structure of the full model also prompts the development of
a model inflammasome formation with finer spatial granularity. The reactions in either ODE
model could easily be extended to PDEs including diffusion. This would allow us to examine
in more detail the role of spatial effects in inflammasome formation. In particular, the mod-
els presented here assume a well-mixed environment, when clearly during inflammasome
formation we approach a situation in which ASC is highly concentrated in one area of the
cell. Extending the models presented here to fully spatial models would allow the effects
of molecular crowding to be considered more easily, as well as introducing interactions with
other cellular structures. It would be particularly interesting to consider interactions with ele-
ments of the cytoskeleton; in particular, it is unclear to what extent interactions with actin or
microtubules might focus the movement of ASC towards the final ASC speck.
Finally, a recurring theme in this modelling process has been the need for more experi-
mental data. This is the case in a number of different contexts; first of all, in order to develop
the characterisation of some processes in more depth (for example, the formation of NLR
oligomers), it would be helpful to have a clearer understanding of, and ideally more qualitative
data describing, how these processes occur in the biological context. Secondly, in order to al-
low development of models with, for example, a spatial element, more high-resolution, three
dimensional datasets would be extremely useful. Finally, as we will see in later chapters, the
lack of concentration data and reaction rate parameters will be a hindrance in attempts to
fit these models to data; however, hopefully the creation of these models will clearly moti-
vate the need for acquisition of such data, and provide a clear mathematical and notational
framework for deriving rate parameter values.
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Chapter 4
Mathematical analysis of the
simplified model of inflammasome
formation
4.1 Introduction
In this chapter I will present analysis of both the deterministic continuous ODE and the dis-
crete stochastic formulations of the simplified inflammasome model (Figure 4.1). The benefit
of the simplified model is that it is considerably more amenable to mathematical approaches
than the full model; unusually for many mathematical models of biological processes, it is
possible to derive analytical solutions both for the simplified ODE model and for the distribu-
tions of characteristic times for the stochastic model. These analytical solutions are espe-
cially useful, in the absence of measured parameter values, for establishing the behaviour
of the model over wide ranges of parameter values without the need to run large numbers of
simulations, and for fitting distributions of characteristic times to experimental data (this will
be carried out in Chapter 6).
(a) Reaction C2 (Cluster
joining)
(b) Reaction C (Filament
branching)
(c) Reaction P (Filament ex-
tension)
Figure 4.1: The simplified inflammasome model revisited
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I will begin by providing an analytical solution to the reduced ODE system presented in
the preceding chapter (System 3.5), which can then be used along with a generating func-
tion approach to solve the simplified ODE model analytically (3.3). I will use these results
to examine the distribution of cluster sizes over time — in particular, using asymptotic tech-
niques to establish the behaviour of the model at small and large times, and for small and
large parameter values. This approach is useful for establishing the role of each process in
inflammasome formation, especially the relative roles of ASC filament extension and branch-
ing. However, I will also demonstrate that the model does not exhibit the required behaviour
at large times, due to the fact that in this model ASC monomers are never fully depleted.
I will then present analysis of the stochastic model, including analytical expressions for
the distribution of the characteristic monomer depletion times, single cluster emergence time,
and first joining time. These can be directly compared to data (see Chapter 6). I will also
demonstrate the role of different processes and parameters in determining distributions of
characteristic times. A particularly notable result is that the initial number of NLR oligomers
plays a comparatively small role in determining the time of single cluster emergence in the
simplified model.
4.2 Analysis of the ODE model
4.2.1 Full solution for the simplified ODE model
In order to establish the concentrations of ASC monomers and clusters over time, I begin by














The equation for X does not involve any other variables and is separable. The system
for x̂ and F can be solved by noting that cdx̂dt + (c + p)
dF
dt = 0. Therefore, the quantity
N = cx̂ + (c + p)F is conserved. From our ICs, N = cx̂0 + (c + p)X0N0. Thus, System 3.5
can be solved by, for example, substituting F = N−cx̂c+p into the equation for x̂. We therefore











cx̂0 + (c+ p)X0N0eNt
A full analytical solution can be found for the full ODE system given in System 3.3 using
the generating function G(y, z, t) =
∑
f,a xf,a(t)y
fza. This is similar to the approach used















xi,j + cx̂[(f − 1)xf−1,a−1 − fxf,a]

















2 − c2XG+ x̂y(c(yz − 1) + p(z − 1))
∂G
∂y
The initial conditions are given by G(y, z, 0) = X0yN0 .













cx̂0 + 10(c+ p)X0eNt
y(c(yz − 1) + p(z − 1))∂G
∂y
Equation 4.3 can now be solved using the method of characteristics. The characteristics






















If we parametrise intial conditions on s = 0 as t = 0, y = ξ, z = η, and G = X0ξN0 ,
clearly t = s and z = η. After substituting t = s (noting that Equation 4.4b is separable and
Equation 4.4d is a Bernoulli equation) the system of equations can be solved to derive a
general solution for G:
G =
4X0
(c2X0t+ 2)2g(y, z, t)N0 − c2X0t(c2X0t+ 2)
(4.5a)


















−Nt + (c+ p)X0N0
N
(4.5d)
The values of xf,a can be derived by finding the coefficients of powers of y and z in a
power series expansion of G.
This analytical expression for the double expansion in y and z does not have a simple
closed form. However, the distributions of numbers of filaments and ASC monomers in
each cluster can also be derived computationally at each time point by calculating the Taylor
expansion for G in terms of the variables y and z (Figure 4.2). The mean and variance of the
number of filament and ASC monomers in each cluster increases over time; the skewness
of the distribution of cluster sizes (either by filament or ASC monomer count) also increases
over time. However, it is simpler to proceed by considering the moments of the distributions
of cluster sizes over time.
4.2.2 Moments and asymptotic analysis







Note that M0,0 and M1,0 correspond to X and F respectively.





























(a) Proportions of number of filaments per
cluster
(b) Proportions of number of ASC monomers
per cluster
Figure 4.2: Violin plots showing proportion of number of filaments and ASC monomers in
each cluster over time, calculated using the Taylor expansion of the generating function
for cluster size. The width of each bar corresponds to the proportion of clusters with size
corresponding to the y-value. Calculated mean size of cluster at each timepoint is shown with
a blue circle, and mean ± standard deviation with a blue star. Distributions are calculated for
p = c2 = c3 = 1, X0 = 0.1, x̂0 = 1, N0 = 10. Both mean filament and ASC monomer counts
increase with time; both distributions show considerable positive skewness, with skewness











































The moments can be used to calculate the centralised moments, including the mean











































































We can use these equations to gain insight into the behaviour of distributions of clusters
over time. In particular, we can see that the mean and variance of the number of both
filaments and ASC monomers in each cluster increases over time, which is in agreement with
the distributions calculated in the previous section (Figure 4.2). We can also use asymptotic
solutions to understand the behaviour of solutions at early and late times, and for extreme
parameter values.
Let us first assume that all parameters are O(1). The asymptotic expansions for large
and small times are given in Table 4.1, and plots of µF , µA, σ2F , σ
2
A and x̂ are given in Figures
4.3 - 4.7.
At small times, x̂ and X are approximately linearly decreasing, σ2F , µA and σ
2
A are lin-
early increasing from zero, and µF is linearly increasing from N0. The rate of decrease in x̂
is proportional to x̂0, X0 and N0, while the rate of decrease in X is proportional to c2 and X0;
thus, at early times, the rate of decrease of monomers and clusters is determined only by the
abundance of monomers and filaments, or the number of clusters and joining rate respec-
tively. The rate of increase of µA and σ2A are proportional to N0, x̂0 and c + p, while µF and
σ2F increase at a rate proportional to N0c(x̂0 +N0X0/2). Thus, we see faster cluster growth
in terms of number of ASC monomers in the cluster when both p and c are larger, whereas
naturally the filament growth rate is dependent on the value of c but not p. The variance of
cluster size (both by number of filaments and number of ASC monomers) increases over
time as cluster sizes initially diverge from the initial conditions, in which all clusters contain
10 NLRs. The initial increases for both mean and variance of cluster sizes are especially
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steep when c is large, since when branching reactions occur, this creates further filaments,
which increases the rate of both C and P-type reactions; in contrast, increasing p increases
the growth rate of clusters, but we do not observe a positive feedback loop as for increasing
c, since no new filaments are formed.
Notably, the solutions for µF , µA, σ2F and σ
2
A at early times approximate the solutions of
the same system with x̂ = x̂0 held constant. It is also notable that there is no initial ‘lag’
either in monomer depletion or cluster growth; in fact, for mean and variance of cluster sizes,
for all parametrisations shown here there is generally an initial sharp increase which slows
at later times. We will see in the next chapter that such a lag can occur for the full model;
this is a key difference between the behaviour of the simplified and full models.
At large times, x̂ and X tend towards zero as desired, as O(e−Nt) and O(t−1) respec-
tively. µf and µa increase approximately linearly for large t, as the system becomes dom-
inated by lower concentrations of large clusters. However, σ2A increases linearly, and σ
2
F
increases quadratically with time. This violates our conditions on successful modelling of
the inflammasome laid out in Section 3.2.3; if the system tends towards a steady state with
a single cluster as experimental observations show, we would expect the variance of the
system to decrease at large times until it reaches zero. Furthermore, we would not expect
the mean size of the cluster to continue increasing indefinitely; as the ASC monomers in
the system are depleted, we would expect the final ASC speck to approach a maximum
size, when it contains all ASC originally in the cell. This failure of the simple ODE model to
converge to a mean cluster size is a result of the fact that the concentration of monomers
is continuous; thus the nonzero monomer concentration can continue contributing to cluster
growth indefinitely.
4.2.3 Models without branching or with branching only
In order to clarify the roles played by the branching (C) and filament extension (P) reactions
in the model, I will now consider the solutions of the model when each of these reactions is
removed in turn; this corresponds to setting c = 0 or p = 0. The case c = 0 corresponds to a
system in which clusters grow only via filament extension; the case p = 0 corresponds to a
system in which clusters grow only by reactions which seed new filaments. Consideration of
these extreme systems will allow us to shed light on how filament-extension-like and branch-
like growth affect the distributions of cluster growth over time. Furthermore, this will enable us
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(a) Varying c (b) Varying p (c) Varying X0
Figure 4.3: Monomer concentrations over time, varying the filament branching rate c, filament
extension rate p and initial NLR concentration X0. Results from numerical solutions of ODE
model are shown. Initial ASC monomer concentration x̂0 = 1 is fixed, and c = p = 1 and
X0 = 0.1 unless stated otherwise. Monomer concentration is depleted in an exponential
fashion, approaching 0 at large t. The rate of depletion is faster for higher values of c and p,
and for higher initial numbers of NLR oligomers.
(a) Varying c (b) Varying p (c) Varying X0
Figure 4.4: Mean number of filaments per cluster over time, varying the filament branching
rate c, filament extension rate p and initial NLR concentration X0. Results from numerical
solutions of ODE model are shown. Initial ASC monomer concentration x̂0 = 1 is fixed, and
c = p = 1 and X0 = 0.1 unless stated otherwise. Following an initial sharp increase, µf
tends towards a straight line with positive gradient; the gradient increases with the value of
X0, and the intercept increases with increasing c and decreasing p. However, this suggests
that the mean cluster size grows indefinitely, which is biologically implausible.
(a) Varying c (b) Varying p (c) Varying X0
Figure 4.5: Variance of filaments per cluster over time, varying the filament branching rate c,
filament extension rate p and initial NLR concentration X0. Results from numerical solutions
of ODE model are shown. Initial ASC monomer concentration x̂0 = 1 is fixed, and c = p = 1
andX0 = 0.1 unless stated otherwise. At large times, the variance of the number of filaments
in each cluster increases quadratically, when we would expect this to tend towards zero as
a single cluster emerges.
(a) Varying c (b) Varying p (c) Varying X0
Figure 4.6: Mean ASC monomers per cluster over time, varying the filament branching rate c,
filament extension rate p and initial NLR concentration X0. Results from numerical solutions
of ODE model are shown. Initial ASC monomer concentration x̂0 = 1 is fixed, and c = p = 1
and X0 = 0.1 unless stated otherwise. Following an initial sharp increase, µA tends towards
a straight line with positive gradient; the gradient increases with decreasing X0, suggesting
the final growth rate is larger when there are fewer NLR oligomers initially present. However,
once again this behaviour is biologically implausible as we would expect the mean cluster
size to approach a constant value as monomers are depleted.
(a) Varying c (b) Varying p (c) Varying X0
Figure 4.7: Variance of ASC monomers per cluster over time,varying the filament branching
rate c, filament extension rate p and initial NLR concentration X0. Results from numerical
solutions of ODE model are shown. Initial ASC monomer concentration x̂0 = 1 is fixed, and
c = p = 1 and X0 = 0.1 unless stated otherwise. After an initial rapid increase, at large
times, σ2A increases linearly, when we would expect σ
2
A → 0 as monomers are depleted.
Variable t 1 t 1

























































Table 4.1: Limits of solutions for the moments for large and small t, assuming all other
parameters are O(1).
(a) Reaction C2 included (b) Reaction C not included (c) Reaction P included
Figure 4.8: The simplified inflammasome model with filament extension only
to assess the behaviour of the model at early and late times, as for the model with branching
and filament extension; in particular, we will be able to judge if either of these reactions is
solely responsible for the unlimited growth of clusters observed in the previous section.
Models without branching
We will first consider the behaviour of the model with no branching, i.e. growth occurs by
filament extension only (Figure 4.8).








(c2X0t+ 2)2y−N0 exp[x̂0(z − 1)(e−pX0N0t − 1)]− c2X0t(c2X0t+ 2)
















The moments at early and late times, assuming other parameters are O(1), are given in
Table 4.2. Examples of the solutions for x̂, µA and σ2A are shown in Figure 4.9.
Model with branching only
We will first consider the behaviour of the model with branching only (Figure 4.10).
The solutions for x̂, X, F and the generating function G are as follows:
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(a) ASC monomer concentration (b) µA
(c) σ2A (d) µF
(e) σ2F
Figure 4.9: Moments for simplified model with no branching, varying the value of the fila-
ment extension rate p. Results from numerical solutions of ODE model are shown. Note that
the mean and variance of the number of filaments per cluster (µF and σ2F ) are independent
of p, increasing linearly and quadratically respectively. Solutions are broadly similar to the
solutions for the model with branching, but reactions generally occur more slowly, due to
the lack of the positive feedback loop of filament creation caused by branching reactions.
At late times, the variances of the number of filaments per cluster and the number of ASC
monomers per cluster fail to tend to zero, so the model does not accurately capture inflam-
masome formation at late times.
Variable t 1 t 1






















Table 4.2: Limits of solutions to the model with no branching for the moments for large and
small t, assuming all other parameters are O(1).
(a) Reaction C2 included (b) Reaction C included (c) Reaction P not included






















The moments are as follows:
(4.16a)µA =
N0x̂0(e























The moments at early and late times, assuming other parameters are O(1), are given in
Table 4.3.
Comparing the models without branching and with branching only
The solutions for the models without branching and with branching only are broadly similar
to the solutions for the model with both branching and filament extension; at small times,
we see an approximately linear decrease in x̂, and a linear increase in µF , σ2F , µA and σ
2
A.
X is unchanged, since the cluster joining process is independent of the filament branching
and extension reactions. At later times, as for the model with both branching and filament
extension, we see that µF and µA increase approximately linearly, while σ2F and σ
2
A increase
approximately quadratically. Once again, the fact that the mean does not tend to a fixed
value, and the variance does not tend to zero, flout the conditions on succesful modelling of
the inflammasome at late times.
Interestingly, the solutions for µF and σ2F in the model without branching are independent
of the filament extension rate p; the total number of filaments in this model are constant, so
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(a) ASC monomer concentration (b) µA
(c) σ2A (d) µF
(e) σ2F
Figure 4.11: Moments for simplified model with branching growth only, varying the value of
the filament branching rate c. Results from numerical solutions of ODE model are shown.
Solutions are broadly similar to the full model, with initial rapid linear increases in cluster size
for large c. Once again, the variances of the number of filaments per cluster and the number
of ASC monomers per cluster fail to tend to zero, so the model fails at late times.
Variable t 1 t 1




























Table 4.3: Limits of solutions to the model with branching growth only for the moments for
large and small t, assuming all other parameters are O(1).
the distribution of filaments per cluster is only affected by the total number of clusters. As
the total number of clusters decreases, the mean number of filaments per cluster increases
linearly, and the variance increases quadratically.
More specifically, at small times, we see that x̂ is broadly unaffected by switching between
branching and non-branching behaviours (if p and c to take the same values). However, the
initial rate of increase of µF and σ2F is slower in the case of the model without branching
compared to the model with branching; in the model with branching, the initial rate of linear
increase has an additional factor of x̂0N0c. For small initial concentrations X0 we also see
a much slower initial increase in µA and σ2A for the model without branching. Once again,
these differences in rates arise from the positive feedback loop of filament creation, which
arises in the model with branching but not in the model without branching.
At later times, the faster increase in cluster growth rate for the branching-only model is
also reflected in the rate of monomer deletion, with an extra factor of −cx̂0t appearing in the
exponent. In general, the values tended to for µF , µA, σ2F and σ
2
A in the model with branching
are also much higher than in the model without branching; once again, this reflects the
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postive feedback effect when branching occurs.
4.3 Analysis of the stochastic model
So far, I have focused on using deterministic methods to analyse the simplified inflamma-
some model; this has given an insight into the roles of the cluster growth and joining pro-
cesses, and in particular, how the number of free ASC monomers and distribution of cluster
sizes changes over time for different parameter values. However, it is evident that the de-
terministic models do not capture some aspects of inflammasome formation which would be
useful to investigate further. For example, the deterministic model fails when the number
of reactants is very small, i.e. at late stages in the process. The deterministic model also
gives us no insight into variation in the inflammasome formation process between cells in
the same population. This motivates a discrete stochastic approach, which addresses both
of these issues. A stochastic system which tracks the size of all clusters over time would
be extremely unwieldy; the relative simplicity of analysing the deterministic system makes it
a more appropriate approach to considering distributions of cluster size. However, it is still
possible to analyse stochastic systems involving the ‘sum variables’ introduced in Chapter 3;
namely, F (t), x̂(t) and X(t) (the total number of filaments, free ASC monomers and clusters
at time t respectively); note that since we are now working with a discrete stochastic system,
these variables now correspond to total abundances of reactants rather than concentrations.
In particular, stochastic analysis of X(t) can allow us to determine the distribution of the
time at which the first joining event occurs between clusters, and the time at which a single
isolated cluster first emerges; neither of these can be obtained from the deterministic model,
but distributions of both times can be analytically obtained from the stochastic model using a
CTMC approach. Analysing x̂(t) is also useful since this is the quantity that can most easily
be compared to the experimental data presented in Chapter 2; in particular, I will present an-
alytical expressions for the probability density functions of the relevant characteristic times.
One particular benefit of using the simplified inflammasome model for stochastic analysis
is that the cluster joining process is independent of cluster growth; therefore, these two
processes can be considered separately. Allowing cluster joining rates to be dependent
on cluster size adds considerably to the complexity of the stochastic model; this will be
investigated further using simulations in Chapter 5.
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(a) Reaction C2 included
(b) Reaction C does not af-
fect this subsystem
(c) Reaction P does not af-
fect this subsystem
Figure 4.12: The cluster joining subsystem for the simplified inflammasome model
Figure 4.13: The number of clusters X(t) forms a continuous-time Markov chain, with tran-
sition rates proportional to the number of joins possible with the clusters present, and inde-
pendent of cluster size.
4.3.1 Stochastic model for number of clusters
We will first consider the subsystem of the model with cluster joining reactions only (Figure
4.12).
In the simplified model, the rate of cluster joining does not depend on cluster size; the
rate at which joining events occur is proportional to the number ways a join could occur







The number of clusters X(t) can be considered as a CTMC, shown in Figure 4.13. Note
that the single cluster state is absorbing.
We can calculate the distribution of the first joining and single cluster emergence times
as first hitting times for states X0 − 1 and 1 in the CTMC. The time taken to jump from one
stateX = n toX = n−1 in our Markov chain is exponentially distributed with rate ec2n(n−1)/2.
For example, the first joining time is exponentially distributed with rate c2
X0(X0−1)
2 . The mean
first cluster joining time is 2c2X0(X0−1) , and the variance is
4
(c2X0(X0−1))2 .
The time to single cluster emergence is the sum of the initial jump times from X = X0
to X = X0 − 1, X = X0 − 1 to X = X0 − 2, · · · , X = 2 to X = 1, each of which is expo-
nentially distributed; the total time to cluster emergence is therefore the sum of exponentially
distributed random variables with rates c2, 3c2, · · · , c2X0(X0−1)/2. By definition, this random
variable is hypoexponentially distributed with parameters c2, 3c2, · · · , c2X0(X0 − 1)/2 [Amari
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Figure 4.14: Analytically-derived distributions of times of first joining event and single cluster
emergence while varying the cluster joining rate c2, fixing the initial NLR oligomer concen-
tration X0 = 100. Note that units of time are scaled by the rate c2. Increasing c2 decreases
both the mean and the spread of both distributions; for all values of c2 the distribution has a
long tail corresponding to rare events at late times.
and Misra, 1997].


















































(X0 − i− 1)! (X0 + i)!
The only parameters which affect first joining time and single cluster emergence time in
this model are c2 and X0 (Figures 4.14 and 4.15). The distributions for both times also show
considerable positive skew, so all have a long tail corresponding to the increasing rarity of
events at later times. As c2 increases, the distributions of first joining and single cluster emer-
gence times decrease both in mean and spread. Hence, for fast joining rates, unsurprisingly
cluster formation is faster, and formation of clusters at later times is extremely rare. Interest-
ingly, varying X0 has fairly little relative effect on the distribution of single cluster emergence
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Figure 4.15: Analytically-derived distributions of times of first joining event and single cluster
emergence while varying the initial NLR oligomer concentration X0, fixing the cluster joining
rate c2 = 1. Note that units of time are scaled by the rate c2. Increasing X0 decreases both
the mean and the spread of the distribution of first joining times; however, varying X0 has
little effect on the time of single cluster emergence.
times, although increasing X0 leads to a slight increase in single cluster emergence times;
the mean single cluster emergence time slowly approaches a limit of 2/c2 as X0 increases.
However, first joining time is extremely sensitive to the value of X0; larger values of X0 lead
to much faster first joining times, with reduced distribution spread.
This model therefore shows that although the first joining time is sensitive to the initial
number of NLR oligomers, this parameter does not have a notable effect on the distribution
of inflammasome formation time. This suggests the variation between cells forming inflam-
masomes in similar conditions arises from other sources, possibly due to a difference in
cluster joining rate. However, this still bears further investigation; in this simplified model, I
have decoupled the cluster joining and cluster growth processes, but this conclusion cannot
be extended to models with size-dependent cluster joining. Since such joining processes
are considerably more involved to analyse analytically, I will examine them further using
simulations in Chapter 5.
4.3.2 Monomer depletion
We now consider the subsystem of the simplified inflammasome model corresponding to
monomer depletion reactions (Figure 4.16).
Let F (t) and X̂(t) be the total number of ASC filaments in the system and the number of
unbound ASC monomers at time t respectively. We can then view F (t) and X̂(t) as a CTMC
starting from initial conditions F (0) = f0 and X̂(0) = x̂0.
134
(a) Reaction C2 does not af-
fect this subsystem (b) Reaction C included (c) Reaction P included
Figure 4.16: The cluster joining subsystem for the simplified inflammasome model
Reference Reaction Propensity function Explanation




P (X̂, F )




Table 4.4: Reactions considered in the stochastic filament extension/branching and
monomer depletion subsystem.
There are two reactions to consider, set out in Table 4.4.
We can regard the process of monomer depletion as a series of jumps on a lattice in
which each point corresponds to a value of X̂ and F (Figure 4.17); the times between jumps
are all exponentially distributed
The two possible jumps out of a point (X̂, F ) are a jump caused by filament extension to
point (X̂−1, F ) with rate pFX̂, and a jump caused by filament branching to point (X̂−1, F+1)
with rate cFX̂.
At any point, the next jump will cause filament branching with probability cX̂F
cX̂F+pX̂F
= cc+p ,
independent of the current number of filaments or monomers in the system, the time of the
jump, and of any previous jumps. Thus, the total number of filaments once all monomers
have been depleted will be binomially distributed with x̂0 total trials and success probability
c
c+p .
Furthermore, we can investigate the monomer depletion characteristic times t1/q for the
monomer population to be depleted by a proportion 1/q. Note that the time taken for N
monomers to be depleted (or N jumps to be taken through the lattice in Figure 4.17) is tN/x̂0 .
We can consider the distribution of tN/x̂0 as a phase-type distribution [Neuts, 1975]; this
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Figure 4.17: The process of monomer depletion and filament formation and extension can
be represented as movement between points on a lattice. Here, the row represents the
number of free ASC monomers and the column represents the total number of filaments.
There are two types of jumps between lattice points - jumps representing the P reaction, in
which the number of monomers X̂ decreases by 1, which occur at the rate pFX̂, and jumps
representing the C reaction, in which X̂ decreases by 1 and F increases by 1, which occur
at the rate cFX̂.
is defined as the time until absorption of a CTMC with an absorbing state. The distribution is
defined by a n × n generator matrix S of transition rates between the non-absorbing states
in the CTMC, and a vector π of probabilities of the system starting in each state. The full





where s is a n × 1 vector of absorption rates and 0 is a 1 × n vector of zeros. Note that




−λ1 λ1 0 · · · 0 0
0 −λ2 λ2
. . . 0 0
...
. . . . . . . . . . . .
...
0 0
. . . −λn−2 λn−2 0
0 0 · · · 0 −λn−1 λn−1
0 0 · · · 0 0 −λn

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where λi is the ith jump rate.
In the case of the monomer depletion and filament growth/branching system , we will de-
fine an ordering of states as follows: (f0, x̂0), (f0+1, x̂0), (f0+2, x̂0), · · · , (f0+N, x̂0), (f0, x̂0−





and F (i) =
f0 + (i− 1) mod (N + 1)
We group all states with X̂ ≤ x̂0 − N into a single absorbing state. Then there are
N(N + 1) non-absorbing states, and the generating matrix is
S =

−(c+p)d1 0 ··· pd1 cd1 0 ··· 0






. . . . . .
...
0 0 ··· −(c+p)dN2−2 0 ··· pdN2−2 cdN2−2






. . . . . .
...
0 0 ··· 0 0 ··· −(c+p)dN2(N+1)2−1 0
0 0 ··· 0 0 ··· 0 −(c+p)dN2(N+1)2

(4.21)
where di = F (i)(x̂0 − X̂(i) + 1) for state i. This matrix is upper triangular, and the only
non-zero entries lie on the main diagonal and the (N + 1)th and (N + 2)th diagonals. Since
we start in the state (f0, x̂0), we put π = (1, 0, · · · , 0)T .
Note that not all states can be reached from this starting condition; in particular, states
with F − f0 > x̂ − X̂ cannot be reached since these would correspond to states in which
more filaments have been created than monomers depleted.
The random variable tN/x̂0 has probability density function ftN/x̂0 (t) = πe
tSs [Neuts,
1975]; some examples for different parametrisations are given in Figure 4.18. As far as I
have been able to determine, this cannot be expressed in a simplified closed form but can
be estimated using computational techniques; in this case, I have used the Matlab fastexp
package to calculate the pdf for a sparse representation of Matrix 4.21 [Higham, 2021].
We can also calculate the mean and variance of this phase-type distribution; the mean of
tN/x̂0 is given by −πS−11, where 1 is a vector of ones, and the variance is given by 2πS−21−
(πS−11)2 [Neuts, 1975]. Some example values are given in Figure 4.19. The mean and
variance of tN0/x̂0 decrease with increasing c, p, f0 and x̂0. This is unsurprising in the case of
c and p since this increases the overall rate at which ASC monomers are depleted; however,
notably, increasing c leads to a much larger reduction in mean and variance than increasing p
by the same amount. This is due to the positive feedback loop caused by C reactions creating
more filaments, which further increases the rate of depletion of monomers. Increasing f0
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(a) Varying c (b) Varying p
(c) Varying f0 (d) Varying x0
Figure 4.18: Analytically-derived Probability density functions of the monomer depletion
characteristic time t1/10 calculated for varying values of the branching rate c, filament exten-
sion rate p, and initial number of NLRs and ASC monomers, f0 and x0 respectively. When
values are not given explicitly, c = p = 1, f0 = 100, x0 = 5000. As c, p, f0 and x0 increase,
the mean and spread of the distributions of t1/10 decrease.
and x̂0 decreases the mean and variance of the distribution of tN/x̂0 , since increasing these
parameters increases the initial rate of ASC monomer depletion. Another notable feature of
these distributions is that, unlike the single cluster emergence times, they display very little
skewness; this may be due to the fact that the time for the monomer population to decrease
by a given fraction is not as sensitive to individual reactions taking a longer time compared
to single cluster emergence (which is particularly sensitive to the time taken for the last few
reactions, when few clusters remain).
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(a) Mean, varying c (b) Variance, varying c
(c) Mean, varying p (d) Variance, varying p
(e) Mean, varying f0 (f) Variance, varying f0
(g) Mean, varying x0 (h) Variance, varying x0
Figure 4.19: Analytically-derived means and variances of t1/10 and t1/2 while varying the
filament branching rate c, filament extension rate p, initial number of filaments f0 and initial
number of ASC monomers x0; other variables are fixed at c = 1, p = 1, f0 = 100, X0 = 5000.
As c, p f0 and x0 increase, mean and variance decrease. This effect is especially marked
for the branching rate c, since as c increases this reinforces the positive feedback loop of
increasing rate of monomer depletion as more branches are formed.
(a) Reaction C2 does not af-
fect this subsystem
(b) Reaction C is not in-
cluded (c) Reaction P is included
Figure 4.20: The simplified inflammasome model with filament extension only
Model without branching
The model becomes much simpler if branching (C) reactions are not included, as is currently
the generally accepted conceptual model of inflammasome formation (Figure 4.20); while
the time of single cluster emergence is not affected, since this is only dependent on the rate
of cluster joining and the initial number of NLR oligomers, the distribution of characteristic
times for monomer distribution tN/x̂0 are affected. In fact, if N monomers are depleted, this
will occur via a series of exponentially distributed jumps down the left-hand side of the lattice
in Figure 4.17 with rates pf0x̂0, pf0(x̂0− 1), pf0(x̂0− 2), · · · , pf0x̂0−N + 1). Thus t1/n will be
hypoexponentially distributed, with rates pf0x̂0, pf0(x̂0 − 1), · · · , pf0(x̂0 −N + 1).
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i is the ith generalised har-




jn . This expression is more amenable to fitting to experimental
data than the full phase-type distribution. Example plots of the probability density function
are given in Figure 4.21; the mean and variance of tN/x̂0 decrease as p increases.
Model with branching but not filament extension
A similar analysis can be carried out in the case that no filament extension (P) reactions
occur and inflammasome formation occurs through branching reactions only (Figure 4.22);
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Figure 4.21: Analytically-derived examples of distributions for the characteristic monomer
depletion time t1/10, for the model without branching, for different values of p, the rate of
branching. As p increases, t1/10 decreases.
(a) Reaction C2 does not af-
fect this subsystem (b) Reaction C is included
(c) Reaction P is not in-
cluded
Figure 4.22: The simplified inflammasome model with branching only
the system undergoes a series of diagonal jumps through the lattice in Figure 4.17. The
times between jumps are exponentially distributed, with rates cf0x̂0, c(f0 + 1)(x̂0 − 1), c(f0 +
2)(x̂0 − 2), · · · , c(f0 + N − 1)(x̂0 −N + 1). Thus tN/x̂0 will be hypoexponentially distributed,
with rates cf0x̂0, c(f0 + 1)(x̂0 − 1), · · · , c(f0 +N − 1)(x̂0 −N + 1).
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If 2N ≥ x̂0−f0, the rates are not unique; in particular, two rates λi = c(f0+i−1)(x̂0−i+1)
and λj = c(f0 + j − 1)(x̂0 − j + 1) are equal when i+ j = x̂0f0. However, for 2N < x̂0 − f0
the rates are all unique, and the probability density function is as follows:
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Figure 4.23: Analytically-derived examples of distributions for the characteristic monomer
depletion time t1/10, for the model with branching but not filament extension, for different








c(f0 + i− 1)(x̂0 − j + 1)
c(f0 + i− 1)(x̂0 − j + 1)− c(f0 + i− 1)(x̂0 − i+ 1)

= c
(f0 +N − 1)! x̂0!
(f0 − 1)! (x̂0 −N)!
N−1∑
i=0
(x̂0 − f0 − i−N)!
i! (N − i− 1)! (x0 − f0 − i)!
(−1)i(x̂0 − f0 − 2i)e−ct(f0+i)(x̂0−i)
(4.24)
When the rates of a hypoexponential function are not unique, the pdf does not have a
simple closed form, but can be calculated using the phase-type representation outlined pre-
viously. Example plots of the probability density function are given in Figure 4.23; notably, as
c increases, the mean and variance of tN/x̂0 decrease. In general, the means and variances
of the monomer depletion characteristic times are considerably less than their equivalents in
the model with filament extension only.
4.4 Discussion
4.4.1 Summary
In this chapter, I have established analytical solutions for the deterministic simplified model
of inflammasome formation and, in particular, the distribution of cluster sizes at each time
point. I have also established the distribution of the following characteristic times in the
stochastic version of the simplified model: the distribution of times of first joining events,
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the time of emergence of a single cluster, and the time taken for ASC monomer abundance
to decrease by a fraction 1/q. These solutions suggest a number of conclusions; firstly,
from the deterministic model we can see that the abundance of free monomers decreases
approximately exponentially over time towards zero, with the rate of decrease increasing with
the rate of filament branching and extension, as well as the initial number of NLR oligomers.
The absence of a ‘lag’ at the beginning of this process is notable, and will be examined in
comparison to experimental data in Chapter 6. The rate of increase of the mean number
of ASC filaments and ASC monomers in each cluster levels off after an initial period of fast
expansion in many cases. The rate of increase in cluster size is particularly marked when
branching reactions are included, since these lead to a ‘positive feedback loop’ in which the
creation of filaments also increases the overall rate of cluster growth. A similar effect can be
observed for the variances of these variables. However, there are limits to the conclusions
we can draw from the model at later times. Asymptotic analysis demonstrates that for all
parametrisations of the model, the mean and variance of cluster sizes increase indefinitely
over time, which is at odds with the depletion of ASC monomers and the emergence of
an inflammasome with static size which is observed experimentally. This is caused by the
inability of the model to accurately capture the system when there are small numbers of
reactants.
I have also derived the distributions of the first joining time, the single cluster emergence
time and the monomer depletion characteristic times from the stochastic formulation of the
simplified model. A particularly notable feature of these results is that both joining rate of
clusters and the initial number of NLR oligomers affect the time of first joining (increasing
either parameter decreases the mean and variance of the first joining time); however, dis-
tribution of the time of single cluster emergence is mainly determined by the rate of cluster
joining, and not the initial number of NLR oligomers. This suggests that the variation be-
tween cells in terms of inflammasome formation time may be due to inherent variation in
cluster joining rate between cells. This could be caused, for example, by cells being different
sizes, or containing varying levels of cellular crowding. However, an intrinsic variation in clus-
ter joining rate would not explain the fact that in some inflammasome systems (for example,
NLRP3 inflammasomes) not all cells form inflammasomes, whereas this is not the case, for
example, with NLRC4 inflammasome formation. However, I will re-examine this conclusion
in Chapter 5 in the light of results from the full model.
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4.4.2 Further work
A natural next step is compare the results from the simplified to results from the full model;
in particular, the different structure of the joining kernel in the full model is likely to lead to
different results for characteristic times related to cluster joining (i.e. first joining time and
single cluster emergence time). This will be considered in Chapter 5.
The distributions for characteristic times can also be compared with those derived from
experimental data; this will be considered in Chapter 6, and fitting will be carried out using
maximum likelihood estimation. One drawback of the analysis carried out here is that the
general expression for the time of single cluster emergence is very unwieldy, and relies on
taking the matrix exponential of a generally very large transition matrix. While this expres-
sion can be used to calculate a probability density function given all parameter values, this
process takes too long to be useful when using a computational algorithm to minimise the
resultant likelihood functions. I have been as yet unable to find a simple closed form for the
probability density function for this very structured phase-type distribution, but this may be
possible.
It may also be possible to extend the analysis carried out in this chapter, in order to
establish the distribution of the times of dominant cluster emergence. This would be more
difficult to derive than the single cluster emergence time, since this would have to take cluster
size into account; however, for example, mean cluster size at a given time could be derived by
calculating the distribution of the number of free ASC monomers by considering the Markov
chain presented in Figure 4.17, and use conservation of monomers to derive the number
of monomers in clusters; this could be divided by the distribution of the number of clusters
which can be calculated from the Markov chain given in Figure 4.13. This would require
considerable further analytical work, and it would be unlikely that a simple closed form could
be found.
Another possible application is to extend the techniques described in this chapter to the
full model; although this would be considerably more complex than the analysis carried out
so far, it would be possible, for example, to define a phase-type distribution for the time of
single cluster emergence in the full model. The generator matrix would be considerably
larger, and would be unlikely to be upper triangular; due to the inclusion of movements be-
tween compartments, the monomer abundance is not monotonically decreasing, and a sin-
gle ordering of states could not be contrived such that all movement between states occurs
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in a single direction. While the generator matrix would still be sparse, calculations involving
probability density functions and mean and variance would be significantly slower than those
required for a triangular matrix.
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Chapter 5
Analysis and simulations of the full
model of inflammasome formation
5.1 Introduction
Having analysed the simplified inflammasome model, we will now return to the full model of
inflammasome formation initially proposed in Chapter 3 (Figure 5.1). The two compartments
corresponding to the nucleus and cytosol are reintroduced, as is the distinction between
unbound NLRs in oligomers and growing ASC filaments. The rate of cluster joining is also
adjusted so that it is once more proportional to cluster size.
I will first examine the behaviour of the deterministic ODE formulation of the full inflamma-
some model; in particular, I will demonstrate the existence of an initial ’lag’ phase in cluster
Reaction C1 (Recruitment of ASC monomer
by NLR in oligomer) Reaction C2 (Cluster joining)
Reaction C3 (Branching of ASC filaments) Reaction P (ASC filament extension)
Reaction M1 (Movement of ASC monomer
from nucleus to cytosol)
Reaction M2 (Movement of ASC monomer
from nucleus to cytosol)
Figure 5.1: The full inflammasome model revisited
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growth and monomer depletion when ASC recruitment rate by NLRs is slow; this is a clear
contrast between the full and simplified inflammasome models. I will also define a set of
parametrisations for the model for which the lag phase does not exist. However, as I did for
the simplified model, I will also demonstrate that the full ODE model displays non-physical
behaviour at later timepoints as the concentration of reactants becomes smaller.
I will then present results from simulations of the stochastic formulation of the full model.
In particular, I will demonstrate that the process of inflammasome formation up to single
cluster emergence can be divided into separate phases: an initial phase before cluster join-
ing commences, an intermediate phase in which clusters begin to join, and a later phase in
which a single dominant cluster emerges. I will also demonstrate that the variation between
simulation runs (and by analogy, between individual cells) arises from stochasticity in the
second phase.
Finally, I will present results from a cohort of simulations run with parameter sets chosen
using Latin hypercube sampling. In order to determine the dependence of the characteristic
times for each simulation run on the parameter set used, I will fit a generalised linear model
to the results for each characteristic time. I will use this model to demonstrate that while
early characteristic times are dependent on a large set of parameters, later characteristic
times (namely, the times of single and dominant cluster emergence) are dependent on very
few parameters. In particular, the time of dominant cluster emergence is dependent on the
branching rate and the initial number of NLR oligomers, whereas the time of single cluster
emergence is dependent on the branching rate and the rate of movement of ASC monomers
out of the nucleus.
I have also generated simulations for variations on the full inflammasome model, in which
some of the initial assumptions have been altered. In particular, I have considered a variation
on the full model in which there is no filament branching, a model in which there is only one
NLR oligomer initially present, and a model in which the initial number of NLRs in each
oligomers is random rather than constant. I will demonstrate the differences arising between
these models and the full models with basic assumptions; all four datasets will be compared
to experimental data in Chapter 6.
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5.2 Analysis of the ODE model
We will begin by considering the deterministic formulation of the full inflammasome model
using the reduced ODE form:
dx̂c
dt


















= c1x̂cN + c3x̂cF + px̂cF
dsF,F
dt
= c1x̂c(2sF,N +N) + c2s
2
F,F + c3x̂c(2sF,F + F )
dsN,N
dt
= c1x̂c(N − 2sN,N ) + c2s2F,N
dsA,A
dt
= c1x̂c(2sN,A +N) + c2s
2
F,A + (c3 + p)x̂c(2sF,A + F )
dsF,N
dt
= c1x̂c(sF,F − sF,N −N) + c2sF,F sF,N + c3x̂csF,N
dsF,A
dt
= c1x̂c(sN,A + sF,N +N) + c2sF,F sF,A + c3x̂c(sF,F + sF,A + F ) + px̂csF,F
dsN,A
dt
= c1x̂c(sN,N − sN,A −N) + c2sF,NsF,A + (c3 + p)x̂csF,N
(3.2 revisited)
Here, x̂c and x̂n are the concentrations of ASC monomers in the cytosolic and nuclear
compartments respectively. X is the total concentration of clusters, F is the total concen-
tration of filaments in the system, N is the total concentration of unbound NLRs, and A is
the total concentration of ASC monomers in clusters. The variables SI,J are the second
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filaments and ASC monomers per cluster respectively, and σ2F and σ
2
A are the variances of
the number of filaments and ASC monomers per cluster respectively.
The intial conditions for the system of equations 3.2 are as follows:
Although (unlike the simplified ODE model) System 3.2 is not analytically solvable, nu-
merical solutions are useful for comparison; I have implemented the system using the ode45




A can then be calculated.
Throughout my analysis of the full deterministic model, I set m2 = 1.3 × m1, and thus
x̂n(0) = 1.3× x̂c(0), assuming the populations of ASC monomers begin in equilibrium. This
value is estimated from experimental data in Section 2.4.1. As in the analysis of the simplified
model, I set c2 = 1 and x̂c(0) = 1 throughout, and asssumed that all clusters begin with 10
NLRs.
One of the notable properties of the full ODE model is that the concentration of clusters
X eventually becomes negative; this is clearly non-physical, and certainly undesirable. This
situation arises due to the size-dependent joining process. In particular, the evolution of X
is governed by the equation dXdt = −
1
2c2F
2. However, the system clearly tends to a fixed
point where x̂c = x̂n = N = 0, and F tends towards a positive constant value. Therefore,
at some point X must become negative. This issue does not arise in the simplified model,





2, so we certainly have X → 0 as t→∞.
This non-physical behaviour arises from the approximation made in the joining term while
setting up the ODE model, in which we do not prevent clusters from joining with themselves
(this is elaborated in Section 3.2.4); essentially X eventually becomes negative, because
when X is small the majority of filaments in fact belong to the same cluster, so there are far
fewer possible joining events than the ODE model suggests. This is an unavoidable feature
within the continuous framework in which x̂c, x̂n and other variables represent concentration
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rather than absolute number of reactants. In order to gain a truly accurate picture of the
behaviour of the system when there are small numbers of reactants, a discrete stochastic
system is more appropriate.
On the other hand, the issue of undesirable behaviour of the ODE model is not present
when reactant numbers are large; therefore it is worth considering the ODE model to un-
derstand the behaviour at early times, until the point where we have X < 0 and the results
become non-physical.
5.2.1 Dynamics of ASC monomer concentration
In the full model, at late times x̂c and x̂n have similar dynamics (exponential decreases
towards zero) to the simplified model for m1 and m2 larger than the cluster growth and joining
parameters (Figures 5.2 and 5.3). However, depletion is slightly slower for x̂n, which is also
to be expected, since ASC monomers are only depleted by cluster growth in the cytosolic
compartment. However, in the case of small c1, when binding of monomers to NLRs are
limited, there is a notable lag before the exponential decrease begins, leading to an overall
sigmoid curve; this is due to an initial bottleneck in cluster growth as filament seeding is
slow (Figures 5.2 and 5.3). The smaller the value of c1, the longer this lag phase. This is in
contrast to the simplified model, in which this bottleneck is absent and no initial lag occurs.
In general, the rates of monomer depletion increase with increasing c1, c3 and p, and
slightly with increasing m1. The dynamics of x̂c and x̂n are not affected by X0, since the
depletion of monomers is dependent only on the total filaments present, regardless of the
number of clusters.
5.2.2 Dynamics of total cluster concentration
The total cluster concentration similarly displays a decrease following initial lag phase, not
present in the simplified model (Figure 5.4). This lag phase increases with decreasing c1,
once again due to the bottleneck in filament seeding; since in this model, clusters merge via
filament-filament interactions, this cannot occur until sufficiently many filaments have been
seeded. The lag time also increases with X0, since it will therefore take longer for the same
proportion of NLRs present to seed filaments. The rate of decrease of X decreases with p
and increases with c3 if all other variables are fixed; since cluster merging is filament-driven,
filament branching contributes to faster merging, whereas linear filament growth does not.
150
5.2.3 Distributions of cluster size
The dynamics of µF , µA, σ2F and σ
2
A differ considerably from their dynamics in the simplified
model, bearing in mind that µF and σ2F are not direct parallels in the simplified and full model,
since in the simplified model, F also includes unbound NLRs (Figures 5.5 - 5.8). In the full
model, all of these variables tend towards a sharp increase (much steeper than in the sim-
plified model), following an initial lag phase with a slow increase not present in the simplified
model. As in the simplified model, the average cluster size naturally increases as merging
and growth occur, and the variance of cluster sizes increases as growth is dominated by
a few larger clusters. However, the initial rate of growth is limited by the filament seeding
bottleneck. Unlike the simplified model, in which an initial period of rapid growth gives way to
linear growth (for mean cluster size variables) or quadratic growth (for variance variables), in
the full model there is an initial slower period of growth which gives way to a sharp increase.
The length of the initial lag phases increase with increasing X0 and decrease with increas-
ing c1. This suggests the presence of separate phases in the cluster formation process: an
initial phase of filament number increase in which linear filament growth dominates, followed
by a phase of rapid mean filament number growth as clusters merge. However, in order to
investigate this phenomenon further, we will turn to a stochastic formulation of the full model,
which remains accurate at late times.
5.2.4 Identifying the length of lag phase for different parametrisations
In order to establish a relationship between the parametrisation of the model and the pres-
ence or absence of an initial sigmoid lag, I solved System 3.2 numerically with parameters
c1, c3 and p ranging between 10−1 to 10, and X0 ranging from 10−10 to 1. I took the calculated
values for x̂c and used an adaptation of a standard technique for determining lag phase in
bacterial growth to gain an approximate measurement for the lag phase (illustrated in Figure
5.9; see, for example, the method outlined in [Adkar et al., 2017]).
Overall, X0 has little effect on the length of the lag phase, as observed previously; how-
ever, there is a clear set of values of the parameters c1, c3 and p for which the calculated
lag phase has length zero - i.e., there is no lag before the rapid phase of ASC monomer
depletion (Figure 5.10). For each pair of values c3 and p, there is a maximum value of c1 for
which a lag phase occurs; above this value there is no lag phase (Figure 5.11). Using the
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(a) x̂c varying c1 (b) x̂c varying c3
(c) x̂c varying p (d) x̂c varying m1
(e) x̂c varying X0
Figure 5.2: Cytosolic ASC concentration x̂c over time while varying the rate of ASC recruit-
ment by NLRs c1, filament branching rate c3, filament extension rate p, rate of movement of
ASC out of the nucleus m1 and initial NLR oligomer concentrationX0. Numerical solutions
derived from the ODE system are shown. Cluster joining rate c2 = 1 and initial monomer
concentration x̂c(0) = 1 are fixed; c1 = c3 = 1,m1 = 1000 andX0 = 0.1 are the default values
when not being varied for comparison. Monomers are depleted in a sigmoid fashion. In the
case of small c1, there is a notable lag phase; the smaller the value of c1, the longer this lag
phase. Rates of monomer depletion increase with increasing c1, c3 and p, and slightly with
increasing m1. Monomer dynamics are not affected by the value of X0.
(a) x̂n varying c1 (b) x̂n varying c3
(c) x̂n varying p (d) x̂n varying m1
(e) x̂n varying X0
Figure 5.3: Nuclear ASC concentration over time while varying the rate of ASC recruitment
by NLRs c1, filament branching rate c3, filament extension rate p, rate of movement of ASC
out of the nucleusm1 and initial NLR oligomer concentrationX0. Numerical solutions derived
from the ODE system are shown. Cluster joining rate c2 = 1 and initial monomer concentra-
tion x̂c(0) = 1 are fixed; c1 = c3 = 1,m1 = 1000 and X0 = 0.1 are the default values when
not being varied for comparison. Overall, dynamics are very similar to those for x̂c, albeit
slightly slower.
(a) X varying c1 (b) X varying c3
(c) X varying p (d) X varying m1
Figure 5.4: Cluster concentration X over time while varying the rate of ASC recruitment by
NLRs c1, filament branching rate c3, filament extension rate p, rate of movement of ASC out of
the nucleus m1 and initial NLR oligomer concentration X0. Numerical solutions derived from
the ODE system are shown. Cluster joining rate c2 = 1 and initial monomer concentration
x̂c(0) = 1 are fixed; c1 = c3 = 1,m1 = 1000 and X0 = 0.1 are the default values when not
being varied for comparison. X decreases following an initial lag phase; the length of the
lag phase increases with decreasing c1 and with increasing X0. The rate of decrease of X
decreases with p and increases with c3. Varying m1 has little effect on the dynamics of X. In
all cases, X ultimately crosses the x-axis, and takes non-physical negative values; after this
point, the model is no longer biologically plausible.
(a) µF varying c1 (b) µF varying c3
(c) µF varying p (d) µF varying m1
(e) µF varying X0
Figure 5.5: Mean number of filaments per cluster over time while varying the rate of ASC
recruitment by NLRs c1, filament branching rate c3, filament extension rate p, rate of move-
ment of ASC out of the nucleus m1 and initial NLR oligomer concentration X0. Numerical
solutions derived from the ODE system are shown. Cluster joining rate c2 = 1 and initial
monomer concentration x̂c(0) = 1 are fixed; c1 = c3 = 1,m1 = 1000 and X0 = 0.1 are the
default values when not being varied for comparison. µF increases rapidly following a lag
phase; the length of lag increases with increasing X0 and decreases with increasing c1.The
rate of increase at late times increases with increasing c3.
(a) σ2F varying c1 (b) σ
2
F varying c3
(c) σ2F varying p (d) σ
2
F varying m1
(e) σ2F varying X0
Figure 5.6: Variance of number of filaments per cluster over time while varying the rate of
ASC recruitment by NLRs c1, filament branching rate c3, filament extension rate p, rate of
movement of ASC out of the nucleus m1 and initial NLR oligomer concentration X0. Numer-
ical solutions derived from the ODE system are shown. Cluster joining rate c2 = 1 and initial
monomer concentration x̂c(0) = 1 are fixed; c1 = c3 = 1,m1 = 1000 and X0 = 0.1 are the
default values when not being varied for comparison. σ2F increases rapidly following a lag
phase; the length of lag increases with increasing X0 and decreases with increasing c1.
(a) µA varying c1 (b) µA varying c3
(c) µA varying p (d) µA varying m1
(e) µA varying X0
Figure 5.7: Mean ASC monomers per cluster µA over time while varying the rate of ASC
recruitment by NLRs c1, filament branching rate c3, filament extension rate p, rate of move-
ment of ASC out of the nucleus m1 and initial NLR oligomer concentration X0. Numerical
solutions derived from the ODE system are shown. Cluster joining rate c2 = 1 and initial
monomer concentration x̂c(0) = 1 are fixed; c1 = c3 = 1,m1 = 1000 and X0 = 0.1 are the
default values when not being varied for comparison. µA increases rapidly following a lag
phase; the length of lag increases with increasing X0 and decreases with increasing c1.
(a) σ2A varying c1 (b) σ
2
A varying c3
(c) σ2A varying p (d) σ
2
A varying m1
(e) σ2A varying X0
Figure 5.8: Variance of ASC monomers per cluster σ2A over time while varying the rate of
ASC recruitment by NLRs c1, filament branching rate c3, filament extension rate p, rate of
movement of ASC out of the nucleus m1 and initial NLR oligomer concentration X0. Numer-
ical solutions derived from the ODE system are shown. Cluster joining rate c2 = 1 and initial
monomer concentration x̂c(0) = 1 are fixed; c1 = c3 = 1,m1 = 1000 and X0 = 0.1 are the
default values when not being varied for comparison. σ2A increases rapidly following a lag
phase; the length of lag increases with increasing X0 and decreases with increasing c1.
Figure 5.9: Schematic diagram showing calculation of the lag phase at the beginning of a
cytosolic ASC monomer trace (shown in blue). The point of inflection is found, and a tangent
line drawn at this point (shown in pink). The end of the lag phase is taken as the intercept of
the tangent with the line x̂c = 1.
Reference Reaction Propensity function
C1 x̂c + xf,n,a
c1n−−→ xf+1,n−1,a+1 c1nx̂cxf,n,a
C2 xf,n,a + xi,j,k
c2fi−−→ xf+i,n+j,a+k c2fixf,n,axi,j,k for (f, n, a) 6= (i, j, k),
1
2c2f
2xf,n,a(xf,n,a − 1) otherwise
C3 x̂c + xf,n,a
c3f−−→ xf+1,n,a+1 c3fx̂cxf,n,a






Table 5.1: Rates of reactions in the stochastic formulation of the full inflammasome model
Matlab function fit to fit a quadratic in c3 and p, an approximation for the surface defined by
these maximum values of c1 is as follows:
(5.2)c1 > 0.546 + 0.385c3 + 0.209p+ 3.60× 10−3c23 − 3.46× 10−3c3p+ 9.48× 10−4p2
This approximately defines the regions in the parameter space for which a lag phase
appears in x̂c; this will be used in fitting data in Chapter 6.
5.3 Simulations of the stochastic model
I will now turn my attention to the stochastic formulation of the full inflammasome model. The
propensity functions, as first presented in Chapter 3, are given in Table 5.1.
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(a) Varying c1 and c3 (b) Varying c1 and p
(c) Varying c3 and p (d) Varying c1 and X0
(e) Varying c3 and X0 (f) Varying p and X0
Figure 5.10: Length of lag phase for the ASC monomer concentration in the cytosolic
compartment varying the rate of ASC recruitment by NLRs, along with the branching rate
c3, the filament extension rate p and the initial number of oligomers X0. Results have
been obtained from numerical solutions of the ODE model. Unless values are shown,
c3 = 1, p = 1,m1 = 1000,m2 = 1.3m1, X0 = 0.1.
Figure 5.11: Minimum values of the rate of ASC recruitment by NLRs c1 for which there is no
lag phase, for a range of values of the branching rate c3 and the filament extension rate p.
For values of c1 beneath this minimum value, there is a lag phase of nonzero length. Results
have been obtained from numerical solutions of the ODE model. The minimum value of c1
for which there is no lag phase is higher for larger c3 and p.
5.3.1 Simulation methods
I have implemented the discrete stochastic model in MATLAB using a variation on the Gille-
spie stochastic simulation algorithm [Gillespie, 1976]. Since I have assumed the move-
ment of ASC monomers between cellular compartments is much faster than cluster growth
and joining reactions, it becomes very inefficient to use the Gillespie algorithm to simulate
the cluster joining and growth reactions and monomer movement reactions simultaneously.
Therefore, I use the Gillespie algorithm to simulate cluster joining and growth reactions C1,
C2, C3 and P only. I assume that the number of ASC monomers in the nuclear and cytoso-
lic compartments are approximately constant between reaction steps; this is justified by the
fast timescale of these reactions. The abundance of ASC monomers in each compartment
is updated at each timestep generated by the Gillespie algorithm, unless this timestep is
longer than a maximum time δt, in which case, the complex joining or growth reaction is dis-
carded, and the number of ASC monomers in each compartment is updated after a timestep
of δt. The Gillespie algorithm is then resumed. The change in number of ASC monomers
in each compartment is calculated by assuming the movement of monomers out of a given
compartment is binomially distributed; specifically, the number of monomers moving from
the nucleus to cytosol between times t1 and t2 is binomially distributed with x̂n(t1) trials and




. The success probability arises from
considering exponentially-distributed jump times of individual monomers. Similarly, the num-
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ber of monomers moving from cytosol to nucleus between times t1 and t2 is binomially





of binomially-distributed random numbers with these parameters is therefore generated for
each time point arising in the simulation. Setting δt = 10−5 was sufficient to avoid major
simulation artefacts for parameters we investigated.
Note that in the discrete stochastic system, self-joining is not permitted; this adds a
correction term to the rate of joining of two complexes of the same size (see Table 5.1.).
I ran simulations for the basic model outlined above, as well as model variants with only
a single initial NLR oligomer (identical to the basic model with the initial number of NLR
oligomers X0 = 1. In order to test sensitivity to the assumption that each NLR oligomer
contains exactly 10 monomers, for each value of X0 I also ran simulations with stochastically
generated initial conditions; in particular, instead of assuming that all oligomers contained
exactly 10 NLRs, I distributed the 10X0 NLRs initially present randomly between the X0
oligomers. I used the multinomial distribution to generate oligomer sizes, with 10X0 trials
and all event probabilities pi = 1/X0. This mimics the assumption that NLR oligomers grow
via a pool of NLR monomers being added at random to a fixed number (X0) of growing
oligomers until all monomers are depleted; since oligomer growth is linear, and independent
of oligomer size. the assumption that the probability that a given NLR monomer joins a given
oligomer is 1/X0 at all times is justified.
For each of these model variants, I varied c2, c3, p,m1,m2/m1 and X0 and fixed c1 = 1
(since this parameter can be scaled out by rescaling time) and x̂c(0) = 104. In particular,
I assumed that the number of ASC monomers in the nuclear and cytosolic compartments
begin in equilibrium, so x̂n(0) = m2m1 × x̂c(0). In general, I have also taken the initial number
of free ASC monomers in the cytosolic region, x̂c(0), to be 104; once again this is somewhat
arbitrary, as all abundances could be scaled out of the model.
Since the majority of the parameter values and ICs in the model are unknown, and in
order to reduce the number of simulations needed to cover the parameter space, I carried
out Latin hypercube sampling, as used by Proctor et al. for analysing NP models [Proctor
et al., 2012]. I generated 100 sets of parameter values and ICs for each model variant,
minimising correlation between parameters in the set; a summary of the ranges of values
sampled for each parameter is given in Table 5.2. I have also given baseline values of
each parameter, which I have used to create the example parameter runs depicted in the
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Variable Role in model Maximum Minimum Baseline
c2 Cluster joining rate 10−1 101 1
c3 Filament branching rate 10−1 101 1
p Filament extension rate 10−1 101 1
m1 Rate of movement of ASC monomers
from nucleus to cytosol
101 103 103
m2/m1 Ratio of movement rates of ASC from nu-
cleus to cytosol, and from cytosol to nu-
cleus
0 2 1.5
X0 Initial number of NLR oligomers 1 103 102
Table 5.2: Ranges of parameter values sampled and baseline values for running simulations
of the full model of inflammasome formation
following section. For each parameter set, I ran 100 simulations, to ensure the robustness
of the results. I also ran the simulations with baseline values 1000 times.
5.3.2 Dynamics of individual simulation runs with baseline parameter values
I will begin by considering results from the large set of simulations with baseline parameter
values, in order to clarify the dynamics of individual simulation runs.
In general, as for the deterministic model results, the number of clusters takes a sigmoid
shape over time, decreasing to one following an initial lag phase. Similarly, the number of
monomers in nuclear and cytosolic compartments decreases to zero in a sigmoid fashion,
with a longer lag and slower decrease for the nuclear compartment. Calculating the vari-
ance over multiple runs of the simulation shows that there is a peak in variance of cluster
and monomer numbers between runs corresponding to a point a little after halfway through
cluster depletion. (Figure 5.12).
When considering the sizes of individual clusters over time, distinct phases of inflam-
masome formation and monomer depletion are evident (Figures 5.13 and 5.14). Initially,
clusters cannot join since this is only possible via ASC-ASC interactions; there is therefore
a lag in cluster growth while ASC monomers join to NLR oligomers, establishing the ASC
filaments required for further ASC-ASC interactions. Once clusters have amassed sufficient
ASC, the first joining event occurs (as in previous chapters, the first joining time is referred
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Number of clusters over time. Results for in-
dividual runs are plotted in black, and mean
number of clusters is show in red.
Number of monomers over time. Results for
individidual runs are shown in green for nu-
clear ASC and blue for cytosolic ASC.
Variance in number of clusters over time Variance in number of monomers over time.
Figure 5.12: Output of 1000 simulations of the full inflammasome model with baseline pa-
rameter values as in Table 5.2. The mean number of clusters tends to 1, and the numbers
of monomers in each compartment tends to 0; as for the ODE models, there is an initial lag
in depletion. Variance between simulation runs increases until around halfway through ASC
speck formation, then decreases to zero.
Figure 5.13: Size of individual clusters over time for one simulation run with baseline param-
eter values. The size of each cluster is plotted with a black solid line; vertical black lines
indicate when two clusters join. The vertical dashed blue line indicates the first join time, and
the vertical dashed red line indicates the dominant cluster emergence time. The single clus-
ter emergence time is shown with a yellow dashed line. Initial growth is slow until after the
dominant cluster emergence time, when there is a rapid increase in the size of one cluster.
to as TF ). A second phase then begins, in which clusters begin to join, although addition
of ASC monomers also continues concurrently. Eventually, the emergence of a single dom-
inant large cluster (at dominant cluster emergence time TD) marks the beginning of a third
stage. This cluster contains significantly more ASC monomers than any other cluster, and
eventually absorbs all other, smaller clusters. The amalgamation of all NLR oligomers into
one single, large cluster (at the single cluster emergence time TS) marks the initiation of a
final phase, in which no further joining events can occur and dynamics of the system are
determined only by the depletion of ASC monomers as they are all eventually incorporated
into the final inflammasome structure.
The initial growth of clusters relates closely to deterministic dynamics, as does growth
following the emergence of a single cluster. However, the dominant cluster and single cluster
emergence times are governed by stochastic dynamics arising during the second phase of
cluster growth. This can be seen by observing that there is very little correlation between
first joining time and dominant cluster or single cluster emergence time; however, there is
a slight positive correlation between dominant cluster and single cluster emergence times
(Tables 5.3 and 5.4). This suggests a large amount of variation in the length of the second
phase of inflammasome growth. The variation in the length of the second phase leads
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(a) Phase 1 (b) Phase 2
(c) Phase 3
Figure 5.14: Simulated run illustrated in Figure 5.13 divided into individual phases. Phase
one shows gradual growth of all clusters. Phase 2 shows clusters beginning to join, but there
is a fairly even distribution of cluster sizes. Phase 3 shows the emergence of one single large












1 0.296 0.089 0.179 −0.011 0.066 0.062
t1/2
cytosol
0.296 1 0.064 0.212 0.008 0.204 0.135
t1/10
nucleus
0.089 0.064 1 0.420 0.035 0.008 0.009
t1/2
nucleus
0.179 0.212 0.420 1 0.007 0.052 0.105
TF −0.012 0.008 0.035 0.007 1 0.087 0.044
TD 0.066 0.204 0.008 0.052 0.087 1 0.070
TS 0.0623 0.135 0.009 0.105 0.044 0.070 1
Table 5.3: ρ values for Spearman correlation coefficient between characteristic times for
1000 simulation runs with baseline parameters. There is a positive correlation between all
monomer depletion characteristic times, as well as between first join time TF , dominant
cluster emergence time TD and single cluster emergence time TS .
to a considerable positive skew on the distribution of dominant cluster and single cluster
emergence times, with a ‘tail’ of longer single cluster emergence times (Figure 5.15). This
is observed in experimental data, and may account for the non-formation of inflammasomes
by some cells, since for some cells inflammasome formation may take so long that it is
interrupted by other cellular processes.
As with the experimental data, depletion of ASC monomers occurs more quickly for cy-
tosolic than nuclear traces; using a one-sided Wilcoxon signed rank test, p ≈ 0 for both t12
and t1/10, suggesting that t1/2 and t1/10 are larger for nuclear traces. However, there is con-
siderable correlation between all monomer depletion characteristic times for both the cytoso-
lic and nuclear regions, suggesting that stochastic variation is less of a factor for monomer


















< 10−8 1 0.042 < 10−8 0.794 < 10−8 1.72× 10−5
t1/10
nucleus





< 10−8 < 10−8 1 0.832 0.099 8.66× 10−4
TF 0.738 0.794 0.262 0.832 1 0.006 0.163
TD 0.037 < 10
−8 0.798 0.099 0.006 1 0.028





Table 5.4: p-values for Spearman correlation coefficient between characteristic times for
1000 simulation runs with baseline parameters. There is a significant correlation between
all monomer depletion characteristic times, as well as between dominant cluster emergence
time TD and single cluster emergence time TS , but not between the first joining time TF and
TS , or between TD and TF .
Times of phases
t1/10 for nuclear and cytosolic traces t1/2 for nuclear and cytosolic traces
Figure 5.15: Violin plots of distributions of characteristic times for 1000 simulation runs as de-
scribed in Figure 5.12. Mean value is shown with a blue circle, mean pm standard deviation
is shown with a blue star, and maximum and minimum values are shown with blue crosses.
Single cluster emergence times show considerable positive skewness. Monomer depletion
times for cytosol and nucleus are fairly symmetrically distributed; depletion of nuclear ASC
is slower than depletion of cytosolic ASC.
5.3.3 Latin hypercube parameter sampling and characteristic time distribu-
tions
I will now consider the results for the Latin hypercube parameter sampling in order to gain a
broader insight into the roles of the different parameters in the model. I will first outline the
results for the full model as initially presented (‘basic’ assumptions), and then compare with
simulations of variants with different initial conditions (i.e. models with no filament branching,
one initial NLR oligomer, or random initial oligomer sizes).
Fitting a generalized linear regression model to basic simulation results
We can investigate the roles of the different parameters in the behaviour of characteristic
times using regression techniques. Since by construction the Latin hypercube gives un-
correlated parameter values, we can investigate how each characteristic time varies over
each parameter value. Standard linear regression is less useful here, due to the nonlinear
relationships between parameters and characteristic times, and also non-normality of char-
acteristic times (characteristic times cannot take negative values, and many parameter sets
show positive skewness in the distribution of some characteristic times, especially single
cluster emergence). However, a generalized linear model (GLM) can be used instead. This
is not intended to be predictive; it need not be a perfect model for the simulation results, but
fitting a model like this can at least give some insight into the role each parameter plays in
determining results.
In this framework, for a characteristic time Y and set of parameters X, we have:
(5.3)E(Y |X) = g−1(Xβ)
where g is an invertible ‘link function’ chosen prior to fitting, and Xβ is the linear predictor
of the data (β is a vector which specifies the linear relationship between the parameters and
the mean value for a given set of parameters, and is determined through fitting the model).
A distribution for Y is also specified; in this case I have used the gamma distribution,
which is often used for positive data with strong positive skewness. I have used a link function
of g(x) = −1/x; this was the most effective at fitting the data from a range of link functions
often used with the gamma distribution (compared with g(x) = log(x) and g(x) = x), and
also has the advantage of being the ‘canonical’ link function for the gamma distribution.
I have also included values of pairwise products of parameters (c2× c3, c2× p, c3× p etc.)
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in the set of dependent variables in X to allow for the fact that there may be interactions
between variables.
We can now fit GLMs to characteristic times extracted from our simulated data. We wish
to derive a model which fits the data well while limiting the total number of parameters which
play a significant role in the values of the characteristic times. Since there are six parameters,
as well as 15 interactions resulting from pairwise combinations of those parameters, this
gives a total of 26+15 possible sets of dependent variables for the model. Instead of fitting
each of these individually, I used a stepwise GLM fitting procedure (using the stepwiseglm
function in Matlab) to choose an optimal model; this process starts with a minimal model,
and systematically adds or removes dependent variables depending on the effect on the
overall likelihood of the model. This process favours models with fewer dependent variables,
while optimising the goodness of fit.
In particular, stepwiseglm starts from a model with only a single, constant term. At each
step of the algorithm, the model is fitted, and the Akaike Information Criterion (AIC) is then
used to determine whether terms should be added or removed from the model. The AIC is
a measure of goodness of fit which penalises models for including increasing numbers of
parameters to avoid overfitting; for a model with k parameters and maximum likelihood L̂,
the AIC is calculated as follows:
(5.4)AIC = 2k − 2 log(L̂)
In general, models with a lower AIC are preferred, since this may indicate a better fit
and/or lower number of fitted parameters.
The algorithm used by the stepwiseglm function is as follows:
1. Fit initial model
2. Consider whether any terms not in the model should be added; if adding any terms
leads to smaller AIC, add these to the model. Then proceed to Step 3.
3. Consider whether any terms in the model should be removed. If the removal of any
terms leads to a smaller AIC, remove the term leading to the largest reduction and
return to Step 2.
The algorithm terminates when the addition or removal of any parameter does not result
in an improved AIC value.
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Estimate Standard error t-statistic p-value
Intercept 43.155 8.453 5.105 3.379× 10−7
c3 ×m1 4.429 0.191 23.241 < 10−8
Table 5.5: Coefficients in GLM for single cluster emergence times derived from Latin hyper-
cube simulated data (100 simulations for 100 parameter sets); only the branching rate c3 and
the rate of movement of ASC out of the nucleus m1 contribute significantly. Error degrees of
freedom: 7729.
Figure 5.16: Illustration of GLM fit for single cluster emergence time to Latin hypercube
simulations (100 repeat simulations for 100 parameter sets). Mean single cluster emergence
times for each parameter set are plotted against the value of c3m1 (the product of branching
rate and rate of movement of ASC out of the nucleus); these are shown as blue points. The
mean value predicted by the GLM is shown as a solid purple line, and a 95% confidence
interval as predicted by the GLM lies between the dotted green lines. The mean and variance
of the fitted gamma distribution decrease as c3X0 increases.
Inflammasome formation times
In the case of the single cluster emergence time TS , the resultant model has R2 = 0.0478
and only has two terms: a constant term, and a term describing an interaction between the
value of c3 and m1. A description of the coefficients is given in Table 5.5. The dispersion
parameter is φ = 6.939; this is defined as φ := 1/α, where α is the shape parameter of the
gamma distribution.












Note that this does not suggest that this is an exact expression for the distribution of single
cluster emergence time, but only that this is the most appropriate model of this form. This
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Figure 5.17: Illustration of GLM fit for dominant cluster emergence time for simulated Latin
hypercube data (100 simulation runs for 100 parameter sets). Mean single cluster emergence
times for each parameter set are plotted against the value of c3X0 (the product of branching
rate and the initial number of clusters); these are shown as blue points. The mean value
predicted by the GLM is shown as a solid purple line, and a 95% confidence interval as
predicted by the GLM lies between the dotted green lines. The mean and variance of the
fitted gamma distribution decrease as c3X0 increases.
suggests that the most important parameters in determining the emergence times of a single
cluster are c3 and m1, and that the mean emergence time decreases as c3 and m1 increase
(Figure 5.16). The shape of the distributions of data also changes with the parameter values;
as c3 and m1 increase, the scale parameter β increases, leading to reduced variance of
results. The large-time ‘tail’ of the distribution also decreases.
This result is in contrast to the results for single cluster emergence time in the simplified
model, presented in Section 4.3.1; in particular, this analysis demonstrated that the cluster
joining rate c2 was the main factor in determining the distribution of the single cluster emer-
gence time in the simplified model. This difference arises from the fact that the cluster joining
rate in the simplified model is independent of cluster size, whereas in the full model, cluster
joining is dependent on the number of filaments in the relevant clusters.
The model fit is somewhat different for the dominant cluster emergence time TD; in this
case we have R2 = 0.4249 and φ = 0.9786. Details of the coefficients in these models are
given in Table 5.6. In comparison to the single cluster emergence times, the only signifi-
cant term identified is an interaction between c3 and X0. This suggests that the mean and
variance of the distribution of dominant cluster emergence time decreases as c3 and X0 in-
crease, but that m1 is less likely to be important. Thus, the larger the initial number of NLR
oligomers, the shorter the time for a dominant cluster to emerge.
Together, these results suggest that X0 is important for determining dominant cluster
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Estimate Standard error t-statistic p-value
Intercept 106488.488 109270.417 0.975 0.330
c3 ×X0 98428.245 1105.533 89.032 < 10−8
Table 5.6: Coefficients in GLM for dominant cluster emergence times derived from Latin
hypercube simulated data (100 simulations for 100 parameter sets). Only the branching rate
c3 and the initial number of clusters X0 contribute significantly. Error degrees of freedom:
9898.
emergence time, but less so for single cluster emergence time, when the availability of free
monomers (which is controlled by m1 at late times) becomes much more important. How-
ever, it is also worth bearing in mind that this model may not be a very precise fit for the
simulated data (see for instance the fairly low values of R2), suggesting that the conclusions
we draw here may be limited.
Meanwhile, the results for first joining time are different again. For this model, R2 =
0.8209 and φ = 0.1596, and details of the coefficients are given in Table 5.7. The model
contains all parameters except p, as well as all interactions between those variables (with
the exception of c3 × X0). It is unsurprising that c2, the parameter which controls joining
rate, is so important, as is the initial number of clusters X0; the same was observed for
the first joining time in the simplified model. However, in the full model, the branching rate
and the parameters controlling movement of ASC between compartments also influence the
distribution of the first joining time. It is also notable that the dispersion parameter is much
lower than for the fitted models for single and dominant cluster emergence times; since
the skewness of a gamma distribtion is given by 2
√
α = 2 ×
√
1/φ, this suggests that the
skewness of the distribution of first joining time is much smaller than the skewness of the
distributions of the other characteristic times examined previously. This further supports the
idea that the skewness that arises for statistics describing inflammasome formation times
arise from late-time dynamics.
Depletion of ASC monomers
We now turn our attention to the monomer depletion characteristic times; in particular, t1/2
and t1/10 for the nuclear and cytosolic regions.
The fitted GLMs for t1/2 and t1,/10 have R2 = 0.9955, φ = 0.0063 and R2 = 0.9963, φ =
0.0027 respectively for the cytosolic region, andR2 = 0.9951, φ = 0.0072 andR2 = 0.9501, φ =
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Estimate Standard error t-statistic p-value
Intercept −2205.614 470.652 −4.686 2.819× 10−6
c2 1374.331 378.581 3.630 2.846× 10−4
c3 7268.171 420.389 17.289 < 10
−8
m1 34.072 3.338 10.208 < 10
−8
m1/m2 2145.964 570.788 3.760 1.711× 10−4
X0 109.589 2.235 49.041 < 10
−8
c2 × c3 −260.598 86.869 −3.000 0.003
c2 ×m1 −1.829 0.938 −1.950 0.051
c2 ×m2/m1 1331.628 289.235 4.604 4.196× 10−6
c2 ×X0 48.134 0.930 51.737 < 10−8
c3 ×m1 −3.006 0.709 −4.241 2.240× 10−5
c3 ×m2/m1 −2240.843 277.869 −8.064 < 10−8
m1 ×m2/m1 7.794 2.197 3.548 3.900× 10−4
m1 ×X0 −0.086 0.005 −17.371 < 10−8
m1 ×X0 −5.000 1.716 −2.914 0.004
Table 5.7: Coefficients in GLM for first joining times derived from Latin hypercube simulated
data (100 simulations for 100 parameter sets). All parameters except the branching rate p
are significant in determining the first joining time. Error degrees of freedom: 9985.
0.048 respectively for the nuclear region. Note the large values of R2, which suggest a par-
ticularly good model fit. Details of the coefficients are given in Tables 5.8, 5.9, 5.10 and
5.11. All models contain all six parameters, as well as most pairwise interactions between
parameters. This is somewhat in contrast to the simplified model, in which the cluster joining
rate c2 does not affect the monomer depletion characteristic times, and naturally the rates of
movement between cellular compartments were not included in this model. This shows that
the movement of ASC monomers between cellular compartments are significant in deter-
mining the dynamics of ASC monomer depletion, supporting the inclusion of the two spatial
compartments in the model.
Having established the key differences arising from different parametrisations with basic
modelling assumptions, we will now consider comparisons to alternative models. In Chapter
6, all of the simulation results described above will be compared to experimental data in
order to ascertain which parametrisations give rise to the closest match.
5.3.4 Comparison with alternative models
We now consider the same set of parameters from our Latin hypercube sampling, and use
them to run the full model with various modifications. In all cases, we can compare the
distributions of each characteristic time for each parameter set; in particular, we can use
the Wilcoxon rank-sum test, a nonparametric test with the null hypothesis that two sets of
data have the same median, and the Kolmogorov-Smirnov test, a nonparametric test with
the null hypothesis that two sets of data are drawn from the same distribution. Before per-
forming Kolmogorov-Smirnov tests, I have subtracted the sample means for each parameter
grouping in order to remove dependence of the results on the centralisation of data.
I have chosen to use nonparametric tests since, as we have already established, charac-
teristic times often have clearly non-normal distributions with considerable positive skewness
and different variances.
These tests allow us to identify significant differences between distributions, and pinpoint
the differences arising from each model modification.
Removing branching from the model
We will first consider a set of simulations in which all parameters are as in the simulations
for the basic assumptions, but with c3 = 0 in all cases; this corresponds to removing branch-
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Estimate Standard error t-statistic p-value
Intercept −95.138 18.842 −5.049 4.513× 10−7
c2 −51.918 2.519 −20.611 < 10−8
c3 2249.963 18.764 119.910 < 10
−8
p 187.772 8.766 21.420 < 10−8
m1 0.170 0.092 1.843 0.065
m1/m2 −89.878 21.793 −4.124 3.751× 10−5
X0 12.606 0.059 212.015 < 10
−8
c2 × c3 44.868 2.819 15.919 < 10−8
c2 × p 43.179 1.222 35.344 < 10−8
c2 ×m1 0.078 0.010 8.047 < 10−8
c2 ×X0 −0.172 0.014 −12.553 < 10−8
c3 × p −144.048 3.166 −45.511 < 10−8
c3 ×m1 −0.113 0.030 −3.761 0.0001
c3 ×m2/m1 −103.850 10.577 −9.818 < 10−8
c3 ×X0 1.660 0.024 70.156 < 10−8
p×m1 0.264 0.020 12.992 < 10−8
p×m2/m1 178.124 6.718 26.515 < 10−8
p×X0 2.097 0.016 132.247 < 10−8
m1 ×m2/m1 0.241 0.060 4.010 6.112× 10−5
m1 ×X0 −0.003 1.328× 10−4 −21.817 < 10−8
m2/m1 ×X0 −0.320 0.050 −6.449 < 10−8
Table 5.8: Coefficients in GLM for monomer depletion characteristic time t1/2 in the cytosolic
region derived from Latin hypercube simulated data (100 simulations for 100 parameter sets);
all parameters are significant in determining t1/2. Error degrees of freedom: 9979.
Estimate Standard error t-statistic p-value
Intercept 138.959 41.340 3.361 7.785× 10−4
c2 −437.162 23.512 −18.593 < 10−8
c3 3173.348 33.949 93.473 0
p 273.207 15.693 17.410 < 10−8
m1 −4.321 0.196 −22.029 < 10−8
m1/m2 −797.637 51.486 −15.492 < 10−8
X0 93.890 0.198 474.001 0
c2 × c3 131.526 4.993 26.344 < 10−8
c2 × p 120.931 3.263 37.062 < 10−8
c2 ×m1 0.256 0.035 7.320 < 10−8
c2 ×m2/m1 250.453 16.231 15.431 < 10−8
c2 ×X0 −0.248 0.044 −5.662 1.538× 10−8
c3 × p −163.143 6.536 −24.962 < 10−8
c3 ×m1 0.279 0.063 4.450 8.680× 10−6
c3 ×m2/m1 −522.830 20.951 −24.955 < 10−8
c3 ×X0 2.491 0.047 53.158 < 10−8
p×m1 0.333 0.048 7.000 < 10−8
p×m2/m1 804.867 15.218 52.889 < 10−8
p×X0 3.030 0.041 73.655 < 10−8
m1 ×m2/m1 2.202 0.154 14.340 < 10−8
m2/m1 ×X0 −1.528 0.149 −10.261 < 10−8
Table 5.9: Coefficients in GLM for monomer depletion characteristic time t1/10 in the cytosolic
region derived from Latin hypercube simulated data (100 simulations for 100 parameter sets);
all parameters are significant in determining t1/10. Error degrees of freedom: 9979.
Estimate Standard error t-statistic p-value
Intercept 2.548 0.264 9.654 < 10−8
c2 0.522 0.045 11.537 < 10
−8
c3 −0.235 0.050 −4.738 2.191× 10−6
p 0.614 0.085 7.242 < 10−8
m1 1.192 0.004 308.794 < 10
−8
m1/m2 0.219 0.205 1.069 0.285
X0 −6.612× 10−4 3.487× 10−4 −1.896 0.058
c2 × c3 −0.028 0.006 −4.896 9.922× 10−7
c2 × p −0.072 0.009 −8.369 < 10−8
c2 ×m1 −0.003 7.104× 10−4 −3.984 6.825× 10−5
c2 ×X0 −5.338× 10−4 6.847× 10−5 −7.797 < 10−8
c3 × p −0.129 0.010 −12.569 5.880× 10−36
c3 ×m1 0.014 6.560× 10−4 21.671 < 10−8
c3 ×m2/m1 0.214 0.032 6.690 < 10−8
p×m1 0.012 6.725× 10−4 17.824 < 10−8
p×X0 −7.235× 10−4 8.580× 10−5 −8.537 < 10−8
m1 timesX0 1/327× 10−4 5.792× 10−6 22.916 < 10−8
m2/m1 ×X0 −6.873× 10−4 3.214× 10−4 −2.138 0.033
Table 5.10: Coefficients in GLM for t1/2 in the nuclear region derived from Latin hypercube
simulated data (100 simulations for 100 parameter sets); all parameters are significant in
determining t1/2. Error degrees of freedom: 9982.
Estimate Standard error t-statistic p-value
Intercept 18.019 4.216 4.274 1.940× 10−5
c2 9.553 0.940 10.167 < 10
−8
c3 1.620 1.527 1.061 0.289
p 15.829 1.428 11.088 < 10−8
m1 4.421 0.049 89.532 < 10
−8
m1/m2 26.015 3.856 6.747 < 10
−8
X0 0.025 0.006 4.475 7.719× 10−6
c2 × c3 −0.753 0.111 −6.767 < 10−8
c2 × p −1.283 0.138 −9.263 < 10−8
c2 ×m1 −0.033 0.009 −3.546 3.923× 10−4
c2 ×m2/m1 −0.559 0.528 −1.058 0.290
c2 ×X0 −0.010 0.001 −8.350 < 10−8
c3 × p −2.747 0.162 −16.988 < 10−8
c3 ×m1 0.351 0.010 33.834 < 10−8
c3 ×m2/m1 1.681 0.667 2.518 0.012
c3 ×X0 −0.006 0.001 −4.647 3.405× 10−6
p×m1 0.189 0.008 19.438 < 10−8
p×m2/m1 −1.050 0.554 −1.895 0.058
p×X0 −0.017 0.001 −12.709 < 10−8
m1 ×X0 0.002 8.053e× 10−5 30.135 < 10−8
m2/m1 ×X0 −0.023 0.006 −3.736 1.879× 10−4
Table 5.11: Coefficients in GLM for t1/10 in the nuclear region derived from Latin hypercube
simulated data (100 simulations for 100 parameter sets); all parameters are significant in
determining t1/10. Error degrees of freedom: 9979.
ing reactions from the model. One-sided Wilcoxon rank sum tests show that all charac-
teristic times with the exception of the dominant cluster emergence times are significantly
lower for the basic assumptions compared to the simulations without filament branching
(p < 0.05), although this may be due to the fact that setting c3 = 0 decreases the over-
all monomer depletion and cluster growth rates, since the filament extension rate p is un-
changed. However, for some parametrisations there is a significant difference between the
shapes of the distributions of single cluster emergence times for the basic assumptions simu-
lations and the simulations without branching, even after the distributions have been centred
by mean (Kolmogorov-Smirnov test, p < 0.05). There is a strong correlation between the
value of c3 in the basic assumption simulations and the Kolmogorov-Smirnov test statistic
(ρ = 0.615, p < 10−8); unsurprisingly, this suggests that the largest differences in distribution
arise when c3 is large in the basic assumptions dataset.
We also see differences in distribution between the basic assumptions simulations and
simulations without joining for t1/2 in the cytosolic region and t1/10 in the nuclear region; this
suggests that branching may be important in determining the levels of ASC in the nuclear
region at early times, but has a larger effect on monomer depletion in the cytosolic regions
at later times. In particular, there is a strong correlation between c3 and the Kolmogorov-
Smirnov statistic when comparing distributions of t1/2 in the cytosolic region (ρ = 0.659, p <
10−8 and t1/10 in the nuclear region (ρ = 0.362, p = 2.16 × 10−4). This is due to the fact
that, as observed previously, as c3 increases the spread of the distribution of single cluster
emergence time decreases.
There is thus clearly a significant difference in the distributions of characteristic times
between the models with and without branching. The simulations without branching will be
compared to experimental data alongside the basic assumptions simulations in the following
chapter.
Removing joining from the model
We will now consider a modification in which we assume there is a single initial NLR oligomer;
we assume that this contains 10 monomer subunits. Naturally, this removes joining from the
model (if we set c2 = 0 we could still start with multiple oligomers, but there would be no
possible mechanism by which a single inflammasome could emerge).
We now fix X0 = 1 and otherwise use the Latin hypercube sample parameter sets,
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keeping the total number of NLRs the same as in the basic model. We will compare only
the characteristic statistics related to ASC monomer counts, i.e. t1/2 and t1/10 in both the
nuclear and cytosolic compartments (the other characteristic times are no longer relevant to
this model).
In virtually all cases, comparing the distribution of characteristic times between the full
model and one-oligomer model gives a significant difference in the medians of t1/2 and t1/10
in the nuclear compartment, and in t1/2 in the cytosolic compartment. However, for t1/10 in
the cytosolic compartment, there is no significant difference in median for the vast majority of
parameter sets. Using right-tailed Wilcoxon rank sum tests shows that for the majority of the
parameter sets, removing joining from the model leads to an increase in the median value of
t1/2 or t1/10 in the nuclear region, and for t1/2 in the cytosolic region. There is no significant
difference in the shapes of distribution for t1/2 and t1/10 in the cytosolic compartment, and
around half of the parameter sets show a significant difference in distribution shape for t1/2
and t1/10 in the nuclear compartment.
This suggests that the inclusion of joining into the system does not significantly affect the
shape of the distribution of characteristic times in the cytosolic region, but that the median
values are changed; the overall rate of monomer depletion is decreased when joining is
removed. However, it is likely that the decrease in the total number of NLR oligomers is
responsible for these changes. The fact that this set of simulations leads to results very
similar to the basic assumption but shifted by mean suggests that the case where exactly
one NLR oligomer is initially present may not be distinguishable from other initial numbers of
NLR oligomers. Nonetheless, I will include this dataset in the comparisons with data in the
following chapter.
Random initial conditions
Considering now the dataset in which we have random initial conditions, we can compare
the results for each parameter set with those for the basic model.
For most parameter sets, emergence times of a single cluster have a different median
(Wilcoxon rank test, p < 0.05), while the distribution of other characteristic times is broadly
unaffected. Likewise, after centering the distributions for both datasets by subtracting the
median, of all characteristic times only the shape of the distribution of emergence times of a
single cluster differs significantly from the corresponding distribution in the full model without
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modification (Kolmogorov-Smirnov test, p < 0.05). This suggests that changing the sizes of
the initial oligomers does not have a significant effect on any characteristic time except for
emergence time of a single cluster.
Comparing now the Kolmogorov-Smirnov test statistic for each parameter set with the
size of those parameters, a dependence emerges between the value of the Wilcoxon rank
test statistic and of the parameter X0 (ρ = −0.857, p = 2.9326 × 10−21). This suggests
that the lower the value of X0, the higher the value of the test statistic, and thus the larger
the difference in median between the full model and the modification with random ICs. Im-
portantly, the total number of NLRs is the same in both models, and it is only the divi-
sion of NLRs between oligomers which is random; this suggests that the smaller the ini-
tial number of oligomers, the larger the effect allowing oligomers of different sizes may
have on the results compared to assuming all oligomers are the same size. Likewise,
for the Kolmogorov-Smirnov test comparing the shape of the distribution of single cluster
emergence time, only X0 shows a significant correlation with values of the test statistic
(ρ = 0.742, p = 2.0026 × 10−13, τ = 0.553, p = 1.4844 × 10−11). This suggests that the
larger the value of X0, the larger the difference in distribution between the full model without
modification and the full model with random ICs; when there are more NLR oligomers ini-
tially, there is the potential for a much more uneven spread of monomers between oligomers,
and thus in these cases it may take much longer for a single cluster to emerge; this will lead
to a longer ‘tail’ for large times in the distribution of single cluster emergence time.




In this chapter, I have presented results for both the deterministic and stochastic formulations
of the full model of inflammasome formation.
Overall, while the full deterministic model displays some similar behaviour to the sim-
plified model, there are evidently more complex dynamics at play; in particular, the distinc-
tion between C1 and C3 processes (ASC monomers joining to free NLRs and ASC filament
branching respectively) leads to clear phases in cluster growth and merging when the joining
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rate of ASC to NLRs is slow. In particular, we see a clear initial ‘lag’ phase, in which growth
and merging is limited due to a bottleneck in filament seeding from NLRs. I have defined a
set of parameters for which the lag phase is not present, as in the simplified inflammasome
model.
However, the full deterministic model still fails to capture some of the behaviour of inflam-
masome formation systems, especially at late times (the tendency of X to become negative
is particularly undesirable). The full deterministic model still does not address the fundamen-
tal inability of ODE models to capture the behaviour of the inflammasome systems at late
times when there are few clusters, at which point we would expect the cluster sizes to level
off, and the variances of cluster sizes to tend towards zero.
Turning our attention to the stochastic formulation, there are a number of conclusions we
can draw from the results of our simulations. By considering a large cohort of simulations
with a basic parametrisation, we have seen that inflammasome formation naturally falls into
several phases: an early phase, in which individual oligomers recruit ASC monomers, a
second phase in which oligomers begin to join but the distribution of oligomer sizes remains
fairly even, and a later phase in which a single dominant cluster emerges. Analysing corre-
lations between the timings of these phases demonstrates that variation between cells in the
same sample appears to arise because of the stochasticity caused by joining events in the
second phase.
I have also run simulations of the model with a large range of parameter values and fitted
a GLM to characteristic times for each parameter set, in order to determine which parame-
ters are most important in determining each characteristic time. We generally see that with
basic assumptions, increasing parameter values has a scaling effect, which in turn increases
the rapidity of the inflammasome formation process as a whole; both the means and vari-
ances of characteristic times decrease as branching rate, filament extension rate and initial
number of NLR oligomers increases. A particularly notable result is that characteristic times
associated with earlier times in the inflammasome formation process (such as the first join-
ing times and monomer depletion characteristic times) are significantly dependent on many
parameters, whereas the characteristic times associated with later stages (single cluster and
dominant cluster emergence) are dependent on few parameters. In particular, we see that
the filament branching rate c3 and the rate of movement of ASC monomers out of the nucleus
m1 are most important for single cluster emergence times, whereas c3 and the initial number
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of oligomers X0 are more important for dominant cluster emergence time. This may give
some insight into why multiple inflammasomes may sometimes be observed in systems with
an overabundance of active NLRs; in particular, since the time of single cluster emergence is
not significantly affected by X0, but the time of emergence of a dominant cluster decreases
as X0 increases, this suggests that as X0 increases the time interval between emergence of
a dominant cluster and the final emergence of a single cluster also increases. It is then pos-
sible that other biological processes might be intervening in inflammasome formation before
the dominant cluster emergence time, if this occurs particularly late. This may explain why
systems which may have smaller initial numbers of NLRs present are less likely to display
inflammasome formation in all cells (for example, in the NLRP3 inflammasome system).
I have also simulated results for the full model when slightly different assumptions have
been used. In particular, I have simulated results for random initial NLR oligomer sizes (com-
pared to the basic assumption, in which all NLR oligomers contain exactly 10 monomers),
a system in which branching does not occur, and also a system in which only a single NLR
oligomer is present. The simulations without branching and random oligomer sizes in par-
ticular are clearly distinct from the simulations for the basic assumptions. All four sets of
simulations will be compared to experimental data in the following chapter, to determine
which model gives rise to results closest to the experimental data.
5.4.2 Further work
Now that we have established the key differences between results for the simplified model
and the full model, as well as the differences arising for different parametrisations of each
model, the natural next step is to compare all of these results to the experimental data
presented in Chapter 2. In particular, we can compare the distributions of characteristic times
both to the distributions derived analytically for the stochastic simplified model in Chapter 4,
and to the empirical distributions arising from the simulations in this chapter. This will be the
subject of the following chapter.
One aspect of inflammasome formation which has not been particularly interrogated here
is the effect of ASC overexpression; in particular, in some ASC overexpression systems we
observe multiple ASC specks forming. This could be examined by running the simulations
with a larger initial ASC count; however, this would be a time-consuming exercise since, in
general, simulations of ASC overexpression systems take much longer to run, since more
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reactions are inovlved. Thus, running simulations covering all of the parameter sets obtained
from Latin hypercube sampling would be extremely slow. In order to make this feasible, it
may be necessary to adapt the (fairly simple) simulation algorithm used here in order for the
algorithm to handle the reactions more efficiently.
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Chapter 6
Comparison of models of the
inflammasome to experimental data
6.1 Introduction
So far, I have mainly considered the experimental dataset presented in Chapter 2, and the
models of inflammasome formation presented in Chapter 3, in isolation; the next stage in
the cycle of model development is to compare the models to experimental data directly.
This allows us to assess whether the models accurately reflect the inflammasome formation
process and identify areas for improvement; we will also be able to discriminate between
the different variants of the models produced in order to ascertain which elements should be
included in a cohesive conceptual model of inflammasome formation. In particular, I have
defined characteristic times which summarise key features of the experimental data and the
outputs from both the simplified and the full inflammasome models.
A key observation established in Chapters 4 and 5 is that, as ASC monomers are de-
pleted, for some parametrisations the full model demonstrates an initial ‘lag phase’ before the
maximum rate of decrease is reached, while the simplified model exhibits a sharp onset of
monomer depletion without such a lag phase. In order to assess which of these models gives
a better reflection of the experimental data, I fitted the traces describing ASC monomer de-
pletion derived from the experimental data to functions approximating either gradual or steep
depletion onsets at early times. I will demonstrate that the most successful fit is obtained
with an initial sharp decrease onset, as in the simplified model; this suggests a minimal role
for the initial formation of filaments in limiting inflammasome formation, and that initial ASC
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recruitment rate by NLRs is comparable in magnitude to other cluster growth parameters.
I then fitted the characteristic times derived from the experimental dataset to the theoreti-
cal distributions derived from the results for the simplified model in Chapter 4; the best fits are
given by models with a low number of NLR oligomers initially present, and with ASC filament
branching included. This suggests that branching does indeed play a role in inflammasome
formation, contrary to many of the predominant conceptual models.
Finally, I compared the characteristic time distributions derived from experimental data to
simulations of the full model presented in Chapter 5; the closest fits arise from inflammasome
systems with random initial sizes of NLR oligomers, ASC filament branching, and joining of
clusters.
6.2 Ascertaining the importance of filament-driven processes
from experimental data
A clear difference between the simplified and full models established in Sections 4.2.2 and
5.2 was that the simplified model shows an immediate sharp decrease in ASC monomer
abundance following infection, whereas the full model can show an initial ‘lag’ before a steep
decrease for small values of c1. This lag arises because there is an initial time period in which
filaments must be established before filament branching and formation can occur. The lag is
not present in the simplified model since there is no initial filament formation stage, as NLRs
are not treated as distinct from ASC filaments.
It is important to establish which model better captures this initial stage of inflammasome
formation for several reasons. Firstly, the lag phase (if it is indeed present) may be biologi-
cally important, for example in introducing a delay before inflammasome formation begins to
proceed in earnest, so that inflammasome formation could be reversed at very early times if
necessary. Furthermore, if we can define the nature of a lag phase at the start of monomer
depletion, this will allow us to obtain an estimate for the time between the introduction of the
inflammasome trigger and the initiation of ASC monomer depletion. This is the starting point
of the mathematical models analysed in previous chapters; in order to be able to compare
the experimental data to the models, the time before ASC monomer depletion begins for
each cell must therefore be subtracted from the other characteristic times prior to analysis.
Previously, in Chapter 2, I described two datasets (referred to as the FLICA and Mito-
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Tracker datasets) consisting of time series imaging of cells in which ASC is fluorescently
labelled undergoing inflammasome formation. A proxy for the total ASC monomer abun-
dance in the nuclear and cytosolic regions can be obtained by integrating the intensity over
these regions in each frame, resulting in intensity ‘traces’, which give the relative ASC abun-
dance over time in each cell. In Section 2.3, I presented a trilinear fitting methodology to
obtain intial estimates for the onset time of ASC monomer depletion. For each intensity
measurement xi in a trace we have:
xi = β0 + β1ti + β2(ti − tb1)+ + β3(ti − tb2)+ + εi (2.1 revisited)
where ti is the time at which measurement xi is taken, tb1 and tb2 are the start and
end point of the interval of speck formation, β0 is the initial intensity, β1, β2 and β3 are the
gradients of each section of the trilinear fit, and εi is the error at datapoint i.
(ti − tbj )+ is defined as follows:
(ti − tbj )
+ =

ti − tbj if ti > tbj
0 otherwise
(2.2 revisited)
In the analysis in Section 2.3, tb1 was taken as the time of ASC monomer depletion
onset, with inflammasome formation taking place between tb1 and tb2 . The values of β0,
β1, β2 and β3 were fitted for each possible pair of breaktimes tb1 and tb2 using maximum
likelihood estimation. The pair of breaktimes tb1 and tb2 giving the largest overall maximum
likelihood were then chosen as estimators for these breakpoints. Identifying the period of
time over which ASC is decreasing was useful for comparing traces in the dataset, and
for determining the rates of monomer depletion, as well as identifying traces which were
too noisy to be analysed, and which could then be removed. However, now that we have
ascertained that the onset may be sigmoid instead of exponential, it is worth refining this
estimate of ASC monomer depletion onset time.
In order to ascertain whether a sigmoid or exponential fit at the onset of monomer de-
pletion fits the data better, for each trace (both nuclear and cytosolic) in both the FLICA and
MitoTracker datasets which met the trilinear fitting conditions laid out in Section 2.3, I iden-
tified the first breakpoint tb1 from the initial trilinear fit. I took as my interval of interest the n
datapoints to either side of tb1 . I then fitted three different models to the datapoints in this
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interval, as follows:
(6.1a)xi = β0 + β1ti + β2(ti − tb)+ + εi
(6.1b)xi = β0 + β1ti + β2((ti − tb)+)2 + εi
(6.1c)xi = β0 + β1ti + β2((ti − tb)+)3 + εi
Similarly to the trilinear model fit presented in Section 2.3, here xi is the ith datapoint
in the interval of interest, ti is the time at which measurement xi is taken, and εi is the
error at datapoint i; I have assumed these are independent and normally distributed with the
same variance so the model can be fitted as a linear model, using the maximum likelihood
estimators for β0, β1, and β2. As in the original trilinear fit presented in Chapter 2, the value
of tb which maximises the maximum likelihood is then chosen.
The model presented in Equation 6.1a is a bilinear model with breakpoint tb. The models
presented in Equations 6.1b and 6.1c both assume a linear mean until a breakpoint tb, after
which the the mean respectively decreases as a quadratic or cubic function. These could
represent a system in which monomer abundance is initially constant, and then begins to
decrease as inflammasome formation commences (I have allowed the initial section of the
model to be linearly increasing or decreasing to account for effects such as photobleaching
or the results of normalising intensities across frames). The bilinear fit is a straight line
after the breakpoint, which approximates an exponential decrease at small times after the
breakpoint; this would correspond well to the results from the simplified model. The models




for constants c and N , at small times after the breakpoint; this is a common
form for a sigmoid function, and would therefore correspond better to the results for the full
model with small c1, with its initial lag phase. Note that it is important to choose n large
enough to allow the models to be fitted, but small enough that these approximations still
hold. In practice, a value of n = 50 was effective, although similar results can be obtained
with other values of n.
Note also that I do not assume that the breakpoint tb coincides with the first breakpoint
tb1 identified for each trace in the trilinear fit established in Section 2.3; tb1 is used here only
to establish a suitable window for fitting the breaktime tb.
From this interpretation, β0 is the initial intensity of the trace, β1 is the gradient of the first
linear section, and β2 is a scaling parameter controlling the rate of decrease in the second
section. An example showing the interval of interest for one representative trace, comparing
the three fits with the trace values, is given in Figure 6.1.
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Figure 6.1: Example of results of fitting varying models to the beginning of one representative
cytosolic trace in the MitoTracker dataset. The new identified breakpoint tb for each fit is
shown with a vertical line of the same colour. The bilinear model gives the best relative
likelihood value.
In order to compare the three models, I fitted each trace and calculated the maximum
log-likelihood for that trace. Suppose the maximum log-likelihood for trace i is li; then the
overall maximum log-likelihood for all traces is the sum of the individual log-likelihoods for
each trace, i.e.
∑
i li. The maximum likelihoods are 5.6042 × 103 for the bilinear model,
5.2111×103 for the quadratic model and 5.1795×103 for the cubic model. This suggests that
the bilinear model is the best fit for the model overall.
In order to directly compare the likelihood of the models, I calculated an AIC value for
each model (A1, A2 and A3 for the bilinear, quadratic and cubic respectively); an in-depth
explanation of the AIC is given in Section 5.3.3. Then, as shown in [Wagenmakers and










We can use this quantity to determine whether any of the AIC values are significantly
different to the others [Wagenmakers and Farrell, 2004]. If any one pi is larger than the
others, this indicates that the corresponding model is most likely to be correct. In this case,
we have p1 ≈ 1, p2 = 1.8945 × 10−171 and p3 = 3.6573 × 10−185. This suggests that the
bilinear model is extremely likely to give the best fit of the three models.
Overall, this analysis suggests that there is no lag phase at the onset of ASC depletion,
suggesting that the inflammasome behaves similarly to the simplfied model. Otherwise, if
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the full model is used, we have c1, c3 and p lying in the region defined in Section 5.2.4:
c1 > 0.546 + 0.385c3 + 0.209p + 3.60 × 10−3c23 − 3.46 × 10−3c3p + 9.48 × 10−4p2. Note that
this region was defined for the parameters c1, c3 and p after they have been scaled by the
parameter c2; in the model without scaling, the defined region is as follows:
(6.4)c1 > 0.546c2 + 0.385c3 + 0.209p+ 3.60× 10−3
c23
c2
− 3.46× 10−3 c3p
c2
+ 9.48× 10−4 p
2
c2
It is particularly interesting that this conclusion has arisen from data measuring the forma-
tion of the NLRP3 inflammasome since, in this case, filament intiation occurs via PYD-PYD
interactions, while we would expect branching to occur via CARD-CARD interactions; there-
fore, the lack of lag phase does not arise from the fact that branching and initiation arise from
the same protein-protein interaction.
Furthermore, we can use the breakpoint identified tb as the time at which ASC monomer
depletion begins following infection. We can therefore examine the distribution of time taken
for preliminary cellular responses to conclude, and for inflammasome formation to begin in
earnest (Figure 6.2). There is no significant difference between the FLICA and MitoTracker
datasets, or between cytosolic and nuclear traces (Kruskal-Wallis test with null hypothe-
sis that distribution of cytosolic traces and nuclear traces for both FLICA and MitoTracker
datasets have the same median, p = 0.4852). This is surprising, since it does not agree
with the primary analysis of the experimental data in Chapter 2 (which suggests that onset
of ASC monomer depletion occurs later in the nuclear region than in the cytosolic region);
however, this is more in line with the results from both mathematical models.
6.3 Comparison of experimental data with simplified stochastic
model
In Chapter 4, I derived the probablity distributions of the monomer depletion characteristic
times t1/q and the single cluster emergence times TS in the simplified model (see Figure 6.3
for an overview of the simplified model). The monomer depletion characteristic times are
directly comparable to the characteristic times t1/q derived from experimental data, while the
single cluster emergence time can be compared to the time of inflammasome emergence
derived from experimental data (in practice, the second breakpoint tb2 for the trilinear fit
in the speck region was used). Prior to analysing either the values of t1/q or the time of
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Figure 6.2: Distributions of onset times for monomer depletion in experimental data deter-
mined using bilinear breakpoints. The mean value is shown with a blue circle, and the mean
± standard deviation is shown with a blue cross. There is no significant difference between
nuclear and cytosolic compartments; this is in line with the interpretation in the mathematical
models.




Reaction P (Filament exten-
sion)
Figure 6.3: The simplified inflammasome model revisited
inflammasome emergence derived from the experimental dataset, in all cases the onset
times established in Section 6.2 were subtracted to remove variability arising from the time
before monomer depletion begins.
Time of inflammasome formation
Let us consider first the time of single cluster emergence (see Figure 6.4 for an overview of
the relevant subsystem of the simplified model).
As demonstrated previously, in the simplified stochastic model, the time of single cluster
emergence is hypoexponentially distributed with rates reliant on the parameters c2, which
controls the rate at which clusters join, and X0, the initial number of NLR oligomers. We can
Reaction C2 is included Reaction C does not affect
this subsystem
Reaction P does not affect
this subsystem
Figure 6.4: The simplified inflammasome model with filament extension only revisited
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fit the distribution to the data for the time of inflammasome emergence by finding the values
of c2 and X0 which maximise the likelihood function.
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We take ti as the set of inflammasome emergence times calculated in Chapter 2 with
the depletion onset times from Section 6.2 subtracted. As demonstrated in Section 4.3,
The value of X0 has fairly little effect on the resulting distribution of times of single clus-
ter emergence, so the analysis can be simplified by considering only a limited selection of
representative values; I took X0 = 10, 50, 100, 500, 1000.
I used the Matlab function fminsearch to find the minimum value of −l for each of these
values of X0 to give the maximum likelihood estimator for c2.
The largest likelihood occurred when X0 = 10, c2 = 7.56× 10−3 (see Table 6.1 for the full
set of values, and Figure 6.5 for a plot of the likelihood functions for different values of X0
and c2). This suggests that these values give the best approximation for the values of these
parameters, based on the values of X0 tested. In particular, it is notable that the smallest
tested value of X0 yields the best fit, suggesting that the initial number of NLR oligomers
may be very small.
Characteristic times for monomer depletion
A similar analysis can be carried out for the characteristic times t1/q. We can use the value of
X0 derived by fitting the single cluster emergence times to determine f0 by setting f0 = 10X0.
assuming there are ten monomers in each oligomer. For ease, I have focused on the values
of t1/2 and t1/10 for the cytosolic compartment in the experimental data. Once again, I
subtracted the fitted onset times derived in Section 6.2 prior to analysis.
The established probability density function for t1/q from Chapter 4 involves taking the
matrix exponential of an extremely large matrix (specifically, N(N + 1) × N(N + 1)) which
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Figure 6.5: Likelihoods for single cluster emergence time derived from analytical results for
simplified model while varying the initial number of oligomers X0 and the cluster joining rate
c2. The largest likelihood occurs for X0 = 10, suggesting a small initial number of NLRs.
Reaction C2 does not affect
this subsystem
Reaction C is not included Reaction P is included
Figure 6.6: The simplified inflammasome model with filament extension only revisited
cannot be calculated in an amount of time which is suitable for maximisation. Therefore,
I have focused on fitting the two extreme models derived in Section 4.3.2: the model with
branching only, and the model with filament extension only (see Figures 6.6 and 6.7 for an
overview of the relevant subsystem of the simplified model).



















where ti are the experimentally observed values of t1/q.
The form of the likelihood for the model with branching only is somewhat more complex
(especially in the case that the rates are not unique), and the full model cannot be fitted
Reaction C2 does not affect
this subsystem
Reaction C is included Reaction P is not included
Figure 6.7: The simplified inflammasome model with branching only revisited
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efficiently to within machine precision. However, the form of this function becomes much
simpler if we consider only the largest contributing terms to the likelihood function, which
correspond to the smallest rates in the hypoexponential distribution. In particular, I calculated
the smallest 10 values of λi = c(f0 + i)(x̂0 − i) with i ranging between 0 and N − 1, calling
these smallest values µ1, µ2, · · · , µ10.














Once again, I minimised the log-likelihood assuming x̂0 = 1000 using the fminsearch
function for both the model without branching and the model with branching only; the fitted
values are given in Table 6.1. Notably, the likelihoods for the model with branching only
are considerably higher than the likelihoods for the model with no branching; this suggests
that branching may play a key role in inflammasome formation, and that ASC monomer
depletion is unlikely to occur via PYD-PYD filament extension reactions only. However, it is
worth bearing in mind that the dataset is reasonably small, which may affect the accuracy
of the results. Furthermore, the likelihood function oscillates considerably for the model with
branching only compared to the model without branching (Figure 6.8); this suggests that the
maximisation step may not be reliable, since it may have located a local (rather than global)
maximum, although using different initial values for the fminsearch function gives reasonably
consistent results in terms of order of magnitude. Finally, this result does not suggest that
inflammasome formation occurs via branching only, but rather that this is a better fit for the
experimental data than the model without branching; this suggests that branching must play
a role in inflammasome formation.
6.4 Comparison of experimental data with full stochastic model
We will now turn our attention to the full inflammasome model once more, carrying out a
similar model fitting exercise to the process used for the simplified model, paying particular
attention to whether fitting the two models gives similar results. A summary of the full model




Figure 6.8: Likelihood plots of single cluster emergence time for models with no branching
and branching only, from analytical solutions for the simplified model, for an initial number
of monomers x̂0 = 1000. The maximum likelihood value is much larger for the model with
branching only, although the function oscillates considerably more, which may lead to inac-
curacies in fitting.
Reaction C1 (Recruitment of ASC monomer
by NLR in oligomer) Reaction C2 (Cluster joining)
Reaction C3 (Branching of ASC filaments) Reaction P (ASC filament extension)
Reaction M1 (Movement of ASC monomer
from nucleus to cytosol)
Reaction M2 (Movement of ASC monomer
from nucleus to cytosol)
Figure 6.9: The full inflammasome model revisited
Fitted parameter Fitted parameter values Likelihood
Ts
X0 = 10, c2 = 7.56× 10−3 3.35× 10−117
X0 = 50 : c2 = 1.03× 10−2 9.38× 10−129
X0 = 100 : c2 = 1.08× 10−2 5.01× 10−133
X0 = 500 : c2 = 1.13× 10−2 4.96× 10−133
X0 = 1000 : c2 = 1.14× 10−2 2.71× 10−133
T1/10, no branching p = 7.21× 10−6 exp(−1.5289× 104)
T1/2, no branching p = 4.35× 10−5 exp(−7.30× 104)
T1/10, branching only c = 1.003× 10−22 exp(−1.14× 103)
T1/2, branching only c = 1.003× 10−22 exp(−1.33× 103)
Table 6.1: Fitted parameter values and likelihoods from comparison of analytical results
from the simplified model with initial number of monomers x̂0 = 1000 with experimental data.
Fitting the time of single cluster emergence suggests that setting the initial number of NLR
oligomers X0 = 10 is the best fit for the data. Fitting T1/2 and T1/10 gives higher likelihoods
for the model with branching only, compared to the model without branching, suggesting that
the former is a better conceptual model of inflammasome formation.
In order to assess whether the full model was a good fit for the simulated data, it was
not possible to use maximum likelihood estimation, since closed forms of probability den-
sity functions for characteristic times had not been obtained; instead, it was necessary to
compare the distribution of each characteristic time from the experimental dataset with the
corresponding distribution for simulated data representing a number of different variants on
the full model, for sample parameter sets (see Section 5.3). In particular, I compared both
the single cluster emergence time and the dominant cluster emergence time calculated by
mean with the second breakpoint in the speck region, adjusted as for the simplified dataset
by subtracting the fitted onset time derived in Section 6.2. I also compared the distributions
of t1/10 and t1/2 for the cytosolic and nuclear regions in the experimental and simulated data.
It is important to note that in the simulated data, time has been scaled by multiplication by the
parameter c1 (which controls the rate of ASC monomer interactions with NLRs). It is there-
fore necessary to scale the times derived from simulations by an estimate for c1 in order for
them to be comparable with the experimental datasets.
I initially compared the simulated datapoints for each characteristic time with the relevant
corresponding dataset derived from the experimental data using a two-sample Kolmogorov-
Smirnov test, with the null hypothesis that the two samples are drawn from the same distri-
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bution. However, since c1 is unknown, it was necessary to test a variety of values of c1 to find
which was most appropriate. In particular, for each comparison of distributions, I determined
the value of c1 which minimised the Kolmogorov-Smirnov test statistic (which corresponds to
maximising the p-value of the test) by applying the fminsearch function to the Kolmogorov-
Smirnov statistic output of the kstest2 function in Matlab, with c1 as the parameter over
which the function was to be minimised.
I carried out this analysis for all simulated datasets - namely, the basic form of the full
model, the full model without branching, the full model without cluster joining, and the full
model with random initial conditions.
The first question of interest was whether the single cluster emergence time or the dom-
inant cluster emergence time was a better fit for the time of inflammasome formation. Inter-
estingly, in general the time of dominant cluster emergence had a much closer distribution to
the distribution of inflammasome emergence time derived from the experimental data com-
pared to the time of single cluster emergence (see Tables 6.3 and 6.2 for examples of the
best fits). This suggests that dominant cluster emergence time may be a better reflection
of inflammasome emergence than single cluster emergence time. The best fit arose for the
basic model, suggesting that this might be the best model of inflammasome formation of
those tested; in particular, these results suggest that ASC filament branching plays a role in
inflammasome formation, and that there are multiple NLR oligomers. However, in compari-
son to the analysis carried out in the previous section, the fitted value of X0 is much larger
than the value of 10 suggested by analysis of the simplified model.
One clear issue is that the fitted values of c1 obtained by fitting the dominant cluster
emergence times are much smaller than the values obtained for the other characteristic times
(single cluster emergence time, and t1/10 and t1/2 for both nuclear and cytosolic regions). In
particular, the parameter values fitted for dominant cluster emergence time were all around
10−11, while the values for the other characteristic times were all between 10−4 and 10−8.
This may suggest that m1 is comparatively much smaller than any of the sampled parameter
values. As demonstrated in Section 5.2, the time of dominant cluster emergence is primarily
dependent on c3 and X0, and is broadly independent of m1, while all other characteristic
times do show a dependence on m1. It is therefore possible that m1 is much larger relative
to the other parameters than any of the values tested using simulations; increasing the value
of m1 would have little effect on the dominant cluster time, but all other characteristic times
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Model c1 × 106 c2 × 106 c3 × 106 p× 106 m1 × 105 m2/m1 X0 p-
value




2.13 1.10 1.06 N/A 2.56 0.928 597 0.516
Random
ICs
1.75 2.58 2.68 9.86 124 1.80 153 0.958
Table 6.2: Fitting simulated results for the single cluster emergence times derived from Latin
hypercube simulated data (100 simulations for 100 parameter sets); details of parameters
giving rise to simulated distributions of single cluster emergence times for the model variant
which is closest to the distribution of inflammasome emergence times derived from experi-
mental dataset. The closest match arises from the Random ICs model.
Model c1 × 1011 c2 × 1011 c3 × 1011 p× 1011 m1 × 105 m2/m1 X0 p-
value




6.95 55.3 29.8 N/A 7.81 0.157 597 0.993
Random
ICs
7.35 8.53 10.1 23.8 191 1.44 787 0.975
Table 6.3: Fitting simulated results for the dominant cluster emergence times derived from
Latin hypercube simulated data (100 simulations for 100 parameter sets); details of parame-
ters giving rise to simulated distributions of dominant cluster emergence times for the model
variant which is closest to the distribution of inflammasome emergence times derived from
experimental dataset. The closest match arises from the basic model.
Model c1 × 106 c2 × 106 c3 × 106 p× 106 m1 × 105 m2/m1 X0 p-value
Basic 5.95 0.855 8.71 0.850 384 0.315 380 0.476
No branch-
ing
7.93 63.0 34.0 N/A 8.91 0.157 597 0.478
Random
ICs
8.79 3.03 67.0 1.86 115 0.619 314 0.480
One
oligomer
1.87 N/A 0.200 9.08 4.96 0.834 N/A 0.478
Table 6.4: Fitting simulated results for the single cluster emergence time and monomer de-
pletion characteristic times derived from Latin hypercube simulated data (100 simulations for
100 parameter sets); details of parameters giving rise to simulated multivariate distributions
across characteristic times for each model variant which are closest to the distribution of in-
flammasome emergence times derived from experimental dataset. The closest match arises
from the Random ICs model. P-values are given for the Cramer-von Mies test.
would increase.
Since the fitted values of c1 were so different to those for the dominant cluster emergence
time compared to the other characteristic statistics, I focused on the other characteristic
times from this point onwards. In order to ascertain which parameter set gave the best
overall match for all characteristic times (with the exception of dominant cluster emergence
time), I used a multivariate non-parametric two-sample Cramer-von Mies test developed by
Baringhaus and Franz [Baringhaus and Franz, 2004], which tests the null hypothesis that
two multivariate samples are drawn from the same multivariate distribution; this could be
regarded as an extension to the KS test for multivariate data. The test has been implemented
as a package cramer [Franz, 2019], in the R statistical software environment [R Core Team,
2016].
I applied the cramer.test function to Ts and t1/10 and t1/2 for both the cytosolic and
nuclear compartments for each all simulated results for each parameter set and for each
model, comparing with the experimentally-derived values; the exception was the simulated
results for the model with one NLR oligomer initially present, for which Ts was excluded. The
closest matches occur for the largest p-values; the results for the closest matching parameter
set for each model variant are given in Table 6.4. There is fairly little difference between the
resulting p-values, although as for the single cluster emergence time alone, the Random ICs
model gave rise to the best match.
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Note that the parameters giving rise to the closest match to the experimental data are
not intended to be a precise estimate for the ‘real’ parameter values, but are instead are the
set of parameters obtained by Latin hypercube sampling that give the results closest to the
experimental data. However, the fact that the models with branching included are generally
more successful than the corresponding models without branching suggests that branching
may be an important factor in inflammasome formation. Furthermore, the most successful
models suggest that there is more than one initial NLR oligomer present, suggesting that
joining of clusters is another process which should be considered in inflammasome forma-
tion. Finally, the reasonably good matches between experimental data and simulated results
for the model with random ICs suggests that instead of each NLR oligomer containing exactly
10 monomers, there may be much more variation in oligomer sizes.
It is also worth noting that for all KS and multivariate tests which give the closest results to
the experimental data, the parameters do not lie in the region for which there is no lag phase,
as defined in Section 5.2.4. This is at odds with the conclusions of Section 6.2, which show
a lack of initial lag phase in monomer depletion. The values of X0 which fit the experimental
data best are also much higher than the value of X0 fitted for the simplified model (Section
6.3), while the value of c2 derived from the simplified model is much higher than those derived
here for the full model. Therefore, the simplified and full models give contradictory results
for some aspects of the model. This should be examined in further detail (ideally, with a
larger and more consistent experimental dataset) before concrete conclusions can be drawn




In this chapter, I have described a number of approaches to comparing the models of in-
flammasome formation I have developed with the experimental data described in Chapter
2. I first fitted curves to the early timepoints for each trace derived from the experimen-
tal data, to establish whether there is a sharp or gradual initial decrease in ASC monomer
abundance following infection. This model fitting suggested that an initial sharp decrease
was more likely, and allowed the time taken before ASC monomer depletion occurred to be
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determined.
I then used maximum likelihood estimation techniques to fit the characteristic times de-
rived from experimental data to distributions derived for the simplified model in Section 4.3.
In particular, this gave an estimate for the cluster joining rate, and suggested that there are
initially around 10 oligomers present. This analysis also suggested that filament branch-
ing occurs during inflammasome formation, and that cluster growth does not occur purely
through filament extension as previous conceptual models have suggested.
Finally, I compared the distribution of the characteristic times from the experimental
dataset with the corresponding characteristic times obtained from simulations of the full in-
flammasome model, both for the basic form of the full models, and for a number of variants,
namely, the models without branching, with a single initial NLR oligomer, and with random
ICs. While some aspects of the analysis presented here are not entirely consistent with
the analysis of the simplified model, they do at least suggest that initially multiple NLRs are
present, and that ASC filament branching plays a role in inflammasome formation. Further-
more, analysis of the full model simulations suggests that there may be more variation in
NLR oligomer size than the existing conceptual model, in which there are a fixed number of
monomers in each NLR oligomer. Finally, the dominant cluster emergence time may give
a better reflection of the inflamamsome formation time than single cluster emergence time.
This may suggest that inflammasome formation time is dependent on the initial number of
NLR oligomers, with smaller numbers of oligomers corresponding to longer inflammasome
formation times.
6.5.2 Further work
One of the main shortcomings in the work presented here is the fairly small size, and in-
consistent nature, of the experimental dataset analysed, especially as many of the traces
derived from the dataset could not be fitted successfully. However, the analysis presented
in this chapter could easily be repeated for another similar dataset, which may shed more
light on the inconsistencies between the results from fitting the initial portion of the traces
(which suggest that the rate of ASC recruitment by NLRs is comparable to the recruitment
of ASC by other ASC monomers) and the results from fitting the simplified and full models
(which suggest that the rate of ASC recruitment by NLRs is much slower than recruitment of
ASC by other ASC monomers). These issues motivate repeating this analysis with a larger
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dataset, ideally with much more consistency in time series length and time between frames
than in the existing data, as well as a higher signal-to-noise ratio. Increasing the size of the
dataset would increase the power of the statistical tests carried out, while decreasing the
noise in the dataset would reduce the possibility of incorrect model fits due to random vari-
ation discontinuities, and increasing consistency would avoid variation between traces due
to avoidable differences between samples. Furthermore, this analysis has only considered
the NLRP3 inflammasome; it would be extremely useful to carry out a similar analysis on a
system in which a different variety of inflammasome is formed. This would be particularly
interesting in cases in which the abundance of NLRs might be different (for example, in the
NLRC4 inflammasome); the effect of changing the initial number of NLR oligomers could
therefore be directly examined as a variable in the model.
Aside from motivating the production of more data similar to the dataset presented in
Chapter 2, the results from this chapter suggest a broader range of areas which would ben-
efit from further general experimental investigation. In particular, the results support the
importance of ASC filament branching, and the initial presence of multiple NLR oligomers
of different sizes. These could be investigated further using alternative experimental ap-
proaches; for example, superresolution imaging of cells with labelled ASC or NLRs during
the process of inflammasome formation.
From the mathematical perspective, one shortcoming of the analysis presented in this
chapter is that the goodness-of-fit of results for the simplified model cannot be directly com-
pared to the statistical tests carried out on the simulated data for the full model. Thus it is
unclear which of the two models gives a better representation of inflammasome formation,
and in particular, which aspects of the full model which have been excluded from the simpli-
fied model are in fact necessary for an accurate representation of inflammasome formation.
The initial analysis carried out in Section 6.2 suggests that, surprisingly, the simplified model
may be sufficient to accurately depict monomer depletion at early times, but it is still unclear
to what extent the constant joining kernel used in the simplified model is appropriate for this
system, and whether the division of the cell into two regions is important in representing the
inflammasome formation process. There are two possible approaches which could be used
to overcome this drawback; either distributions of characteristic times could be derived for
the full model, in a manner similar to the analysis carried out for the simplified model, or the
distributions derived for the simplified model could be abandoned in favour of using simu-
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lated results. The former approach may be possible, although more technically demanding
than the analysis carried out so far (for example, phase-type distributions similar to those
presented in Section 4.3 could be developed, although this may require the calculation of
the matrix exponential of many large matrices); the latter would potentially be much simpler
but, as with the analysis of the full model carried out here, it would still be reliant on the
availability of good-quality data to fit.
Finally, as established when analysing the results from the full model, results for the dom-
inant cluster emergence time suggest that a wider range of parameter values should have
been considered when running Latin hypercube parameter sampling. This could easily be
remedied by carrying out more simulations over a larger range of parameter values, although




Discussion of intracellular modelling
of the inflammasome
In the previous chapters, I have presented a first approach to modelling inflammasome for-
mation on the intracellular level, coupled with analysis of a typical experimental dataset. This
research has had a number of key outcomes, the first being the models themselves; this is
especially significant since, to my knowledge, there are no existing mathematical or compu-
tational models of inflammasome formation with any more sophistication than very simple
aggregation mechanisms [Cheng et al., 2010]. The models lay the groundwork for other
similar approaches; in particular, by identifying the most important behaviour we would wish
an inflammasome formation model to display, and showing how we can integrate structural
information about individual protein-protein interactions to gain understanding of the whole
inflammasome complex. I have also identified potential problems which may arise from
modelling the inflammasome, including the need to use discrete approaches at late times
when there are small numbers of reactants present, to avoid biologically-implausible results
including clusters which can grow indefinitely in size. The models themselves are also of
some mathematical interest, since they contribute to the field of coagulation modelling; this
is a novel system which simultaneously includes multiple classes of reactants, movement
between spatial compartments, and Smoluchowski-like joining of clusters.
Another key result from this project has been the development of data processing and
analysis methodologies, which may be useful beyond this project alone. In particular, the
experimental data presented in Chapter 2 is fairly characteristic of imaging data which may
be obtained from time series live-imaging of inflammasome formation, and the pipeline de-
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veloped here could easily be adapted for use with other experimental datasets. These tech-
niques may be particularly useful since they do not rely on data derived from very intensive,
high-resolution but low-throughput techniques such as cryo-EM or NMR imaging, for which
live cell imaging is generally not possible, since confocal microscopy provides sufficient res-
olution for the analysis carried out in this project. Furthermore, this indirect analytical ap-
proach is much easier to scale up to analyse larger datasets.
Finally, the results presented in the preceding chapters give an insight into the key pro-
cesses occurring within the cell during inflammasome formation at a level of detail which
would be difficult to achieve through experimental means. This allows us to draw conclusions
about the process of inflammasome formation which are currently poorly understood, build-
ing towards a truly cohesive and logically consistent conceptual model of the inflammasome
formation process. While this project will ideally be only the first step in a continuing cycle
of modelling and experimentation of inflammasome formation, already the initial outcomes
of this process challenge received wisdom around inflammasome signalling processes, and
suggest answers to some of the unresolved questions in this field.
7.1 Towards a conceptual model of inflammasome formation
The results of the model and data analysis suggest a number of key stages in the process
of inflammasome formation. Initially, NLRs form oligomers as a response to DAMP or PAMP
detection; the results presented here suggest that these oligomers may vary in size, rather
than the common assumption (at least for NLRC4 inflammasomes) that all NLR oligomers
contain the same number of monomers; this supports the proposed filamentous structures
of NLRC4, NLRP1 and AIM2 oligomerisation [Diebolder et al., 2015, Li et al., 2018, Gong
et al., 2021, Hollingsworth et al., 2021, Matyszewski et al., 2021]. Furthermore, also contrary
to many conceptual models of inflammasome formation, it is likely that there is more than
one initial seeding NLR oligomer.
The NLR oligomers then recruit ASC monomers; I have suggested that this process oc-
curs via a chain reaction of ASC ‘activation’, analogous to the activation of NLRs, but in the
case of ASC, allowing the recruitment of further ASC monomers; this model was suggested
by the prion-like behaviour of ASC [Cai et al., 2014]. This mechanism explains why aggre-
gation of ASC does not occur spontaneously in endogenous cells. The results presented in
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previous chapters also suggest that ASC recruitment and aggregation occurs via both linear,
filamentous growth, and the formation of ‘branches’ in these linear filaments. This challenges
the popular view of ASC aggregation, which asserts that ASC recruitment initially occurs ex-
clusively via PYD-PYD interactions, with the resulting filaments crosslinking at later times via
CARD-CARD interactions [Broz and Dixit, 2016, Dick et al., 2016, Franklin et al., 2018]; how-
ever, it does coincide with the branching ASC filament structures observed by Kuri et al. [Kuri
et al., 2017]. I have proposed that PYD-PYD interactions lead to filamentous growth, while
CARD-CARD reactions are responsible for branching; however, recent studies have sug-
gested that CARD-CARD reactions can also be responsible for linear, filamentous growth [Li
et al., 2010, Nambayan et al., 2019, de Alba, 2019, Hollingsworth et al., 2021]. Regardless,
CARD-CARD and PYD-PYD interactions are not strictly attached to either mechanism of
growth in the mathematical models; rather, the models suggest that there are two methods
of growth occurring simultaneously, both of which may be filamentous, but that these two
modes of growth are independent; this allows up to two monomers to attach to any growing
filament, thus leading to a branch. The models also demonstrate that branching of ASC fila-
ments would allow quicker recruitment of further ASC monomers, which would lead to faster
overall formation of the inflammasome once this process has been initiated, since filament
branching may lead to a positive feedback loop. Furthermore, I have demonstrated that it is
likely that incipient clusters of NLRs and ASC may join partway through formation, since this
is necessary for the formation of a single inflammasome.
The analysis presented in previous chapters suggests that as inflammasome formation
begins, there is initially a very fast, exponential drop in free ASC monomer counts. This
suggests that an initial lag in ASC aggregation does not occur, and that this is not a limiting
factor in inflammasome formation. I have also demonstrated that there is a clear separation
of ASC monomers in the nuclear and cytosolic regions of the cell, since the inflammasome
generally forms outside the nucleus; this causes a slower depletion of ASC in the nuclear
region.
Simulations demonstrate the existence of clear phases in the inflammasome formation
process, based on the dominant processes at different times and the variation between runs.
There is an initial slow phase of growth as NLRs accumulate ASC. Once joining of clusters
first occurs, a second phase of rapid growth begins, with a large amount of variation between
cells (or simulated experiments). Eventually, one large cluster emerges, which begins to
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absorb all smaller clusters. Growth of this cluster begins to slow as ASC monomers and
clusters are depleted; at later times, all clusters have been absorbed into a single large
cluster. It is important to note that in real biological systems, the process of inflammasome
formation takes place concurrently with numerous other cellular processes; in some cases,
if the series of phases outlined above takes a particularly long time, the cell may never
display the later phases of inflammasome formation simply because other processes have
intervened, and the completion of the inflammasome formation process may never occur.
In particular, simulated and analytically-derived distributions of dominant cluster emergence
time and single cluster emergence time generally have long ‘tails’ to late times, suggesting
that in some cases, some cells would by chance take so long to form inflammasomes that
this process is interrupted by other within-cell systems.
The time taken to reach each of the stages outlined above is dependent on different pa-
rameters in the model. For example, the time taken to overcome the initial expansion phase
before joining occurs is highly dependent on the initial number of NLR oligomers and the rate
of ASC recruitment by NLRs; meanwhile, the time taken for a dominant cluster to emerge is
dependent on the rate of ASC branching and the initial number of NLRs; and the time of sin-
gle cluster emergence is dependent on the rate of ASC branching and the rate of movement
of monomers from the nuclear to the cytosolic compartment. Interestingly, comparisons of
the models to experimental data suggest that dominant cluster formation may be the best fit
for inflammasome formation times; the fact that the large-time ‘tail’ of the distribution of dom-
inant cluster emergence time is reduced as the initial number of NLRs increases may explain
why in some systems (for example, NLRC4 inflammasome formation [Man et al., 2014a]) al-
most all cells form inflammasomes, whereas in others (for example, NLRP3 inflammasomes
- see the data presented in Chapter 2) many cells do not form inflammasomes. In the latter
case, there may be fewer NLR oligomers present initially, leading to dominant cluster emer-
gence times with much greater positive skewness, and thus theoretically a greater chance
of inflammasome formation occurring at times after other cellular processes intervene.
While the framework outlined above is certainly not yet either a definitive or compre-
hensive model of all processes involved in inflammasome formation, this project has led to
the development of useful alternatives to the predominant conceptual models, and presents
hypotheses which may be confirmed or rejected on the basis of future experimental work.
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7.2 Further work
A clear first stage in building on this project would be to repeat the analysis on further
datasets similar to the experimental results presented in Chapter 2. Firstly, it would be
useful to repeat the experiments exactly as described in Chapter 2, in order to generate a
larger and more consistent dataset, which could be used to establish whether the results pre-
sented here are reproducible. It would also be useful to repeat the experiments with other
DAMPs/PAMPs, in order to establish the differences between different inflammasome for-
mation processes. This may require some adjustment to the pipeline developed during this
project; for example, direct investigation of responses to Salmonella infection would require
infected cells with Salmonella expressing fluorescently-tagged flagellin. In this case, the in-
flammasome formation process in each individual cell would not begin when the bacteria are
introduced to the sample, but rather when that cell is infected. However, it would be possible
to establish the time of infection by identifying the time point when the fluorescently-labelled
flagellin first appears in the cell. It would also be extremely useful to rerun the analysis in
cells in which the relevant NLR has also been fluorescently labelled; this would allow us to
interrogate the proposed results relating to NLR oligomerisation presented in earlier chap-
ters.
However, as well as simply rerunning the analysis established in this project with differ-
ent experimental data, it is also necessary to test the conceptual models proposed above
through independent experimentation. One possible approach would be the use of high-
resolution techniques such as cryo-EM; in particular, ongoing unpublished work imaging the
inflammasome when it is partially formed appears to show branched ASC filament structures
similar to those proposed in this project.
As discussed previously, there are also a number of clear limitations to the mathemati-
cal models of inflammasome formation proposed here; these could be examined in further
iterations of models. There are four main areas in which the models presented here are par-
ticularly limited; these are the underlying assumptions of the behaviour of NLRs and ASC,
the focus on very early stages of inflammasome formation, the lack of inclusion of other
regulatory processes involved in inflammasome formation, and the limited spatial element of
the models.
Firstly, in order to construct the model, a number of simplifications were made regarding
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ASC and NLR behaviour. In order to explain the lack of ASC aggregation in the absence
of any inflammatory stimulus, I assumed that ASC undergoes a change of conformation
upon interaction with an activated NLR, which allows it to recruit further ASC monomers.
While this is a fairly parsimonious explanation of this biological process which coincides
with the prion-like characterisation of ASC, the precise reasons for the lack of spontaneous
ASC aggregation are unknown. Naturally, this could be established by further structural
analyses of ASC before and after recruitment by NLRs, but alternative hypotheses could
also be investigated in a modelling context. One possible such alternative hypothesis could
be that ASC can aggregate prior to PAMP/DAMP detection, but that these interactions are
highly transient; however, interactions with an NLR oligomer could have a stabilising effect
on these aggregates, leading to a reduced dissociation rate.
Another key assumption was that NLR oligomers are initially fully-formed, and do not con-
tinue to grow once ASC recruitment begins. This assumption was made since the precise
nature of NLR activation and oligomerisation is not entirely clear, and moreover, the method
of oligomerisation is different for different PRRs; therefore, by not including the oligomeri-
sation process in the model, it remains applicable to all forms of canonical inflammasome
formation. It would be possible to include an input term in the models accounting for the
activation of inactive NLRs, although there is currently no existing quantitative data available
describing how NLR activation rates change over time. A mathematical alternative would be
to investigate a range of different possible functions over time for input of NLR oligomers (for
example, constant, decreasing and increasing functions), which could then oligomerise and
recruit ASC monomers. This may be able to shed some further light on the complex process
of NLR activation without the need for further experimental work. Finally, in some cases
the reactions included in the model may be physically impossible due to the geometry of
the clusters. This is one reason why intra-cluster reactions were not included in the models
created in this research, since space limitations are very likely to affect crosslinking reac-
tions within a cluster. A rigorous representation of the spatial limitations in inflammasome
recruitment would rely on including detailed spatial and structural models of the protein in-
volved; this would be laborious and come at the cost of a model which can be investigated
analytically. However, an intermediate possibility would be to create a network model of in-
teractions within the inflammasome. The individual proteins could be considered as nodes
within a network, with different classes of edges connecting those nodes once CARD-CARD
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or PYD-PYD interactions join those proteins; these could be added stochastically over time
in a manner similar to the stochastic simulations conducted in Chapter 5. The network prop-
erties could then be analysed; in particular, characteristic times such as the time of single
cluster emergence (i.e. the time at which the network becomes connected) could be de-
termined for the network and compared with experimental data in a manner similar to the
analysis carried out for the models described in previous chapters. Properties of the network
could also be used to avoid the inclusion of interactions which might be physically unlikely,
for example, tight loops caused by in ASC filaments joining to themselves.
The second limitation of the model presented here is that it is only applicable to the early
stages of inflammasome formation, and it includes neither the crosslinking which must occur
within inflammasome complex to create the resultant compact ASC ‘speck’, nor the down-
stream recruitment of caspase-1. A network model as described above may be useful in
addressing the former problem; a metric based on the compactness of the network could be
used to assess whether the resultant speck is compact in shape, similar to the endogenous
ASC speck, or more reminiscent of filamentous ‘Medusa’s head’ phenotypes [Sahillioglu
et al., 2014]. The latter problem could be addressed by adding pro-caspase 1 and caspase-
1 as reactants to the models. As well as giving an insight into the involvement of caspase-1
in the inflammasome, the presence of caspase-1 may affect the depletion of ASC in later
stages of inflammasome formation, since caspase-1 recruitment to the inflammasome may
block further recruitment of ASC monomers (both occur via CARD-CARD interactions).
Another element which could be added to the model is a more detailed account of the
regulatory systems controlling NLR activation, for example, COPs and POPs, or proteins
involved in NLR PTMs. This was not included in the current model since the process of
NLR oligomerisation was not included; furthermore, very little quantitative data is available
describing NLR PTMs and interactions with COPs and POPs. A number of points may need
to be clarified (for example, the abundance of COPs and POPs before and after DAMP/PAMP
detection) before model development could take place, in order to avoid the proposed models
being purely speculative.
Finally, a major drawback to the model as presented is that it does not include a spatial
element beyond the division of the cell into nuclear and cytosolic compartments; otherwise, I
have assumed that the reactants are well-mixed within these compartments. However, within
the space of the cell, the need for clusters and monomers to be in spatial proximity in order
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to join together is likely to increase the time required for inflammasome formation processes
to occur, especially late in the process when there are small total numbers of reactants
remaining. It would also be useful to include other subcellular structures which have been
implicated in inflammasome formation, including the cytoskeleton — with microtubules and
actin having been implicated in NLRP3 and NLRC4 inflammasome formation respectively
[Misawa et al., 2013, Man et al., 2014a, Li et al., 2017] — and mitochondria, which have
been associated with NLRP3 inflammasome formation [Zhou et al., 2011, Misawa et al.,
2013]. The inclusion of the cytoskeleton in particular may direct reactants towards a focal
point in which the inflammasome forms, which may explain how reactants come to be in
close proximity.
Overall, this research has opened up considerable potential for further modelling in the
field of inflammasome signalling; at the broadest possible level, the results presented will
be most useful feeding into our understanding of inflammasome formation within the larger
context of inflammatory response, both temporally (i.e., considering the downstream effects
of cytokine release and cell death), and spatially (i.e. at tissue, organ and organism lev-
els). The models presented here could ultimately form a sub-component of a much broader
model, which encompasses these wider effects. These methods could then be the basis
for a much wider investigation into the effects of inflammation, and provide a platform which
could be used to test possible medical interventions, either to infection, damage or autoin-
flammation. This will be examined further in the final discussion, Chapter 12.
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Chapter 8
Development of a spatial model of
lesion formation
8.1 Introduction
Having explored the dynamics of inflammasome signalling in response to infection at the
cellular level, we now turn our attention to the larger-scale effects of inflammasome formation
and, in particular, the formation of lesions in the liver following Salmonella infection.
In order to better understand the processes which define the spatial organisation of le-
sions in Salmonella infection, I have created a spatial PDE model describing the dynamics
of infected and uninfected phagocytes as well as bacteria and chemokines over time. In this
chapter, I will describe the processes included in the model, as well as the simplifications
and assumptions involved. I also describe a basic set of parameters which can be used with
this model, which have been derived from experimental literature.
8.2 Lesions model with single phagocyte population
8.2.1 Variables and reactions
I have focused my attention on four variables: the numbers of infected and uninfected phago-
cytes, as well as the number of extracellular bacteria and the concentration of chemokines
released by phagocytes while infected. I track each of these variables over time, and over
a spatial domain representing an area of liver tissue. I assume that all phagocytes as well
as chemokines and extracellular bacteria diffuse freely across the spatial domain, but that
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Variable Explanation
S Concentration of uninfected phagocytes
I Concentration of infected phagocytes
b Concentration of extracellular bacteria
c Concentration of phagocyte-attracting chemokine
Table 8.1: Variables used in the spatial lesion model
all phagocytes undergo chemotactic attraction towards areas with a high concentration of
chemokines. When in spatial proximity, bacteria may infect uninfected phagocytes. Infected
cells may undergo lysis or apoptosis; in the former case, bacteria are released from the
cells. Chemokines are degraded and extracellular bacteria die at a constant rate. Although
I assume that bacteria reproduce within the cellular environment, I do not explicitly track the
number of bacteria in the cell, but simply assume that a constant number N of bacteria are
released when a cell is lysed. Finally, I assume that uninfected phagocytes are introduced
to the system at a constant rate throughout the domain, and are removed at a linear rate.
The variables and parameters used in the model are given in Tables 8.1 and 8.2 respec-
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= Dc∇2c︸ ︷︷ ︸
Diffusion
Chemokine production by infected cells︷ ︸︸ ︷
+rcI −γcc︸ ︷︷ ︸
Chemokine decay
The domain of the system is a two-dimensional area D = [0, L]2, with reflecting boundary
conditions; this is a somewhat arbitrary choice which is particularly amenable to analysis,
and thus a good choice for a first modelling attempt; considering only a two-dimensional
domain further simplifies analysis, although these choices of domain architecture may affect
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(a) Movement of reactants in the spatial lesions model. Uninfected and infected phagocytes, bacteria
and chemokines diffuse with diffusion coefficients DS , DI , Db and Dc respectively. Uninfected and
infected phagocytes undergo chemotaxis up a gradient of chemokine concentration with chemotaxis
parameters χS and χp respectively.
(b) Non-spatial reactions in the spatial lesions model. Uninfected phagocytes are introduced at a
constant rate rS , and are removed from the system at a rate γS . Bacteria infect uninfected phagocytes
at a rate β. Infected phagocytes produce chemokines at a rate rc. Infected cells lyse and apoptose
at rates l and a respectively. Cells which lyse release N bacteria. Bacteria and chemokines are
removed at rates γb and γc respectively.
Figure 8.1: Reactions considered in the spatial model of lesion formation.
Parameter Explanation
DS , DI , Db, Dc Diffusion coefficients
χS , χI Chemotaxis rates
β Bacterial infection rate
b1/2 Half-saturation concentration for bacterial infection
rS Rate of introduction of uninfected phagocytes
γS Rate of removal of uninfected phagocytes
l Lysis rate of infected phagocytes
a Apoptosis rate of infected phagocytes
N Average bacterial release following lysis
γb Bacterial death/removal rate
rc Chemokine production rate
γc Chemokine decay/removal rate
Table 8.2: Parameters used in the spatial lesion model
the structure of the solutions.
The intial conditions are S(x, 0) = S0(x), p(x, 0) = 0, b(x, 0) = b0(x) and c(x, 0) = 0
for some functions S0(x) and b0(x). These functions represent the distribution of resident
phagocytes and bacteria introduced at t = 0, when the infection begins. In general, I have
assumed that resident phagocytes are initially evenly distributed across the domain, while
bacteria are introduced in a localised area.
8.2.2 Simplifications and assumptions
The model presented here is clearly a very much simplified representation of the biologi-
cal process of lesion formation. However, I have attempted to identify the key processes
driving the dynamics and spatial distribution of the reactants in order to create the most par-
simonious possible model, to test whether these processes alone are sufficient for lesion
formation; if this is unsuccessful in modelling lesion formation, the model may be adjusted
to change the characterisation of the biological processes included, or to include other pro-
cesses.
Firstly, I have assumed that the domain is spatially homogeneous, and that cells, bacte-
ria and chemokines undergo diffusion freely throughout the domain. I have not considered
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the lobule structure of the liver tissue, or interactions with other cells and structures such
as hepatocytes and the ECM. This reduces the complexity of the model, and furthermore it
is unclear how interactions with other structures and cells affects lesion formation, if at all.
Likewise, I have not explicitly modelled the blood supply in the domain, but for simplicity I
assume that phagocytes are introduced at a constant rate throughout the domain; this is
naturally a considerable simplification of the system, and other similar models include an in-
put term proportional to the local concentration of chemokines [Dunster et al., 2014, Bayani
et al., 2020a]. However, the constant input of phagocytes has two advantages: firstly, in
the absence of bacteria, infected phagocytes, and chemokines, the system remains at an
equilibrium with S = rS/γS ; unlike a model in which phagocyte input in a given area is pro-
portional to local chemokine concentration, this would allow a nonzero population of resident
phagocytes to persist in the absence of infection. Secondly, if local phagocyte input is pro-
portional to local chemokine concentration, this may limit the input of uninfected phagocytes
to areas already containing infected cells; essentially, this may result in a situation in which
uninfected phagocytes can only be introduced to the system very close to an existing lesion.
I also assume that the cells, bacteria and chemokines cannot leave the domain, but also
that no chemokines or bacteria can enter the domain. Of course, during the course of an
infection we would expect bacteria to enter the liver over an extended time period; however,
in the interest of simplicity and parsimony I have not considered this possibility here.
Another key simplification in this model is the grouping of phagocytic cells only by their
infection status; namely, I do not distinguish between neutrophils and macrophages. This
is justified since the initial neutrophil response is extremely transient, and differentiating be-
tween the roles played by the different cells may not be necessary to explain the spatial
dynamics of this system. Furthermore, I have not included macrophage activation in this
system, since the classification of macrophages based on activation status would require
the inclusion of further variables in the model, which would be unlikely to materially affect
results beyond a delay as macrophages pass from the inactive to activated class. I have also
assumed that cells do not replicate within the timescale of this model, and that infected cells
do not die by any other means than programmed cell death following infection.
Likewise, I have amalgamated all chemokines released by infected cells into a single vari-
able; naturally, in the biological system, multiple chemokines are released, and play subtly
different roles in driving inflammation including recruitment of other innate immune cells. The
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use of a single variable is a parsimonious construction which allows us to focus on the poten-
tial role played by chemokines in recruitment of phagocytes, since the focus for this model
is understanding the interplay between bacteria and cells, rather than the roles of individual
chemokines. Furthermore, I have not included chemokine production from uninfected cells
which have come into contact with extracellular bacteria, or release of chemokines follow-
ing lysis. The total amount of chemokines released by either of these processes is likely
to be much less than the chemokines released by infected cells during their lifetimes, and
furthermore, no quantitative data is available to parametrise these processes; therefore, the
omission of these processes is justified. Finally, I have assumed that chemokine binding to
cell receptors is transient, and that chemokines are thus not removed from the system by
binding; this is justified by the extremely short timescale of these reactions compared to the
process of lesion formation.
I have also made a number of assumptions about the behaviour of bacteria. I have
assumed that bacteria infect uninfected cells only; this is justified since bacteria are much
less likely to infect cells which are already infected [Gog et al., 2012]. I have assumed that
infection occurs at a rate proportional to the local concentration of uninfected cells and a
Michaelis-Menten type function of the local concentration of bacteria; this reflects saturation
in the infection process, and is important in representing limitations in the number of bac-
teria which can be taken up by cells due to spatial constraints. This form has been used
in other models of bacterial infection [Lauffenburger and Kennedy, 1983, Schokker et al.,
2013]. Furthermore, I have assumed that bacteria do not reproduce extracellularly, but do
reproduce intracellularly, reflecting the preferential conditions for bacteria in the intracellular
environment. It would certainly be possible to add a simple linear term to include extra-
cellular bacterial reproduction, but for the sake of model parsimony this was excluded from
the current model. Although naturally there is a distribution of numbers of bacteria released
upon cell lysis, I assume that a fixed number N > 1 of bacteria are released whenever
a cell lyses. While it would be possible to introduce a distribution of possible numbers of
bacteria released upon lysis rather than a single fixed value, or even to explicitly model intra-
cellular bacterial reproduction, since the number of bacteria released upon lysis is generally
extremely low the use of a constant number of bacteria released is justified [Brown et al.,
2006, Gog et al., 2012, Man et al., 2014a].
Finally, the use of linear death rates, chemotaxis rates and rate of introductions of new
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phagocytes are certainly not a perfect representation of the biological system, but since
these rates have not been quantified, this is a logical choice for a first model of this system.
This model contrasts to previous spatial models of inflammatory processes in a number
of respects. The innovative aspects of this model can be generally considered either as
processes which have been included which are unusual in other models (for example, explicit
quantification of bacteria and the inclusion of lysis), or processes which have been simplified
since they are of less interest to this research (for example, consolidating different varieties
of cells and chemokines into single variables).
Firstly, the focus on bacterial dynamics in this model is fairly unusual, especially in spatial
PDE models, which have often been more general in nature rather than specifically focusing
on bacterial infections; in particular, it is extremely unusual for models to include lytic cell
death, and the release of bacteria following lysis. However, since the balance of lysis and
apoptosis are particularly important in understanding the role of the inflammasome, I have
included both in this model.
Secondly, in this model, parameters describing movement of phagocytes may be dif-
ferent for infected and uninfected cells. This is an unusual distinction, since most models
assume that rates of diffusion and chemotaxis are the same for all cells of the same class,
regardless of infection status. However, in examining the downstream effects of inflamma-
some formation, one area of particular interest is the observed effect of decrease in cellular
motility; allowing movement rates to vary between infected and uninfected cells will allow the
effect on lesion formation to be examined more systematically.
Thirdly, neutrophils and macrophages are regarded as a single class of cells. While they
naturally play different roles in the resolution of infection, for the reasons outlined above,
these have been consolidated into a single class of cells for the sake of parsimony.
8.2.3 Expected behaviour of the model
In order to accurately represent the process of lesion formation, we expect the results of our
model to show a number of key characteristics. Firstly, it is vital that we see the formation of
distinct clusters of infected phagocytes which represent lesions. We would expect these to
be static, and roughly spherical in shape (circular in the 2D model). If such solutions were not
possible with the model as it stands, this would demonstrate the need for inclusion of another
process to stabilise clusters as they form, such as the late arrival of fibroblasts to ‘close off’
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clusters. This has been proposed as a hypothetical mechanism for lesion formation.
Secondly, we expect to see lesions which do not grow significantly over time once they
have reached a certain size, and that instead the total number of lesions increases as the
bacterial population increases.
Finally, we would not expect to see infected macrophages or extracellular bacteria mi-
grating between clusters, but rather infected macrophages remain associated with one le-
sion until cell death occurs, and that any intracellular bacteria will either remain associated
with the lesion they originated from (for example, infecting new macrophages which have
been recruited to the lesion) or form new lesions elsewhere.
8.3 Parametrisation
In order to analyse the behaviour of the models described above, it was necessary to fix
the values of some parameters in the model to reduce the overall size of the parameter
space. In many cases, direct measurements have not been taken experimentally, but suitable
estimates can be obtained by using experimentally-derived values for parameters describing
similar systems. In particular, I have used parameters calculated for TNF-α as representative
chemokine parameters in this model, as well as parameters measured for macrophages for
phagocyte parameters. An overview of the parameters is given in Table 8.3.
For their estimate of macrophage diffusion coefficients in their model of atheroscelro-
sis, Hao and Friedman use an experimentally-derived estimate presented by Kim et al for
the diffusion coefficient of glioma cells (10−11cm2s−1) [Kim et al., 2011, Hao and Fried-
man, 2014]. They also use an estimate of chemotactic sensitivity derived by Kim et al.
((1.8− 4.2)× 10−7cm2g−1s−1), also originally for glioma cells. These are used as estimates
for DS and χS respectively.
Yeh et al. calculate values of the diffusion coefficient of macrophages in different cell
densities [Yeh et al., 2017]; all results lie in the range (0.47−0.60)×10−3mm2s−1, suggesting
that the estimate used by Hao and Friedman is reasonably reliable.
For their model of sarcoidosis, Hao et al. estimate the rate of production of TNF-α by
macrophages to be 2.86× 10−3d−1 [Hao et al., 2014]. I have used this as an estimate for rc.
Man et al. demonstrate that following infection, macrophages undergo stiffening and
thereafter experience a reduction in motility [Man et al., 2014a]. They suggest that this
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may be a strategy to reduce infection. Since the chemotaxis and diffusion rates for infected
macrophages and neutrophils have not been formally quantified, I will use this model to
investigate the results upon varying these rates in the following chapters. As a baseline,
I set DI and χI to be equal to zero. This is not necessarily intended to be an accurate
reflection of the processes occurring in vivo, but instead gives a particularly extreme solution
which can be contrasted with solutions when different parametrisations are used (see Figure
8.2).
In their examination of Salmonella pattern formation on agar, Woodward et al. estimate a
diffusion coefficient of 2.8× 10−6cm2s−1, while Furter et al. give an estimate of 0.233µm2s−1
for the diffusion coefficient of bacteria in the colon mucus surface [Woodward et al., 1995,
Furter et al., 2019] . Since these are approximately in the same order of magnitude, I use
the result of Furter et al. as an estimate for Dc.
Ross and Pompano derive estimates for free diffusion coefficients of various cytokines
(including human and murine TNF-α), as well as diffusion coefficients for these cytokines
in lymph node tissue [Ross and Pompano, 2018]. The measured diffusion coefficients for
murine TNF-α in T-cell and B-cell zones are 4.4 × 10−7cm2s−1 and 5.4 × 10−7cm2s−1 re-
spectively. Since these are of the same order of magnitude, I use the former estimate for
Dc.
Brown et al. establish a constant lysis rate of cells independent of bacterial count, and
find the mean number of bacteria released during cell lysis to be 7.16 [Brown et al., 2006]; I
use this as an estimate for N .
Schokker et al. present a model of S. enterica proliferation in chicken intestinal tissue;
they use estimates of the infection rate of macrophages by Salmonella as 0.1d−1, adjusting
this term by including a Michaelis-Menten-like factor to reflect saturation of bacteria uptake by
cells with half-saturation value 6×105cm−3 [Schokker et al., 2013]. I use these as estimate for
β and b1/2 respectively. Schockker et al. also use a lysis rate of infected cells of 0.8d−1, which
is used as an estimate for l, and give a baseline death rate of extracellular Salmonella as
27.8d−1, which is used as an estimate for γb. They also assume that the rate of macrophage
influx is approximately 1% of the initial number of macrophages per day, giving an estimate
of 3× 105cm−3d−1. I use this as an initial estimate for rS , although this is further explored in
the following chapters.
The role of apoptosis in infected cells is debated; similarly to the movement parameters
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(a) Infected phagocyte motion removed (b) Apoptosis removed
Figure 8.2: Baseline model of lesion formation. Infected phagocyte movement and apoptosis
are removed.
for infected cells, I also initially set the apoptosis rate a for infected cells to be zero, not
because this is expected to be an accurate reflection of the processes occurring in vivo,
but rather to give an extreme baseline against which results for other parametrisations can
be compared. The results of varying the apoptosis rate are explored in later chapters. A
summary of the baseline model of lesions modelling is given in Figure 8.2.
The standard set of parameters used for the model is given in Table 8.3.
I have also used estimates derived from literature to set the initial conditions of the models
(the precise spatial distributions will be explained in more detail in Section 10.2).
The density of hepatocytes in pig livers is around 1.47× 106 mm−3 [Junatas et al., 2017].
Hepatocytes account for 60% of the total cell population, while Kupffer cells account for
around 10% [Williams and Iatropoulos, 2002]. Thus I used a mean initial concentration
of 1.47 × 106 ÷ 6 ≈ 2.45 × 108cm−3 for the resident uninfected phagocytes. In the model
developed by Schokker et al., the initial density of Salmonella in tissues is estimated to be
200cm−3; this estimate is also used here.
8.4 Discussion
8.4.1 Summary
In this chapter, I have presented a simple PDE model of lesion formation in the liver during
systemic Salmonella infection, similar to other models of inflammation in a tissue context.
However, unlike other existing models, I have included bacterial dynamics and cell lysis, as
well as allowing movement parameters to differ for infected and uninfected cells, in order to
examine the downstream effects of inflammasome formation. I have described in-depth the
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Parameter Value used Unit Source
DS 8.64× 10−7 cm2d−1 [Hao and Friedman, 2014], [Hao et al., 2014]
DI 0 cm
2d−1 [Man et al., 2014a]
Db 2.01× 10−5 cm2d−1 [Furter et al., 2019]
Dc 3× 10−2 cm2d−1 [Hao et al., 2014],[Ross and Pompano, 2018]
χS 1.61× 10−2 cm4g−1d−1 [Hao and Friedman, 2014], [Kim et al., 2009]
χI 0 cm
5g−1d−1 [Man et al., 2014a]
β 0.1 d−1 [Schokker et al., 2013]
b1/2 6× 105 cm−2 [Schokker et al., 2013]
rS 3times10
5 cm−2d−1 [Schokker et al., 2013]
γS 0.03 d
−1 [Dunster et al., 2014]
γI 0 d
−1 [Man et al., 2014a]
l 0.8 d−1 [Schokker et al., 2013]
a 0 d−1 NA
N 7.16 NA [Brown et al., 2006]
γb 27.8 d
−1 [Schokker et al., 2013]
rc 2.86× 10−12 d−1 [Hao et al., 2014]
γc 55.45 d
−1 [Hao et al., 2014]
Table 8.3: Parameter values used in the spatial PDE model of lesion formation
underlying assumptions and simplifications in this model, as well as criteria for the solutions
of such a model to be regarded as successful. Finally, I have also established a ‘standard’
set of parameters which can be used as a baseline for this model, based on experimental
estimates. In some cases, parameters are not explicitly known, but the results from varying
these parameters will be investigated in future chapters.
8.4.2 Further work
Naturally many simplifications and assumptions have been made to create a model which
balances parsimony and tractability with inclusion of the main important processes in this
system. As a first model, I have aimed for the simplest possible summary of the processes
involved; if this model is shown to be non-optimal, this initial model can then be revised in
the ongoing process of model refinement. Nonetheless, there are some obvious areas which
could be altered in future iterations of this model.
In particular, a clear next step would be to introduce spatial heterogeneity to the domain,
for example, incorporating the tissue structure of the liver by creating separate spatial com-
partments representing lobules of the liver, or defining the location of blood vessels within the
domain. This would require only alteration of the domain on which the model is defined, and
the boundary conditions. However, for the initial modelling process, I decided to use a sim-
ple square domain in order to establish whether interactions with a more complex boundary
were necessary for lesion formation.
It would also be relatively simple to include more different classes of cells to the model;
for instance, differentiating between neutrophils and activated and inactive macrophages.
This could be achieved similarly to the models presented by Dunster et al. and Bayani et
al. [Dunster et al., 2014, Bayani et al., 2020a]. This would be a reasonably easy change to
introduce, but would mostly be important if we were particularly interested in the difference
in behaviour between the subdivisions of the existing variables, which is not the case for this
research.
There are also a number of processes which are not currently included in the model,
which could be added. For example, we could include a source term similar for that of input
of new systemic phagocytes representing the arrival of new bacteria over time. Likewise, we
could use a more biologically accurate function for this source term rather than the constant
input term used in the model presented here. However, we currently know reasonably little
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about the temporal aspects of this process; it might be particularly interesting to consider this
model embedded within a larger model tracking the movement of bacteria and macrophages
between organs in the body. This need only be fairly simple, with a few key organs repre-
sented as separate compartments as in the model developed by Grant et al. modelling the
movement of different bacterial populations between the blood, liver and spleen, combined
with a branching process model of bacterial population growth [Grant et al., 2008a]. A similar
simple within-host model could potentially be coupled with the spatial model presented here
to give more of a organism-level view of the effects of bacterial replication within lesions.
An alternative to the assumption that upon lysis all infected cells release exactly N bac-
teria would be to explicitly include bacterial reproduction within the cell. The class of infected
cells could be divided into subclasses I1, I2, I3, · · · where In is the concentration of cells
containing exactly n bacteria. This could potentially also be coupled with allowing bacteria
to reproduce extracellularly, for example, using logistic growth. While this would be an ex-
tremely interesting extension to the model, the large number of variables introduced greatly
increases the complexity of the model, so in this project I have confined my interest to at
most two classes of infected cells.
Finally, we could allow bacteria to infect cells which have already been infected; analysis
by Gog et al. has already established the reinfection rates of cells which have already been
infected in S. Tymphimurium infection [Gog et al., 2012], so this would certainly be feasible,
although I did not consider this completely necessary for a first model. Likewise, the dynam-
ics of chemokine release could be made more representative of the biological system by the
inclusion of the release of chemokines during lysis and by uninfected cells which have been
in close contact with bacteria (for example, in a manner analogous to macrophage activa-
tion in the model of Dunster et al. [Dunster et al., 2014]). However, it would be useful to
have more experimental data in order to quantify the respective rates of chemokine release
through these processes.
It is worth bearing in mind that some of the limitations in this modelling process are due
to the lack of availability of formal quantitative data describing this system. Many of the
parameter estimates have been taken from other, similar systems; much of the experimental
data on lesion formation consists of two-dimensional images of histological samples, which in
general have not been subjected to a particularly sophisticated level of quantitative analysis.
This therefore demonstrates that this field has great future potential for further collaboration
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between modellers and experimental biologists.
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Chapter 9
Analysis of the spatial model of
lesion formation
9.1 Introduction
While the models presented in Chapter 8 are relatively simple examples of spatial PDE mod-
els, it is still not possible to find analytic solutions. Although I will present numerical solutions
to the models in Chapter 10, it is nonetheless possible to gain some insight into the behaviour
of these models using analytical approaches. In particular, I will examine parametrisations of
the model for which spatial patterning can occur; these naturally-occurring spatial patterns
may be the reason for stable lesion formation. I will use methods similar to those established
by Turing [Turing, 1952], and used in other models of inflammatory response (for example,
[Keller and Segel, 1970, Penner et al., 2012, Bayani et al., 2020a]).
In particular, I will investigate how varying parameters corresponding to processes of
particular interest (apoptosis, and the motility of infected cells) affects the stability of the
solutions, and establish whether spatial patterning can occur. I will also demonstrate that
the stability of the solution is sensitive to the rate of input of uninfected phagocytes into the
system (a parameter for which we do not have a well-established value estimate). I will
demonstrate that spatial patterning is possible only for particular combinations of values for
these parameters, and that the formation of spatial patterning is particularly dependent on
the rates of apoptosis and uninfected cell influx. I will also show that increasing apoptosis
rate increases the overall stability of the model, while increasing the influx of uninfected cells
or the motility of infected cells has a destabilising effect.
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Finally, this analysis allows us to establish estimates for the approximate size of struc-
tures formed during spatial patterning as a function of the parameters in the model; this could
be compared to experimental data to establish which parameter sets are most likely to lead
to lesion-like spatial patterns. Throughout this chapter, I will use the baseline parameter set
established in Table 8.3.
9.2 Stability analysis
9.2.1 Simplified model
We will consider the spatial PDE model of lesion formation presented in the previous chapter:
∂S
∂t
= DS∇2S −∇ · (χSS∇c)− βS
b
b+ b1/2
+ rS − γSS
∂I
∂t
= DI∇2I −∇ · (χII∇c) + βS
b
b+ b1/2









= Dc∇2c+ rcI − γcc
(8.1 revisited)
In order to establish when spatial patterning is possible, we are looking for a possible
state which is spatially inhomogeneous but stable over time. This may arise when a spatially
homogeneous system is perturbed away from a stable steady state, and transport terms
(diffusion and chemotaxis) destabilise the system. We can demonstrate that such an insta-
bility can occur in solutions to our lesion by stability analysis; we first identify a stable steady
state in our system in the absence of transport terms, and then demonstrate that once trans-
port terms are re-introduced some perturbations may grow with time, allowing patterns to
emerge.
Note that, throughout this chapter, I will assume that valid parametrisations of the model
will have all parameters taking non-negative values. Solutions are valid when S, I, b and c
are non-negative for all time.
We write solutions in the form u(x, t) = (S(x, t), I(x, t), b(x, t), c(x, t)).
























= rcI − γcc
The spatially homogeneous system has a unique nontrivial fixed point at u∗ = (S∗, I∗, b∗, c∗)
where S∗, I∗, b∗, c∗ are as follows:
(9.2a)S∗ =
rS(Nl − (l + a)) + b1/2γb(l + a)
(β + γS)(Nl − (l + a))
(9.2b)I∗ =
βrS(Nl − (l + a))− b1/2γbγS(l + a)
(β + γS)(a+ l)(Nl − (l + a))
(9.2c)b∗ =
βrS(Nl − (l + a))− b1/2γbγS(l + a)
γb(β + γS)(l + a)
(9.2d)c∗ =
rc(βrS(Nl − (l + a))− b1/2γbγS(l + a))
γc(β + γS)(a+ l)(Nl − (l + a))
This fixed point corresponds to a steady state in the homogeneous system, in which
bacteria and infected phagocytes exist in equilibrium with macrophages and chemokines.
Note that there is also a disease-free steady state S = rS/γS , I = 0, b = 0, c = 0; this is
the equilibrium in which the system exists in the absence of bacteria or infected phagocytes.
The non-zero value of S here may correspond to the resident macrophage population.
The nontrivial fixed point u∗ exists when the following conditions hold:
(9.3)Nl > l + a
(9.4)b1/2γbγS(l + a) < βrS(Nl − (l + a))
We can apply these conditions to varying a and rS , the two parameters we wish to inves-
tigate further. In particular, if we take all other parameters as in the standard parametrisation





The second condition gives a lower bound for rS when a = 0, i.e. rS > 8.12 × 105.
Note that this condition cannot be satisfied for non-negative a when rS = 3 × 105, as in the
standard parametrisation. Therefore, I will establish a range of values of a and rS which may
lead to spatial pattern formation.
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0 rc 0 −γc

Substituting in the values of b and S at u∗ gives
(9.7)J =

−γS −A 0 −B 0
A −(l + a) B 0
−A Nl −γc −B 0
0 rc 0 −γc








The eigenvalues of J establish the stability of the the fixed point at u∗ in the spatially
homogeneous system; if all eigenvalues have negative real part, the system is stable to
perturbations. This establishes a range of values of rS for each value of a in the range
0 − 4.93 for which the spatially homogeneous system has a stable fixed point, and thus for
which spatial patterning can occur. In order to explore the range of values for which u∗ is
stable in the spatially homogeneous system, I used the eig function in Matlab to find the
largest real part of the eigenvalues of J for combinations of values of a and rS in the ranges
0 < a < 4.93 and 0 < rS < 1013. This shows that instability only occurs for a very close to
the upper limit of 4.93, or for small rS (Figure 9.1). The boundary between the regions for
which the fixed point u∗ in the spatially homogeneous system is stable is complex, but the
majority of parametrisations within the region satisfying Conditions 9.5a and 9.5b also lead
to a stable fixed point. In general, if a < 4.7 and rS > 1.21 × 108 then u∗ is stable. This
establishes the existence of a persistent disease equilibrium if the system is well-mixed (i.e.
there is a stable fixed point for which the bacterial and infected phagocyte populations are
non-zero). It is useful to note that the disease-persistent equilibrium does not exist for large
a or small rS ; if a is too large, all bacteria are removed from the system, and the persistent
infection state is destroyed, while if rS is insufficiently large, phagocytes are depleted from
the system by high levels of cell death, and the infectious steady state cannot persist since
the hosts are eliminated too quickly. In both cases, the system would then tend towards the
disease-free steady state at S = rS/γS , I = 0, b = 0, c = 0.
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Figure 9.1: Largest real part of eigenvalues of the Jacobian J of the spatially homogeneous
system for varying values of the parameters rS (rate of influx of uninfected phagocytes) and
a (apoptosis rate), shown here for rS < 1010. The boundary of the region at which the fixed
point exists is shown by a black line; the fixed point exists for all points to the left of and below
this line. When all eigenvalues have negative real part, the spatially homogeneous system
is stable; this is the case for the majority of values in this plot, with the exception of a very
close to the upper limit of 4.93, or rS very small; the lower limit for rS is around 1.21× 108.
9.2.2 Turing instability analysis
We now return to the full PDE system, with transport terms:
∂S
∂t
= DS∇2S −∇ · (χSS∇c)− βS
b
b+ b1/2
+ rS − γSS
∂I
∂t
= DI∇2I −∇ · (χII∇c) + βS
b
b+ b1/2









= Dc∇2c+ rcI − γcc
(8.1 revisited)
We perturb away from the fixed point u∗ to assess stability of the system once transport
terms are reintroduced. We consider solutions of the following form, corresponding to a
plane wave perturbation:
(9.8)u(x, t) = u∗ + ûeik·x
We assume |û| 1.






where JT is a modified Jacobian including transport terms, evaluated at u∗:
(9.10)JT =

−γS −A− k2DS 0 −B rS + k2S∗
A −(l + a)− k2DI B k2I∗
−A Nl −γc −B − k2Db 0
0 rc 0 −γc − k2Dc

Here, k = |k|. The eigenvalues of JT at each value of k then determine the stability
of the fixed point u∗ following spatial perturbation, with the inclusion of transport terms; in
particular, if the real parts of all eigenvalues are negative, the components of the perturbation
are damped with time, while if any real part of an eigenvalue is positive, the corresponding
mode grows with time, and the system moves away from u∗. This is a necessary condition
for spatial patterning to emerge.
Varying nonspatial parameters
Once again, we investigate the effects of varying the apoptosis rate a, and the rate of influx of
uninfected cells rS , now with transport terms introduced into the system. For all values of a in
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the range 0 < a < 4.93, there are some values of rS which permit instability of the fixed point
u∗ in the spatially inhomogeneous system, while u∗ is stable to spatial perturbations in the
spatially homogeneous system. In particular, for intermediate values of the wavenumber k,
the maximum eigenvalue of the Jacobian JT is positive. In order to establish which parameter
combinations of spatial patterning occur, I used the eig function in Matlab to determine the
largest real part of the eigenvalues of JT for combinations of parameter sets 0 < a < 4.7
and 1.21 × 108 < rS < 1013. Examples of the maximum real part of the eigenvalues of JT
while varying a, rS and k, are given in Figures 9.2 and 9.3 respectively; note in particular
that for all results shown in these figures, the dispersion relations intercept the x-axis at
two points; these give the minimum and maximum values of the wavenumber k for which
patterning is possible. The relationship between these maximum and minimum values of k
and the parameters a and rS are shown in Figures 9.4a and 9.4b, while the range of values
of k permitting pattern formation are shown in Figure 9.4c.
It is important to note that not all combinations of values of a and rS can result in spatial
patterning; once again, the boundary of the region in which spatial patterning can occur is
not simple, but by fitting the edge of the region where patterning occurs in Figure 9.4 using
the Matlab function polyfit we can see that patterning is possible for most values of a and
rS satisfying rS < 1.9356×1011a+1.6949×1011. If a is too large or rS is too small, the system
becomes too stable to admit spatial patterning (in both cases, the bacterial population would
be eliminated).
The stabilising effect of apoptosis is further confirmed by examining the effect of varying
a on the dispersion relations. In particular, increasing a leads to a decreasing overall range
of values of k for which patterning is possible; as a increases, the minimum value of k
permitting patterning increases, and the maximum value of k decreases (Figures 9.2, 9.4a,
9.4b and 9.4c). This suggests that a wider range of wavelengths of spatial patterns are
possible when there is less apoptosis in the system. In contrast, as rS increases, the range
of values of k permitting patterning decreases, with the minimum value of k decreasing
(albeit by a very small amount), and the maximum value of k increasing (Figures 9.3, 9.4a,
9.4b and 9.4c). This suggests that a greater influx of uninfected cells into the system would
have a destabilising effect on the system, allowing spatial patterning for a larger range of
wavelengths.
We can also gain an insight into what sizes of spatial pattern are most likely to occur
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Figure 9.2: Dispersion relations (maximum real part of eigenvalues of the modified Jaco-
bian JT plotted against values of the perturbation wavenumber k) for varying values of the
apoptosis rate a, with standard parametrisation and rS = 1012. For all values of a, the dis-
ease persistent fixed point becomes unstable (the maximum real part of eigenvalues of JT
is positive), and spatial patterning can occur, for intermediate values of the wavenumber k.
The range of values of k for which instability occurs decreases with increasing a; as a in-
creases, the lower boundary increases and the upper boundary decreases. This shows that
apoptosis has a stabilising effect on the system. The dominant mode, marked with a star,
also decreases as a increases, suggesting that spatial structures would become larger as a
increases.
by considering the wavenumber of the dominant mode (i.e. the value of k which leads to
the largest maximum real part of all eigenvalues of JT ). Since we are considering a two-
dimensional system, the wavelength of the dominant mode gives an indication of the size of
spatial patterning we are likely to see [Murray, 1993]. In particular, increasing a decreases
the wavenumber of the dominant mode (which would lead to the formation of larger spatial
structures), whereas increasing rS increases the wavenumber of the dominant mode (lead-
ing to smaller spatial structures); a comprehensive view of the dominant wavenumber over
varying values of a and rS is given in Figure 9.4d. In particular, the dominant wavenumbers
are all in the range 5−50cm−1, suggesting wavelengths of 0.2−2mm. Since we would expect
lesion diameters to be closer to the lower end of this range, this suggests that a parameter
set with a and rS near the boundary of stability might be most likely [Richter-Dahlfors et al.,
1997, Man et al., 2014a].
Varying motility of infected cells
We now turn our attention to the other process of interest, namely the decrease in motility
of infected cells. I have assumed that upon infection, both the diffusion and chemotaxis
coefficients are decreased by a constant factor; in particular, χI = scale × χS and DI =
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Figure 9.3: Dispersion relations (maximum real part of eigenvalues of the modified Jacobian
JT plotted against values of the perturbation wavenumber k) for varying values of the phago-
cyte influx rate rS , with standard parametrisation and a = 2.5. For all values of rS shown
here, spatial patterning can occur for intermediate values of the wavenumber k. The range
of values of k for which instability occurs increases with rS ; the minimum value of k changes
relatively little with varying rS , but the maximum value of k increases with increasing rS . This
shows that the influx of uninfected phagocytes has a destabilising effect on the system. The
dominant mode, marked with a star, also increases as rS increases, suggesting that the size
of spatial structures would decrease with increasing rS .
scale×DS for a motility scale factor (scale). I repeated the analysis carried out in the previous
section, establishing the maximum real part of the eigenvalues of JT for various combinations
of rS and awith values of the motility scale between 0 and 1. Examples of dispersion relations
are given in Figure 9.5.
Unlike the results when varying a or rS , varying the motility of infected cells has little over-
all effect on the stability of solutions; the minimum, maximum and range of wavenumbers
allowing patterning as well as the dominant mode, are broadly unchanged (Figures 9.5, 9.6
and 9.7). Increasing the motility of infected scales slightly decreases the minimum wavenum-
ber allowing patterning, and slightly increases the maximum wavenumber, suggesting that
increasing motility of infected cells would lead to a very slight destabilising effect; however,
surprisingly, varying the motility of infected cells can have a nonlinear effect on the domi-
nant wavenumber of the system, although increasing motility of infected cells overall tends
to increase the dominant wavenumber of the spatial patterns formed.
9.3 Discussion
In this chapter, I have analysed the spatial PDE models for lesion formation established in
Chapter 8. In particular, I have shown that spatial pattern formation can arise for many
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(a) Minimum wavenumber allowing patterning
(b) Maximum wavenumber allowing pattern-
ing
(c) Range of wavenumbers allowing patterning (d) Dominant mode
Figure 9.4: Minimum, maximum and range of values of the perturbation wavenumber k allow-
ing spatial patterning, shown for a range of values of apoptosis rate a and phagocyte influx
rate rS (standard values are used for other parameters). Parameter values in white areas
do not display spatial patterning, since there is no instability upon introduction of transport
terms. For fixed values of rS , increasing a increases the minimum value of k allowing pat-
terning, and decreases the maximum value of k allowing patterning. The viable range of
values of k increases as rS increases, and decreases as a increases. The wavenumber of
the dominant mode generally decreases with increasing a, and increases with increasing rS .
Overall, this suggests apoptosis has a stabiising effect on the system, while phagocyte influx
has a destabilising effect.
Figure 9.5: Dispersion relations (maximum real part of eigenvalues of the modified Jacobian
JT plotted against values of the perturbation wavenumber k) for varying values of a scaling
parameter linking rate of movement of infected and uninfected phagocytes, with standard
parametrisation and a = 2.5, rS = 5 × 1012. The minimum wavenumber allowing patterning
decreases slightly as motility of infected cells increases, and the maximum wavenumber
increases slightly. However, the relative change in minimum and maximum wavenumber are
very small; the dominant mode is also changed very little. This suggests that decreasing the
motility of infected cells has a very slight stabilising effect.
different parametrisations of the model, and I have derived necessary conditions for spatial
pattern formation on the parameters.
Notably, there is a relationship between apoptosis rate and the rate of input of uninfected
phagocytes into the system, which establishes a minimum value for the phagocyte input rate
as a function of the apoptosis rate. This suggests that a high rate of uninfected phagocyte
input may be especially important in the development of lesions, and this process cannot be
excluded from the model. I have also demonstrated that spatial patterning is not possible if
apoptosis rates are too high; this suggests that apoptosis may limit the ability of the system
to form lesions, since it has a stabilising effect on the system. I have also shown that,
surprisingly, changing the comparative motility rates in infected and uninfected cells does not
have a particularly large effect on the ability of the system to form spatial patterns, although
the dominant mode of the resultant spatial pattern is affected. Finally, I have established the
wavenumber of the dominant mode for the parameter sets considered here, which gives an
indication of the size of the resulting spatial structures.
9.3.1 Further work
It would naturally be possible to extend this analysis to consider the stability behaviour when
varying any other parameter in the model, or even to consider a larger-dimensional space
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(a) Minimum wavenumber allowing patterning
(b) Maximum wavenumber allowing pattern-
ing
(c) Range of wavenumbers allowing patterning (d) Dominant mode
Figure 9.6: Minimum, maximum and range of values of the perturbation wavenumber k
allowing spatial patterning, shown for a range of values of the motility scale for infected cells
and apoptosis rate a, with rS = 5 × 1012 (standard values are used for other parameters).
Increasing the motility of infected cells slightly decreases the minimum wavenumber allowing
patterning, and slightly increases the maximum wavenumber allowing patterning as well as
the range of wavenumbers allowing patterning. Increasing the motility of cells also overall
tends to increase the wavenumber of the dominant mode. This suggests that increasing the
motility of infected cells slightly decreases the stability of the system, and increasing motility
of cells may lead to larger wavenumbers in the spatial patterns formed.
(a) Minimum wavenumber allowing patterning
(b) Maximum wavenumber allowing pattern-
ing
(c) Range of wavenumbers allowing patterning (d) Dominant mode
Figure 9.7: Minimum, maximum and range of values of the perturbation wavenumber k al-
lowing spatial patterning, shown for a range of values of the motility scale for infected cells
and the phagocyte influx rate rS , with a = 5 × 1012 (standard values are used for other
parameters). Similarly to the results for varying a (Figure 9.6), increasing the motility of in-
fected cells slightly decreases the minimum wavenumber allowing patterning, and slightly
increases the maximum wavenumber allowing patterning as well as the range of wavenum-
bers allowing patterning. Once again, overall increasing the motility of cells tends to increase
the wavenumber of the dominant mode. This suggests that increasing the motility of infected
cells slightly decreases the stability of the system, and may lead to larger wavenumbers in
the spatial pattern formed.
in which stability can occur by varying multiple parameters at once; however, this analysis
quickly becomes extremely unwieldy and difficult to interpret, so I have confined my interest
to the parameters which are most biologically interesting or for which a reliable estimate is
not available.
Furthermore, the wavenumbers of the dominant modes give an indication of the size of
the spatial patterns which can develop in these systems; these may be directly comparable
to the diameter of lesions in vivo. It would be extremely useful to develop an experimental
dataset including the measured size of lesions in histological samples; this would allow us to
establish further conditions on the parameters varied in this chapter, by demonstrating which
parameters give rise to spatial pattern structures of a similar size to experimentally observed
lesions.
While this analysis has enabled us to establish some bounds on some of the parameters
in the model if lesions are the result of Turing instability-like spatial pattern formation, and
also to gain a clearer insight into which processes might promote or oppose spatial pattern
formation, there are limits to what such an approach allows us to establish. While we can
find the fastest-growing wavenumbers of the spatial patterns which may form, it is still un-
clear what sort of spatial patterns are possible in this system. Furthermore, this analysis
focuses on long-term behaviour of the system rather than demonstrating how the spatial
patterns actually form. In the next chapter, I will therefore present numerical solutions for the




Simulations of the spatial model of
lesion formation
10.1 Introduction
As demonstrated in the previous chapter, stable spatial pattern formation is possible for
some parametrisations of the lesion formation model; this could correspond to the distinctive
spatial arrangement of lesions. However, the analytical work carried out so far can only give
us limited insight into what kinds of patterns are possible in biologically realistic scenarios,
and whether these correspond to in vivo observations of lesion formation. This motivates
further investigation of the possible solutions of these models; since they are not analytically
solvable, I will use numerical integration techniques to approximate solutions for different
parametrisations of the model over space and time.
In this chapter, I will use the insight into stability arising from different parametrisations
from the previous chapter to guide an analysis of the lesion formation models using simulated
solutions. I will explain the methodology used for solving the systems of PDEs in the models,
then present solutions for a variety of parametrisations. In particular, I will demonstrate that
isolated areas of bacteria input can give rise to round, lesion-like areas of concentrated
infected phagocytes, which are stable in size for the first 1-2 weeks of infection, although at
later times these lesions begin to grow in radius at a linear rate. Similarly, infected phagocyte
and extracellular bacteria levels are initially very low, but begin to grow at an approximately
quadratic rate at around 1-2 weeks after the initial infection.
Thus, at least at early times, the solutions for this model coincide with the account of
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lesion growth laid out in Chapter 8. It is likely that other biological processes may intervene,
either during the initial phase of constant lesion size, or early in the growth phase, to prevent
unbounded linear growth. I also establish that increasing the apoptosis rate and decreasing
the phagocyte influx rate may lead to lesions which are stable in size for longer, and grow
more slowly during the growth phase. Meanwhile, the level of motility of infected phagocytes
determines the initial lesion size, as well as the rate of growth during the growth phase.
This suggests that apoptosis and reduction of infected cell motility both play a key role in
stabilising the spatial spread of infection, as well as the bacterial burden, while the influx of
phagocytes must be carefully regulated to prevent infection growth.
10.2 Simulation methods
Once again, we will be considering the spatial PDE model originally presented in Chapter 8:
∂S
∂t
= DS∇2S −∇ · (χSS∇c)− βS
b
b+ b1/2
+ rS − γSS
∂I
∂t
= DI∇2I −∇ · (χII∇c) + βS
b
b+ b1/2









= Dc∇2c+ rcI − γcc
(8.1 revisited)
With the exception of the apoptosis rate a, the rate of influx of uninfected phagocytes rS ,
and the rates of motility of infected cells (the diffusion coefficient DI and chemotaxis rate
χI ), the standard parametrisation established in Chapter 8 is used (Table 10.1).
For simplicity, I set the domain to be a two-dimensional square [0, L]2; while naturally the
tissue in which lesions are formed is three-dimensional, an initial model in two dimensions
simplifies the problem while still allowing spatial patterning in the solutions.
To solve the PDEs in System 8.1, I used the method of lines; this is a standard approach
to numerically solving PDEs by discretising the domain on which they are to be solved, and
approximating the solutions at each point by an ODE system. I discretised the domain using
a n × n grid, with gridlines spaced a distance L/n apart. The concentrations of reactants
are calculated at each point in the grid; in particular, variable X is discretised as Xi,j(t) =
X(( iLn ,
jL
n ), t) for i, j ∈ {0, 1, · · · , L}. The PDE system can then be converted to a system of
ODEs, which can be solved using a standard numerical method. For example, the Laplace
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Parameter Value used Unit
DS 8.64× 10−7 cm2d−1
Db 2.01× 10−5 cm2d−1
Dc 3× 10−2 cm2d−1
χS 1.61× 10−2 cm4g−1d−1
β 0.1 d−1









rc 2.86× 10−12 d−1
γc 55.45 d
−1
Table 10.1: Parameters used in simulations of the spatial PDE model of lesion formation




(Xi+1,j +Xi−1,j +Xi,j+1 +Xi,j−1 − 4Xi,j)
In order to define the reflecting Neumann boundary conditions, we can define the values





This discretisation is mostly straightforward except for the chemotaxis term. It would be
possible to apply a similar scheme to the Laplace operator terms (Equation 10.1); however,
there are often difficulties with smoothness and positivity of solutions in solving chemotaxis-
type terms in PDE systems. In fact, applying a straightforward discretisation scheme to the
chemotaxis terms in this particular system gives rise to negative solutions. This is a well-
documented issue with solving reaction-diffusion-chemotaxis systems numerically [Gerisch
et al., 2001, Gerisch and Verwer, 2002, Gerisch and Chaplain, 2006], particularly when the
chemotaxis parameter is many orders of magnitude larger than diffusion coefficient (as is the
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case with this model). The discontinuities often arise as the system displays concentrated
areas with large abundances, which are difficult to render in a discretised system. Further-
more, the reaction-diffusion terms often lead to a stiff system, which requires a specialised
approach for solving; coupled with the relatively large terms due to chemotaxis, this often re-
sults in very small timesteps, ultimately causing the method to be extremely computationally
intensive.
Here I have chosen to use a method based on an approach designed by Gerisch et al.
[Gerisch et al., 2001]. In particular, this method uses spatial discretisation coupled with a
Van Leer flux limiter [Sweby, 1984], which ensures the positivity of solutions for all time. This
method also uses a splitting scheme to solve the chemotaxis and reaction-diffusion parts of
the equation separately; thus the stiff parts of the PDE can be treated separately using an
appropriate solver, while the solution to the chemotaxis part of the system can be derived
using larger timesteps. The method is broadly as outlined in a previous study [Gerisch et al.,
2001], although I have adapted the method so that the flux is two-dimensional.
The diffusion parts of the equations were discretised using the system outlined above
(10.1). The chemotaxis parts were approximated using the following scheme:
(10.3)∇ · (χX∇c)i,j = F xi,j + F
y
i,j
where F xi,j and F
y
i,j are the fluxes due to chemotaxis in the x and y direction respectively.
These fluxes are functions of the velocities (fxi,j and f
y
i,j) of the reactant X in the x and y
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(fxi+1,j − fxi,j) if (Xi,j > 0 and fi,j < 0)










Here the function Φ(r) is the van Leer limiter function, which ensures non-negativity of
Xi,j .
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Together with the reaction and diffusion parts of the system, this gives a system of ODEs




= f1(u) + f2(u)
where f1 represents the chemotaxis terms and f2 represents the reaction and diffusion
terms. Thus we have separated the ODEs into stiff (f2) and non-stiff (f1) parts. We can now
solve Equation 10.7 using an iterative process as follows:
Suppose an estimate u∗ for the solution of System 10.7 is known at time t∗. We define a
series of variables z1(t), z2(t), z3(t) as the solutions to the following equations:
(10.8)
dz1
dt = f1(z1) z1(t
∗) = u∗
dz2




dt = f1(z3) z3(t
∗ + τ/2) = z2(t
∗ + τ)
The calculated solution for z3(t∗+ τ) can then be used as an approximation for u(t∗+ τ).
Note that since only z2 relies on integrating f2, this step is the only part of the problem which
requires solving the stiff system resulting from reaction-diffusion terms, whereas deriving z1
and z3 relies only on the chemotaxis terms. This scheme can be applied iteratively, using
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the ICs for the model to give the initial values of u∗, using a stiff ODE solver to solve the
equation for z2, and a non-stiff ODE solver to solve the equations for z1 and z3.
I used this technique for a 100 × 100 grid in Matlab, using a simple fourth-order Runge-
Kutta approach to solve the equations in System 10.8 involving f1, and the ODE15s function
to integrate the equations involving f2. For the latter case, the system is very large, so it is
necessary to use a sparse Jacobian both for speed and maximum memory considerations.
Overall, this method was successful at keeping solutions positive but still efficient. I ran
simulations for various parameter values and initial conditions from 0 to 30 days - lesions
should be well established by around 1 week following infection, but it was also useful to
examine the longer-term behaviour of the system.
Once I had generated a simulation for a particular parameter set, I isolated the size of the
lesions at each timepoint by converting the infected phagocyte concentrations into a binary
image representation using the Matlab function imbinarize; this isolated areas of high con-
centration, which were deemed to lie within a lesion. I also tracked the total concentrations
of infected phagocytes and extracellular bacteria over time, in order to analyse the growth
of infection. This was accomplished simply by integrating the respective variables over the
spatial domain at each timepoint.
10.3 Results
10.3.1 Results for basic parameter set
I initially ran simulations for a 1mm × 1mm square, with an initial bacterial density of zero
everywhere except at the centre of the grid, with one square set to a density of 200cm−2
(Figure 10.1). Over time, a concentrated area of infected phagocytes and bacteria appears
in the centre of the domain, around the point at which bacteria are initially introduced (Figure
10.2). Uninfected phagocyte concentration in this central area is comparatively very low,
although chemokines are also concentrated in this area, and there is also a diffuse area of
lower levels of chemokine radiating outward from the centre of the area of highest concen-
tration. This defined area of phagocytes and bacteria corresponds well to the definition of
a lesion outlined previously (note that the area of infected phagocytes is slightly larger than
the area of bacteria, suggesting that the bacteria are confined by infected phagocytes). We
only see one lesion-like area forming, with no seeding of further lesions across the domain.
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The size of the lesion is approximately constant at early times (until around 1-2 weeks
post-infection). Thereafter, the lesion begins to grow at an approximately linear rate over time
(Figures 10.3 and 10.4). I will refer to these distinct phases in the infection as the ‘plateau’
and ‘growth’ phases. The concentration of bacteria and infected phagocytes at the centre of
the lesion becomes very high at later times, increasing exponentially to the point that the stiff
ODE solver is unable to execute a timestep within an accuracy tolerance of 3 × 1014. Thus,
the reaction system becomes too stiff even for a robust stiff ODE solver such as ode15s.
Up to the point that the ODE solver fails, we also see the total concentration of infected
phagocytes and bacteria increasing over the first thirty days of infection; after an initial period
during which time both concentrations are very low, both begin to increase approximately
quadratically (Figure 10.5). There are therefore ‘plateau’ and ‘growth’ phases for the total
concentrations of bacteria and infected phagocytes, analogous to those observed for the
lesion size.
These results suggest that with the standard parametrisation, the model quickly reaches
a reasonably stable state which appears similar to experimental accounts of lesion formation.
However, at least for this domain and the bacterial initial conditions tested here, this spatial
structure is ultimately unstable. This suggests that we do not, in fact, see stable spatial
patterns as suggested by the Turing instability analysis of the previous chapter. The infected
phagocytes and bacteria are spatially arranged much as we would expect for lesions during
the initial plateau period, when the lesion size is constant, although they are somwhat smaller
than experimental observations (around 25-100 µm [Richter-Dahlfors et al., 1997, Man et al.,
2014a]). However, following this plateau, the lesion-like areas grow linearly over time, rather
than remaining limited in size and seeding further lesions elsewhere. This late-stage growth
has not been observed experimentally, but it is worth noting that this growth phase tends
to occur fairly late during the infection, and it is possible that another process intervenes
to stabilise the growing lesions and prevent further growth (for example, the introduction
of fibroblasts, which have not been included in this model, or the intervention of adaptive
immune responses at later times).
In order to be able to compare simulation results easily between different parametrisa-
tions, and to be able to divide the solutions into plateau and growth phases, I fitted a bilinear
model to the calculated lesion radius over time (Figure 10.4). This was very similar to the
bilinear fit carried out in Chapter 6 on the traces extracted from the time series showing in-
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(a) Uninfected phagocytes (b) Infected phagocytes
(c) Bacteria (d) Chemokine
Figure 10.1: Initial conditions for simulations of the spatial PDE lesions model. Uninfected
phagocytes are initially uniform randomly distributed with mean 2.45 × 108cm−2. Bacteria
concentration is zero everywhere except for one cell in the centre of the domain with con-
centration 200cm−2. Infected phagocyte and chemokine concentrations are zero throughout
the domain.
(a) Uninfected phagocytes (b) Infected phagocytes
(c) Bacteria (d) Chemokine
Figure 10.2: Results from lesion formation calculated numerically, with apoptosis rate
a = 2.5, phagocyte influx rate rS = 2 × 1011 and no movement of infected phagocytes,
10 days from start of infection. Bacteria and infected phagocytes are confined in a roughly
circular area, from which uninfected phagocytes are largely absent; chemokines are also
concentrated in this area, but diffuse outwards. This area corresponds to a lesion.
(a) Day 5 (b) Day 10
(c) Day 15 (d) Day 17
Figure 10.3: Concentrations of infected phagocytes between 0 and 17 days post-infection
calculated numerically, with apoptosis rate a = 2.5, phagocyte influx rate rS = 2 × 1011 and
no movement of infected phagocytes. The area of infected phagocytes is centred around
the input of bacteria and is roughly circular, and initially very small, although growth begins
to occur at around day 8 post-infection.
flammasome growth, although I assumed the lesion radius is constant for the initial phase.
The model is as follows:
(10.9)ri = β0 + β1(ti − tb)+ + εi
where ri is the ith measurement of the lesion radius, ti is the ith timepoint, tb is the
breakpoint, and εi is a normally-distributed random error for the ith measurement.
Once again, (ti − tbj )+ is defined as follows:
(ti − tbj )
+ =

ti − tbj if ti > tbj
0 otherwise
(2.2 revisited)
β0 then corresponds to the size of the lesion during the plateau phase, the breakpoint tb
marks the end of the plateau phase and the start of the growth phase, and β1 represents the
growth rate during the growth phase.
I carried out a similar fit for the total concentration of infected phagocytes and bacteria; in
this case, however, I assumed that the concentration during the first section is zero, and in-
creases quadratically in the second section (this gives a closer match to results than bilinear
or exponential fits). The model is as follows:
(10.10a)Itoti = βI(ti − tIb)+ + εIi
(10.10b)btoti = βb(ti − tbb)+ + εbi
where Itoti and b
tot
i are the ith measurement of the total infected phagocyte and bacteria
concentrations respectively, tIb and t
b
b are the calculated breaktimes for infected phagocytes
and bacteria, and εIi and ε
b
i are the errors for the ith measurement of infected phagocytes
and bacteria. In this case, βI and βb are the growth rates during the growth phase, and tIb
and tbb are breakpoints between the plateau and growth phases. Note that I do not assume
that the breakpoints tb, tIb and t
b
b are equal.
Examples of the fits are given in Figures 10.4 and 10.5.
10.3.2 Varying apoptosis rate and phagocyte input rate
In order to discern the effect of varying the apoptosis rate a and the phagocyte input rate
rS , I fitted the bilinear models described above to the lesion area, the total concentration of
infected phagocytes, and the total concentration of bacteria over time for simulated results
for a range of values of a and rS , with no movement of infected phagocytes. I determined the
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Figure 10.4: Radius of lesion between 0 and 15 days post-infection (shown in purple), ex-
tracted from numerical solutions of the PDE model, with apoptosis rate a = 2.5, phagocyte
influx rate rS = 2 × 1011 and no movement of infected phagocytes. After the initial plateau
phase, the lesion grows over time at an approximately linear rate (growth phase). A fitted
bilinear model with constant first section is shown in green.
(a) Infected phagocytes (b) Bacteria
Figure 10.5: Total concentration of infected phagocytes and bacteria between 0 and 19 days
post-infection (shown in purple), extracted from numerical solutions of the PDE model, for
apoptosis rate a = 2.5, phaogcyte influx rate rS = 2 × 1011 and no movement of infected
phagocytes. Following an initial plateau phase during which the number of infected phago-
cytes and bacteria is approximately zero, the populations of both infected phagocytes and
bacteria begin to grow at an approximately quadratic rate (growth phase). A bilinear fit with
first section zero and second section quadratic is shown in green.
range of values of a and rS to be used from the Turing analysis carried out in the previous
chapter. The results are shown in Figures 10.6 and 10.7.
The lesion size throughout the infection is sensitive to changes in both a and rS (Figure
10.6). While there is no clear relationship between a or rS and the size of the lesion during
the initial plateau, the length of the plateau phase is certainly dependent on a and rS ; for
larger values of a and smaller values of rS , the time spent in the early plateau phase is
longer. This suggests that higher rates of apoptosis and lower rates of phagocyte influx lead
to lesions which remain at a small, stable size for longer before linear growth begins. The
rate of this linear growth increases as a decreases and rS increases, suggesting again that
for higher apoptosis rates and lower phagocyte influx rates, the eventual rate of lesion growth
is slower. Likewise, the maximum time reached by the solver is higher for higher a and lower
rS since a slower rate of lesion growth is likely to result in a longer time before the solver
fails.
The growth of infection is also sensitive to a; as a increases, the fitted breaktimes (i.e.,
the end of the initial plateau) for both infected phagocytes and bacteria increase. There is
no clear relationship between the length of the plateau phase and rS . This suggests that
for higher apoptosis rates the overall levels of infection remain low for longer. On the other
hand, the rate of the final increase decreases as a increases, and once again there is no
clear relationship with rS . This suggests that when the lesions do begin to increase in size,
this occurs at a slower rate when apoptosis rates are higher.
Similar results are observed for the total concentrations of bacteria and infected phago-
cytes (Figure 10.7); the breaktimes for both variables increase as a increases, and the final
growth rate decreases as a increases. This suggests that for higher rates of apoptosis, the
infection level remains stable for longer, and the growth of the infection during the growth
phase is slower.
Note that the breaktimes for the bacterial and infected phagocyte concentrations are
generally earlier than those for lesion growth, especially when a is large, although there is
a strong correlation between these three variables (Figure 10.8). This suggests that lesion
growth occurs after, and presumably as a result of, the expansion in infected phagocyte and
bacteria populations.
Overall, these results suggest that high rates of apoptosis and lower rates of phagocyte
influx are favourable for keeping the system in the initial plateau phase, during which lesions
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(a) Initial plateau level (b) Breaktimes
(c) Final slope (d) Maximum time reached
Figure 10.6: Lesion size results while varying apoptosis rate a and rate of phagocyte influx
rS , with no motion of infected phagocytes. Results are extracted from numerical solutions of
the PDE model. The initial plateau level is independent of a and rS . The breaktimes (i.e. the
end of the plateau phase) increase with increasing a. The final lesion growth rate increases
as a decreases and increases slightly as rS decreases. The maximum time reached before
the solver fails increases as a increases and decreases as rS increases. This suggests that
the lesion remains in the plateau phase for longer for larger a and smaller rS .
are limited in size, and bacteria and infected phagocyte levels are low; the rates of growth
at later times are also slower for higher apoptosis rates. This suggests that higher levels
of apoptosis in the system are more likely to lead to stronger control of infection. However,
perhaps counter-intuitively, the influx of immune cells appears to be beneficial to the spread
of infection, since this supplies more possible hosts for bacteria. Although we do not see a
precise analogue of Turing patterning in this system, these results concur with the results
from the previous chapter (apoptosis contributes to the stability of the system, phagocyte
influx contributes to instability).
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(a) Breaktimes (infected phagocytes) (b) Final slope (infected phagocytes)
(c) Breaktimes(bacteria) (d) Final slope (bacteria)
Figure 10.7: Infection level results while varying apoptosis rate a and rate of phagocyte influx
rS , with no motion of infected phagocytes. Results are extracted from numerical solutions
of the PDE model. The breaktimes (i.e. the end of the plateau phase) for both infected
phagocytes and bacteria increase with increasing a, and decrease slightly with increasing
rS . The final growth rate for both bacteria and phagocytes increases as a decreases. This
suggests that the levels of infection remain low for longer, and final growth rates are lower,
for larger a.
(a) Lesion size vs infected phagocytes (ρ =
0.920) (b) Lesion size vs bacteria (ρ = 0.921)
(c) Infected phagocytes vs bacteria (ρ = 0.998)
Figure 10.8: Correlations between length of plateau phase for growth in lesion size, total in-
fected phagocyte concentration and total bacteria concentration. Results are extracted from
numerical solutions of the PDE model. All three variables are strongly correlated, though
not identical (breaktimes for infected phagocyte and bacteria concentrations occur later);
Spearman’s rho is given for all, p < 10−8 in all cases.
10.3.3 Varying movement parameters for infected phagocytes
Following analysis of the apoptosis and phagocyte influx rates, I then repeated the anal-
ysis with different values of a parameter scale relating the movement rates of phagocytes
prior to and subsequent to infection; in particular, as in Chapter 9, DI = scale × DS and
χI = scale×χS . Unsurprisingly, varying the motion of infected phagocytes has a clear effect
on the geometry of lesions. While the relationships established in the previous section be-
tween a, rS and lesion growth still hold, the overall size of the lesion and the rate of growth
vary depending on the rate of infected phagocyte motility (example results for a = 2.5 and
rS = 2× 1011 are given in Figure 10.9 but the following conclusions hold for other parametri-
sations). In general, the size of lesions during the plateau phase increases as the motility
of infected phagocytes increases; likewise, with the exception of some simulations run for
very low motility, the slope during the growth phase increases as infected phagocyte motility
increases. This is unsurprising, since a higher level of motility of infected phagocytes will
lead to more spread away from the centre of the lesion area. However, in general, the break-
times and maximum time reached are approximately constant as the motility of infected
phagocytes is varied. Similar results are observed for the total concentrations of bacteria
and infected phagocytes; in particular, breaktimes are generally constant as motility of in-
fected phagocytes varies, and rate of growth during the growth phase increases as motility
of infected phagocytes increases.
This suggests that decreasing the motility of infected phagocytes has the overall effect of
reducing the size of lesions during the plateau phase, and reducing the growth rate of lesions
during the growth phase (and likewise, the rate of growth of bacteria and infected phagocyte
populations). Note that there are some unusual results for very low infected phagocyte
motility (very high final slopes, and relatively low breaktimes and maximum time reached).
This may suggest that it is in fact optimal for phagocytes to have low, but non-zero, motility
following infection, although it is not clear why this might be the case, and this is possibly an
artefact of the simulations. However, it is clear that the reduction of cellular motility observed
following infection (see [Man et al., 2014a]) is important for reducing both the spatial spread
and overall bacterial burden of the infection.
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(a) Initial plateau level (b) Breaktimes
(c) Final slope (d) Maximum time reached
(e) Breaktimes (infected phagocytes) (f) Final slope (infected phagocytes)
(g) Breaktimes(bacteria) (h) Final slope (bacteria)
Figure 10.9: Effects of varying motility of infected phagocytes on lesion growth, shown here
for apoptosis rate a = 2.5 and phagocyte influx rate rS = 2×1011. Results are extracted from
numerical solutions of the PDE model. The level of the initial plateau increases as motility
scale increases, i.e., lesion size during the plateau phase increases as infected phagocytes
become more mobile. Following an initial spike, the final growth rate of lesion area, infected
phagocyte population and bacteria population increases as the motility of infected phago-
cytes increases. In general breaktimes are not affected by the motility of infected cells.
10.4 Discussion
10.4.1 Summary
In this chapter, I have outlined a methodology for simulating the results of the model pre-
sented in Chapter 8, and presented the results for a range of different parametrisations.
Even in this simple model, we can see stable lesion-like structures which persist during
the first few weeks of infection; this demonstrates that lesions may form simply due to the
balance of infection, phagocyte influx, lysis and apoptosis. Infected bacteria and phagocytes
are concentrated in round areas which are reminiscent of lesions. However, at later times,
these areas grow over time in a linear fashion, with the concentration of bacteria and infected
phagocytes in the centre of the lesion increasing exponentially, until the ODE solver used to
calculate results fails. This is growth phase is not seen in experimental systems; it is possible
that the parameters in the model are such that stability is maintained long enough for another
biological process to prevent growth at later times (the arrival of fibroblasts which ‘close off’
the nascent lesion is a possible explanation). Furthermore, seeding of new lesions does not
occur.
I have shown that the length of the initial plateau phase, and the rate of growth of lesions
at later times, is considerably slowed when apoptosis is included in the system. On the other
hand, increasing the influx rate of phagocytes generally has a destabilising effect, leading
to faster onset of lesion growth and more rapid lesion growth and bacterial burden at later
times. This suggests that a balance between apoptotic and lytic cell death, as well as influx
of uninfected phagocytes, is an important factor in maintaining lesions and reducing overall
bacterial load.
I have also shown that increasing motility of infected cells increases the size of lesions
early in infection, and the growth rate of lesions, infected phagocytes, and bacteria during
the growth phase; this confirms that reduction of motility in infected cells plays an important
role in reducing the spatial spread of infection, as well as the bacterial burden, to keep the
level and spread of infection at a lower level before other processes intervene.
10.4.2 Further work
The model of lesion formation as it stands may give an account for why stable lesions are
observed at early times, up to around 1-2 weeks post-infection, but the sharp rate of growth
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of lesions thereafter is unexpected; it is unclear whether other biological systems might
be interfering to prevent the growth at later times (for example, the action of fibroblasts,
or the initiation of the adaptive immune response), or whether instead this is merely an
artefact of the mathematical model which does not arise in the biological system. In order to
investigate this further, there are a number of more immediate steps which may be carried
out without further alteration of the model itself. Firstly, it may be useful to run the simulations
again with a different method of lines scheme, to ensure that the rapid growth at late stages
is not an artefact of the solver used here. Furthermore, the standard parametrisation as
established in Chapter 8 is mostly based on comparisons to similar systems; in particular,
I have focused on varying the apoptosis rate, the rate of phagocyte influx, and the motility
of infected phagocytes. A useful next step may be to explore the parameter space of the
model more thoroughly, in order to establish whether lesion-like results can be established
for any parametrisation. This may also explain why the observed lesions in the solutions for
this model are smaller than expected.
It may also be worth investigating different choices of initial condition, especially since at
no point did we see new lesion structures forming — in particular, when there are multiple
sources of bacteria. This would allow us to determine whether multiple lesions form in this
system, and whether they interact.
It is also worth investigating further why the trends in behaviour of the system as motility
of infected phagocytes decreases do not hold when motility of infected phagocytes is close
to zero. Once again, this may be an artefact arising from inaccuracies in the ODE solving
system used, or in breakpoint fitting; however, if these anomalies persist even with differ-
ent methodologies, this may suggest that it is in fact not optimal for infected phagocytes to
become completely immobile.
Finally, so far the results from this modelling project have not been formally compared
to experimental data. An ideal dataset would be stained histopathological samples of liver
tissue at different timepoints during infection, with lesions identified and their size and dis-
tribution through the tissue formally quantified. The availability of a good-quality dataset will
be vital to the further development of models in this field.
Improvements to the existing model and suggestions for further work will be discussed in
more detail in the following chapter.
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Chapter 11
Discussion of tissue-level modelling
of lesion formation
In the preceding chapters, I have established a novel spatial PDE model of lesion formation
in the liver following Salmonella infection; the model focuses particularly on the effects of
lytic cell death of infected phagocytes, and the differences in motility between infected and
uninfected phagocytes. In this chapter I will explain how the results from this model affect
our understanding of lesion formation, and suggest possible extensions to the model which
may be useful.
11.1 An account of the formation of lesions during Salmonella
infections
Both analytical, Turing instability-style analysis and numerical solutions of the spatial PDE
model of lesion formation show that round, lesion-like structures can form spontaneously as
a result of the interplay between influx of phagocytes, chemotaxis, and a balance between
apoptotic and lytic cell death. This is in contrast to the existing models of inflammation, which
tend to focus on the overall bacterial burden as a result of infection rather than the spatial
structures formed, and in general do not include bacterial release due to phagocyte lysis, or
differentiate between the motility of infected and uninfected phagocytes.
A key feature of the simulated solutions to this model is that lesion-like spatial structures
are stable in size for the first 1-2 weeks following infection (‘plateau phase’). The extracellular
bacteria and infected phagocyte population levels are also relatively low during this time.
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However, following this initial plateau, there is a rapid (approximately quadratic) increase in
infected phagocyte and bacteria concentration, followed by a linear increase in lesion size
(‘growth phase’). While this growth phase has not been observed experimentally, it tends
to occur fairly late in the infection, so it is possible that other biological processes intervene
to prevent unlimited growth; however, parametrisations which lead to solutions with longer
plateau phases, and lower growth rates during the growth phase, are more likely to reflect
overall stability of lesions.
This characterisation of lesion formation is in contrast to previous modelling studies of
inflammatory response which do consider spatial structure (in particular, [Pigozzo et al.,
2012] and [Bayani et al., 2020a]); these generally show gradual growth of the infected area
over time, without a distinct initial lag. It is also notable that the model presented here does
not separate the class of phagocytes into neutrophils and active or inactive macrophages
(as most existing models do); while the model is therefore unable to capture some of the
subtleties of the roles of these different classes of cells, nonetheless the distinction between
these roles is not necessary for the development of lesion-like structures.
The length of the initial plateau and the growth rate of the lesion area during the growth
phase (as well as the size of infected phagocyte and bacteria populations) are sensitive to
the apoptosis rate, the rate of influx of phagocytes, and the motility of infected phagocytes.
In particular, the plateau lasts for longer, and the final growth rate is slower, for higher apop-
tosis rates; this suggests that apoptosis has an important stabilising effect on the system,
dampening growth and spatial spread of bacteria. In contrast, the plateau becomes shorter
as the rate of phagocyte influx increases. The growth rate during the growth phase is also
lower for higher levels of apoptosis. Overall, these results suggest a critical balance between
apoptotic and lytic cell death in controlling infection both spatially and in terms of the overall
bacterial burden; it also suggests that the influx of phagocytes from the bloodstream must
be carefully controlled to avoid providing too many hosts for bacteria.
It is worth considering, especially in the light of the stabilising effect demonstrated for
apoptosis, why lytic cell death takes place at all; in this simple model, there is no real benefit
for the host for lytic, rather than apoptotic, cell death taking place. It is worth bearing in mind
that in biological systems, lytic cell death releases a large concentration of cytokines (and
possibly inflammasomes) which promote further inflammation. This was not included in the
current model due to lack of quantification of ‘burst’ release of chemokines, but may be a
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useful factor to build into future models.
Another important result is that increasing infected phagocyte motility leads to larger
lesions during the plateau phase, and faster growth of lesions (as well as overall infected
phagocyte and extracellular bacteria populations) during the growth phase. This supports
the hypothesis previously suggested in a study of cellular stiffening carried out by Man et al.,
that a reduction of motility in phagocytes following infection and inflammasome activation is
an important factor in limiting spatial spread and population growth of bacteria and infected
cells [Man et al., 2014a]. On the other hand, it is worth noting that the Man et al. study
shows an increase in the number of lesions in systems with NLRC4 knockout cells (which do
not show full inflammasome activation — thus, cell motility is not decreased upon infection of
these cells); it is not clear whether the lesions differed in size between wild-type and knock-
out samples. This would be worth investigating further, both using mathematical modelling
techniques (i.e., developing a model in which seeding of new lesions can take place), as well
as carrying out further experimental work to establish explicit measurements of lesion size
and distribution for wild-type and NLRC4 knockout systems, at different timepoints during
infection.
There are a number of possible reasons for the late time growth phase of lesion size
and bacterial burden seen in the model presented here. Firstly, it may simply be an artefact
of this particular model. Secondly, other biological process could be intervening before the
growth phase can take place; for example, fibroblasts could surround the lesion, preventing
further growth. However, this would not prevent the sharp growth of bacteria and infected
phagocyte populations. It is also possible that adaptive immune processes are engaged
at later time points. Another possible explanation is that the lesion has reached a critical
size or concentration, but there is no mechanism for new lesions to be formed instead of
bacteria remaining associated with the originating lesion. In particular, note that for the initial
conditions used here (one single initial point of bacterial infection) we see the formation of
only one lesion. This is in contrast to observed experimental data, in which we see that
lesions certainly seed the formation of further spatially distinct lesions. It is possible that the
continuous deterministic model presented here is unable to capture instances of bacterial
‘escape’ from existing lesions, as this may be a somewhat rare event limited to a small
number of bacteria. This would relieve the intense concentration of bacteria and infected
phagocytes which builds up in the centre of the lesion in the spatial PDE model. This theory
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would also explain why the growth phase of the lesion begins after the bacteria and infected
phagocyte populations begin to grow. These are certainly considerations which could be
investigated in future modelling, either by including more variables in the model (for example,
a variable representing fibroblast concentration) or by creating a discrete stochastic version
of the model (which may be able to represent bacterial ‘escape’).
11.2 Further work
There are a number of possible further directions for the work presented here. Many of
these centre around possible adjustments which could be made to the model as presented
previously; this is a natural stage in the process of model evolution. It will be particularly
important to investigate aspects of the results which do not concur with experimental ob-
servations — for example, the presence of a growth phase for lesion size and bacteria and
infected phagocyte population size.
One key simplification made in the construction of this model was the representation of
bacterial dynamics. In particular, I have excluded extracellular bacterial replication in this
initial model. In order to render the bacterial dynamics in the model more accurately, the















Here, rb is the initial growth rate and B is the carrying capacity. This representation of
the extracellular bacterial population has previously been used elsewhere, and values of rb
and B have been estimated based on experimental data (see, for example, [Schokker et al.,
2013]); a term of this form was not included in the initial model since it leads to considerably
more complex dynamics than in the simple model presented here. In particular, there would
be multiple fixed points in the spatially homogeneous system, and a full bifurcation analysis
would be necessary before Turing instability analysis could take place.
It would also be possible to expand the bacterial replication dynamics within infected
phagocytes. The class of infected cells could be divided into subclasses I1, I2, I3, · · · where
In is the concentration of cells containing exactly n bacteria. The rates of reproduction of
bacteria have been shown to be dependent on the current bacterial load in the cell; in par-
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ticular, the rate of reproduction when there are n bacteria is αn = α0e−αen where α0 and
αe are constants which have been calculated in the case of S. enterica infection [Brown
et al., 2006]. It would therefore be fairly straightforward to include a term moving infected
cells from the class In to In+1 with this rate. This would lead to a much larger model (in
particular, with a large number of infected phagocyte classes), and analysis would be cor-
respondingly more laborious; however, this may be useful to gain a deeper understanding
of the balance between bacterial replication within the cell, bacteria release upon lysis, and
bacterial proliferation outside the cell.
Another possible alteration to the model would be adding another process which sta-
bilises lesion formation at a late stage, to prevent explosive growth occurring. For example,
adding fibroblasts to the model would be particularly useful to examine the hypothesis of
whether fibroblasts stabilise and surround nascent lesions, and in particular, whether the
inclusion of fibroblasts in the model can avert the late growth stage observed in the solutions
for the current model.
The input term for phagocytes is currently set to be constant throughout the domain; this
is a somewhat unrealistic depiction of the input of phagocytes from the bloodstream, since
this is likely to be localised to areas surrounding a blood vessel. The limitation of uninfected
phagocyte input to areas where chemokines are present may also be partially responsible
for why seeding of new lesions is not observed in this model. The localisation of phagocyte
input could be built into a simulation by including a spatial representation of the blood vessel
network overlaid on the domain, and allowing phagocytes to enter the domain only from
points on this network, possibly at a rate proportional to the concentration of chemokines
integrated over the entire domain, or some local neighbourhood of the point of entry (a similar
technique has been used elsewhere - see, for example [Pigozzo et al., 2012]). However,
such a model would be less amenable to methods of analysis used in Chapter 9.
Another key issue is that the square domain used here, although a simple option which
could be used initially, is a poor reflection of the architecture of liver tissues. Rerunning
simulations with a more realistic domain architecture may lead to more realistic results - for
example, a hexagonal domain would be a better representation of the structure of hepatic
lobules. It would also be useful to adjust the simulations to explore the behaviour of the
model in three dimensions; once again, a two-dimensional representation was a useful first
step but ultimately this is not a good representation of the liver tissue, and adding a third
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dimension may substantially change the dynamics of the system and the final spatial pattern
formed.
Finally, as described above, some of the processes in the spatial PDE model may be
clarified by switching to a discrete stochastic representation. This may be able to capture
seeding of new lesions from existing lesions through bacterial ‘escape’. Furthermore, the
exact size of the lesion may be easier to determine, unlike in the spatial PDE model; for
much of the spatial domain the concentrations of all variables is greater than zero for all time,
but at many points the concentration is extremely low. This is an artefact of the continuous
model, and many of these concentrations are so low that in reality they would correspond
to an absence of the corresponding reactant. To delineate the lesion area in the continuous
solutions for the PDE model, it was therefore necessary to divide the domain into ‘lesion’
and ‘not lesion’ using a somewhat arbitrary threshold.
The discrete stochastic version of the spatial PDE model need not be as complex as the
ABMs outlined in Chapter 1 (in particular, the models developed by Shi et al. [Shi et al.,
2016a, Shi et al., 2016b]). It would be sufficient to track infected and uninfected phagocytes
and bacteria as agents in the model, executing a random walk (biased by chemokine levels)
on a two-dimensional grid similar to the spatial domain used here and undergoing reactions
using a Gillespie-like algorithm similar to that outlined for simulations of the stochastic model
of inflammasome formation (see Chapter 5 in particular). Chemokines could be tracked
as a background continuous variable, since they are likely to be present at much higher
abundances than phagocytes or bacteria. A similar technique to that oulined for the in-
flammasome formation simulations could be used to understand how varying parameters in
the model affects results; in particular, characteristics of each simulation run (for example,
number and size of lesions at specific times, or rate of increase of bacteria and infected
phagocytes) could be derived for a set of simulations across a range of parametrisations,
and the resulting characteristic statistics compared. It would also be possible to prevent
overcrowding of cells (which would certainly be an issue with the concentrations arising at
late times in the spatial PDE model) by, for example, setting a maximum number of agents
allowed to occupy a point in space.
Looking beyond alterations to the spatial PDE model, a further possible extension would
be to unite the lesion model presented here with both smaller-scale (within-cell) and larger-
scale (organ or host level) modelling. It would also be greatly beneficial to the development
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of further models in this field to produce a comprehensive dataset of lesion formation over
time; this would allow the model to be parametrised more accurately, as well as providing a
concrete reference to test the model’s performance. Both of these issues are very broad in




As outlined in the introduction chapter, the very broadest aim of this research was to improve
our understanding of the innate immune response to Salmonella infection through the use
of mathematical modelling techniques. Within this broad aim, I focused on two specific
questions related to distinct, though related, innate immune processes. The first question —
how does the inflammasome form? — was addressed in the early chapters of this thesis.
The second question — why do lesions form? — was addressed in the latter chapters of
this thesis. The results of the research presented go some way towards answering these
questions, but they are by no means fully resolved. In the previous discussions (Chapters
7 and 11) I summarised the conclusions from the inflammasome signalling models and the
lesion formation model separately, as well as considering the limitations of the approaches
used, and suggesting short-term aims for future work. In this final chapter, I will take a
broader view; I will discuss the wider implications of the work presented in this thesis as a
whole, as well as avenues for future investigation for which this research may serve as a
foundation.
12.1 Implications of research
There are clear differences between the broader implications of the two research questions
explored in this thesis, mainly due to the fact that the fields of inflammasome signalling and
the study of innate immune response to infection at the tissue level are somewhat different.
In particular, in addressing the problem of inflammasome formation, there were virtually
no existing models to build on, with the exception of the fairly simplistic model proposed by
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Cheng et al. [Cheng et al., 2010], whereas numerous models of inflammation due to infection
at a tissue level have been constructed already (in particular, the work of Shi et al. [Shi et al.,
2015a, Shi et al., 2016b, Shi et al., 2016c], which explicitly considers Salmonella infection in
the liver). Therefore, the construction of a model of inflammasome formation is particularly
significant, as it provides an initial framework for the interplay between experimental work in
this field and mathematical or computational approaches, while the model of lesion formation
builds on existing modelling literature, albeit with a different emphasis to many of the models
constructed previously.
The purposes of the inflammasome formation and lesion formation research presented
here were also subtly different. The reasons for creating models of inflammasome formation
were to integrate existing experimental observations, and to challenge the accepted wis-
dom which had arisen from experimental work. In contrast, the aim of the lesion formation
research was to draw attention to an unusual aspect of this system (namely, the unusual spa-
tial structure of lesions) which had not been fully explained either in experimental accounts or
in previous models of this system. The research presented in this thesis has gone some way
towards meeting these aims, although the results have not always been entirely conclusive
(especially in the case of the inflammasome formation models); nonetheless, modelling of
inflammasome formation has highlighted areas of the existing conceptual models of this sys-
tem which require further experimental investigation, and modelling of Salmonella infection
at the tissue level has proposed one possible explanation for the spatial structure of lesions
(i.e., that these stable structures may form naturally due to the interplay of cell death and
phagocyte influx). Both research threads represent the first iteration in a cycle of modelling
and experimental work which are mutually beneficial; this cycle will hopefully continue into
the future, as well as forming part of a wider movement towards the use of more quantitative
approaches in the study of innate immunity.
12.2 Future directions for mathematical modelling in investigat-
ing innate immune response to Salmonella infection
Although the results presented in this thesis suggest some immediate avenues for further
research, which I have outlined in previous chapters, on a broader level there are a number
of key gaps in the existing literature on Salmonella infection. I will now discuss a number of
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areas which would particularly benefit from the use of mathematical modelling and compu-
tational techniques.
12.2.1 Mapping regulation of NLR activation
A recurring issue in creating quantitative models of inflammasome formation is that NLR
activation and oligomerisation is mediated by numerous other reactants which may control
PTMs or bind to inflammasome constituents to prevent further interactions. This is especially
an issue in the case of NLRP3 oligomerisation, which is regulated by a particularly complex
network of PTMs and chaperones.
Many of the existing studies in this area have focused on a specific element in NLR acti-
vation; for example, individual studies have considered the role of NEK7 in stabilising NLRP3
oligomers [He et al., 2016, Schmid-Burgk et al., 2016, Shi et al., 2016b], the role of COPs
and POPs in blocking CARD-CARD and PYD-PYD interactions respectively [Stehlik et al.,
2003a, Dorfleutner et al., 2007a, Dorfleutner et al., 2007b, Atianand and Harton, 2011], and
the role of numerous proteins in phosphorylation and other PTMs [Kelley et al., 2019, Swan-
son et al., 2019, Yang et al., 2019]. However, there is currently a lack of information regard-
ing how these regulatory processes interact, and together coordinate the oligomerisation of
NLRs. This issue was circumvented in the inflammasome models presented in this thesis,
by taking pre-established NLR oligomers as inputs for the model, and assuming NLR activa-
tion and oligomerisation takes place prior to the processes included in the model. However,
this temporal separation of NLR activation and oligomerisation is a major assumption which
should certainly be tested further in future models of inflammasome formation.
One possible approach to unifying the existing literature surrounding NLR activation
would be to draw on methodology developed in a systems biology context, and integrat-
ing results from the experimental literature to build a network model of regulatory processes
of NLR activation and oligomerisation. This approach is commonly used in other biological
fields (for example, in constructing gene regulatory networks). A network could be developed
with nodes corresponding to specific residues in NLRP3 which may be modified by PTMs,
individual proteins responsible for coordinating PTMs, stimuli, or PAMPs/DAMPs, and edges
corresponding to relationships between these which have been experimentally established
(for example, activation or inhibition). A simple binary network may be sufficient initially (with
edges being turned ‘on’ or ’off’ corresponding to different cellular conditions, and the re-
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sults integrated over the network to give an overall NLRP3 activation level). This network
could also form the basis of a large ODE model of interactions between residues in NLRP3,
inflammasome stimuli, and proteins responsible for PTMs, although this may require more
quantitative data for parametrisation to be possible.
Establishing such a network of control of NLR oligomerisation would be extremely useful
for understanding downstream effects on inflammasome formation, but this is also a key
part of the innate immune response to infection in its own right; clarifying the relationships
between the individual parts of the network which controls NLR oligomerisation may be
particularly relevant in understanding the pathology of conditions involving overactivation of
NLRs such as CAPS and MAS.
12.2.2 The inflammasome in a cell-wide context
The modelling of inflammasome formation presented here has mainly focused on the overall
abundances of inflammasome constituents over time. As for much of the existing literature
describing modelling of lesion formation, the focus has been mainly on the outcome of the
process based on different model parametrisations, and spatial structure has not been taken
into account. In particular, the final position of the inflammasome within the cell and interac-
tions with other organelles has not been considered. However, particularly in the case of the
NLRP3 inflammasome, correlations between the position of the inflammasome and other or-
ganelles (including Golgi, endoplasmic reticulum and mitochondra) have been noted [Zhou
et al., 2011, Misawa et al., 2013, Li et al., 2017], as well as MARK4-driven movement along
microtubules [Li et al., 2017]), although results from different studies have been contradic-
tory, and there is no cohesive narrative of subcellular locations of inflammasome constituents
throughout the inflammasome formation process. Furthermore, it has been shown that the
actin cytoskeleton is reconfigured upon infection of macrophages by Salmonella [Méresse
et al., 2001, Miao et al., 2003, Poh et al., 2008], and that the actin cytoskeleton is once more
reconfigured leading to cellular stiffening as a result of the NLRC4 inflammasome forma-
tion process [Man et al., 2014a]. One key question is therefore to what extent interactions
with the cytoskeleton (either actin, or microtubules in the case of NLRP3) may contribute
towards the formation of the inflammasome, and in particular, whether inflammasome con-
stituents might be actively directed towards a focal point by movement along actin filaments
or microtubules.
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One way to address this question would be to extend the full stochastic model presented
in Chapter 3 to include a spatial element. In particular, the cell could be represented as
a lattice, with individual inflammasome constituents (free ASC monomers, NLR oligomers,
and clusters) executing random walks on this lattice to simulate diffusion; the same reactions
and associated propensities could be used as in the stochastic model from Chapter 3, but
reactions would only be permitted to occur when reactants are in close spatial proximity. This
simulation could be run many times, possibly with different parametrisations. This simple
model with inflammasome formation occurring by diffusion only could be compared to a
more complex model, in which interactions with the cytoskeleton are included; this could
be as simple as a secondary lattice representing the cytoskeleton network overlaid on the
original lattice, which permits more direct movement towards a focal point. Characteristic
times similar to those described in this thesis (for example, time of single cluster emergence)
could then be derived for simulations of both models, and compared, to determine whether
diffusion alone is sufficient for inflammasome formation, or if more directed movement of
constituents is necessary.
It would also be possible to include other organelles in these simulations, although this
may lead to a considerable increase in complexity; ultimately, it may be useful to use an
existing software package developed to simulate within-cell reactions such as VCell [Schaff
et al., 1997, Cowan et al., 2012], since these have generally been optimised for efficiency.
12.2.3 A survey of lesion size and distribution in infected tissues
A key limitation in the lesions modelling presented previously is that there is currently a
lack of quantitative data describing the formation of lesions in various organs over time,
following Salmonella infection. Existing datasets tend to consist of average lesion counts
over a given area, measured from histological samples taken from livers of infected mice, in
which macrophages have been stained; the dataset presented in the previously mentioned
study carried out by Man et al. is a good example [Man et al., 2014a]. However, in order to
compare experimental data directly with the results of lesion modelling, it would be useful for
quantifying the size and density of distribution of lesions throughout the tissue. In particular,
the consistency of size of lesions over time, and between hosts, would be of interest. It
would also be useful to measure the extent to which lesions tend to fall into spatial clusters,
or spread out evenly across the tissue, and whether there is any particular colocalisation
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with the blood supply.
It would therefore be useful to establish a set of samples taken from mice infected with
Salmonella at a number of different timepoints throughout infection; as with the Man et al.
study, it would be especially useful to create a matching dataset for NLRC4 knockout mice,
which do not show a decrease in macrophage motility following infection. This would allow
us to establish more rigorously the effect of infected cell motility on lesion formation and
infection spread.
Naturally, to limit the total number of mice required, judicious experimental design is vital
here. The possibility of acquiring data at later times after infection may also be limited, as
the health of the mice deteriorates. However, specifically for investigation of plateau and
growth phases observed in the spatial PDE lesion formation presented in earlier chapters
of this dissertation, it would be particularly useful to take samples early in infection (around
3-5 days), at an intermediate point (7-10 days) and at a later time (approximately 2 weeks)
to establish how consistency in lesion size might vary between samples. Samples could be
taken from the liver, spleen and bloodstream at each timepoint, rather than just focusing on
one organ, which would be extremely useful for establishing results about lesion formation
beyond just the liver, and furthermore could be used to parametrise a multi-scale model, as
discussed below.
12.2.4 A multi-scale within-host model of Salmonella infection
Much of the modelling presented in this thesis has considered the problem of bridging spa-
tial and temporal scales; in particular, creating models of both inflammasome signalling and
lesion formation involved integrating results known about individual interactions between re-
actants to give a full picture of behaviour on a whole-cell or tissue level as appropriate.
However, so far I have only considered cell-level and tissue-level responses to infection sep-
arately. A natural next step would be to build a model which bridges these two scales, to give
a full picture of how inflammasome formation drives lesion formation and infection control on
a larger scale. It would even be possible to add an additional larger scale (i.e. interactions
between organs) to gain insight into infection clearance on a host-wide level.
There are two possible approaches which could be taken here. The first is to link the
spatial PDE model of lesion formation in its continuous form with a model of inflammasome
signalling. This could be as simple as introducing time-dependent terms to account for
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chemokine release from infected cells, decline in motility of infected cells, or death of infected
cells, based on output from the inflammasome model; for example, we could rewrite the
spatial PDE model of lesion formation as follows:
∂S
∂t
= DS∇2S −∇ · (χSS∇c)− βS
b
b+ b1/2





DI(0)∇2I −∇ · (χI(0)I∇c) + βS bb+b1/2 − (l(0) + a(0))I if τ = 0
DI(τ)∇2I −∇ · (χI(τ)I∇c)− (l(τ) + a(τ))I if τ > 0
∂I(x; τ, t)
∂τ
















Here, I = I(x; τ, t) where τ is the time since infection; x and t represent spatial position
and time as before. Motility of infected cells (diffusion rateDI and chemotaxis coefficient χI ),
death rates of infected cells (lysis rate l and apoptosis rate a), rate of chemokine production
(rc) and number of bacteria released during lysis N are all dependent on the time τ since
infection. We could determine the functions DI(τ), χI(τ), l(τ), a(τ) and rc(τ) using a model
of inflammasome formation and associated downstream processes; for example, we could
extend one of the inflammasome formation models presented in the earlier chapters of this
dissertation to include cytokine processing, and use this model to estimate the levels of
cytokine production over time to give rc(τ); N(τ) could be estimated building on the work of
Brown et al. [Brown et al., 2006]. The spatial PDE model of lesion formation as presented
in Chapter 8 does not take into account the time taken for different inflammasome-regulated
processes to take place, nor does it consider the fact that the levels of (for example) lysis,
apoptosis and chemokine production are not constant over time for each cell. We could use
this more sophisticated model to gain more insight into how the various downstream effects
of inflammasome formation affect infection on the tissue level over time.
An alternative approach would be to construct a cross-scale ABM of infection which could
span cell, tissue and whole-host scales. For example, for each cell in a spatial ABM of lesion
formation, motility, chemokine release and lysis could be controlled by an individual inflam-
masome model running within that cell, while other processes (such as diffusion) still take
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place on a tissue level only. The total levels of infection resulting from this model could even
be used as an input for a larger-scale ABM spanning different organs (for example, liver,
spleen and bloodstream, as in the model presented by Grant et al. [Grant et al., 2008a]).
This would give insight into how processes at the within-cell level control the outcomes of in-
fection at a whole-host level. Furthermore, provided that reliable parameter estimates could
be obtained, this would allow us to move from the explanatory modelling approach used
throughout this dissertation, with its focus on parsimony and providing broad explanations
for experimental observations, to a more specialised model less suitable for broadening sci-
entific understanding, but with more predictive power, which may be particularly useful for
simulating infection, inflammation and treatment in biomedical contexts.
The research presented in this thesis therefore has the potential to act as the basis for a
wealth of new directions in modelling innate immune response to infection; it is my hope that
this will be among many such studies in the years to come.
12.3 Conclusions
As laid out in Chapter 1, this research was guided by two very broad questions about the
nature of the innate immune response to infection: why does the inflammasome form? And
why do lesions form? This thesis goes some way towards answering these questions. In
particular, the first half of the thesis establishes one possible logically coherent account
of the early stages of inflammasome formation, and in particular, proposes challenges to
some existing popular views of inflammasome formation (for example, by suggesting the
need for branch-like reactions between proteins). The models presented also give possible
answers for some unanswered questions surrounding the inflammasome formation process
(for example, we have seen that variations between inflammasome formation times may be
caused by differences of abundance in NLR oligomers).
Meanwhile, the second half of this thesis proposes a mathematical structure within which
lesions may arise in tissues simply through the interactions of bacteria, phagocytes and
chemokines. Furthermore, the model presented demonstrates how upstream processes
such as cellular stiffening, and the balance of apoptotic and lytic cell death, can play impor-
tant roles in determining the nature of the structure of lesions.
Despite the encouraging progress presented in this thesis, the results presented are only
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the first step towards answering our questions about inflammasome formation and lesions.
In both cases, the mathematical and computational results presented here will need to be
verified through further experimental work. More broadly, however, it is my hope that the
research presented here will form a useful foundation for future iterations of the cycle of
modelling and experimentation. This interdisciplinary way of working will undoubtedly prove
valuable to further deepening our understanding of inflammasome and lesion formation, and
more broadly, the innate immune response to infection as a whole.
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Antón, J., Buján, S., Couillin, I., Brough, D., Arostegui, J. I., and Pelegrı́n, P. (2014). The
NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflam-
matory response. Nature immunology, 15(8):738–748.
[Bauernfeind et al., 2009] Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., Mac-
Donald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A.,
Hornung, V., and Latz, E. (2009). Cutting Edge: NF-κB Activating Pattern Recognition
and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3
Expression. The Journal of Immunology, 183(2):787–791.
[Bayani et al., 2020a] Bayani, A., Dunster, J., Crofts, J., and Nelson, M. (2020a). Mecha-
nisms and Points of Control in the Spread of Inflammation : A Mathematical Investigation.
Bulletin of Mathematical Biology, 82:45.
[Bayani et al., 2020b] Bayani, A., Dunster, J. L., Crofts, J. J., and Nelson, M. R. (2020b).
Spatial considerations in the resolution of inflammation : Elucidating leukocyte interac-
tions via an experimentally-calibrated agent-based model. PLoS Computational Biology,
16(11):e1008413.
280
[Beattie et al., 2016] Beattie, L., Sawtell, A., Mann, J., Frame, T. C., Teal, B., de Labastida
Rivera, F., Brown, N., Walwyn-Brown, K., Moore, J. W., MacDonald, S., Lim, E. K., Dalton,
J. E., Engwerda, C. R., MacDonald, K. P., and Kaye, P. M. (2016). Bone marrow-derived
and resident liver macrophages display unique transcriptomic signatures but similar bio-
logical functions. Journal of Hepatology, 65(4):758–768.
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murine Salmonella typhimurium infection. Microbial Pathogenesis, 8(2):135–141.
[Murakami et al., 2012] Murakami, T., Ockinger, J., Yu, J., Byles, V., McColl, A., Hofer, A. M.,
and Horng, T. (2012). Critical role for calcium mobilization in activation of the NLRP3
inflammasome. Proceedings of the National Academy of Sciences of the United States of
America, 109(28):11282–11287.
[Murray, 1993] Murray, J. (1993). Mathematical biology. II: Spatial models and biomedical
applications. Springer-Verlag, 3 edition.
[Murray and Hartley, 1935] Murray, R. C. and Hartley, G. S. (1935). Equilibrium between
micelles and simple ions, with particular reference to the solubility of long-chain salts.
Transactions of the Faraday Society, 31:183–189.
301
[Nagaraja et al., 2014] Nagaraja, S., Wallqvist, A., Reifman, J., and Mitrophanov, A. Y.
(2014). Computational Approach To Characterize Causative Factors and Molecular In-
dicators of Chronic Wound Inflammation. The Journal of Immunology, 192:1824–1834.
[Nambayan et al., 2019] Nambayan, R. J. T., Sandin, S. I., Quint, D. A., Satyadi, D. M., and
de Alba, E. (2019). The inflammasome adapter ASC assembles into filaments with integral
participation of its two Death Domains, PYD and CARD. Journal of Biological Chemistry,
294(2):439–452.
[Nauciel and Espinasse-Maes, 1991] Nauciel, C. and Espinasse-Maes, F. (1991). Role of
gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium
infection. Infection and Immunity, 60(2):450–454.
[Neuts, 1975] Neuts, M. F. (1975). Computational uses of the method of phases in the theory
of queues. Computers and Mathematics with Applications, 1(2):151–166.
[Nnalue et al., 1992] Nnalue, N. A., Shnyra, A., Hultenby, K., and Lindberg, A. A. (1992).
Salmonella choleraesuis and Salmonella typhimurium associated with liver cells after in-
travenous inoculation of rats are localized mainly in Kupffer cells and multiply intracellu-
larly. Infection and Immunity, 60(7):2758–2768.
[Noureddini and Timm, 1992] Noureddini, H. and Timm, D. C. (1992). Kinetic Analysis of
Competing Intramolecular and Intermolecular Polymerization Reactions. Macromolecules,
25(6):1725–1730.
[Nowak et al., 1998] Nowak, M. A., Krakauer, D. C., Klug, A., and May, R. M. (1998). Prion
infection dynamics. Integrative Biology, 1(1):3–15.
[Ojcius et al., 2019] Ojcius, D. M., Jafari, A., Yeruva, L., Schindler, C. W., and Abdul-Sater,
A. A. (2019). Dicer regulates activation of the NLRP3 inflammasome. PLoS ONE, 14(4):1–
9.
[Olesen et al., 2005] Olesen, P., Ferkinghoff-Borg, J., Jensen, M. H., and Mathiesen, J.
(2005). Diffusion, fragmentation, and coagulation processes: Analytical and numerical
results. Physical Review E - Statistical, Nonlinear, and Soft Matter Physics, 72(3):031103.
[Oosawa and Kasai, 1962] Oosawa, F. and Kasai, M. (1962). A theory of linear and helical
aggregations of macromolecules. Journal of Molecular Biology, 4(1):10–21.
302
[Oroz et al., 2016] Oroz, J., Barrera-Vilarmau, S., Alfonso, C., Rivas, G., and de Alba, E.
(2016). Asc Pyrin Domain Self-Associates and Binds Nlrp3 Using Equivalent Binding
Interfaces. Journal of Biological Chemistry, 291(37):jbc.M116.741082.
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